Sogen Data · Datasets · 数据专题
心肌病数据集锦
单细胞 · bulk 转录组
本专题承自 Sogen Data 数据整理体系,逐条人工复核,附研究设计、样本量、平台与 GEO/PubMed 直达链接。
人源单细胞
Human · Single-cell
-
01 GSE145154 对人类正常心脏和心力衰竭心脏的单细胞RNA测序,分离心肌组织中的CD45-细胞与外周血中的CD45+免疫细胞,同时采集左心室非梗死、梗死及心力衰竭样本,部分ACKR1+内皮细胞经CXCL8蛋白刺激后进行转录组检测,采用3'和5'scRNA-seq技术,比较不同组织状态及刺激条件下的细胞转录特征差异。
设计对人类正常心脏和心力衰竭心脏的单细胞RNA测序,分离心肌组织中的CD45-细胞与外周血中的CD45+免疫细胞,同时采集左心室非梗死、梗死及心力衰竭样本,部分ACKR1+内皮细胞经CXCL8蛋白刺激后进行转录组检测,采用3'和5'scRNA-seq技术,比较不同组织状态及刺激条件下的细胞转录特征差异。
摘要we performed single cell RNA sequencing (scRNA-seq) in both normal and failed human heart. CD45- cells in the myocardium and immune cells (CD45+ cells) were isolated from myocardium and corresponding peripheral blood were sorted for scRNA-seq. Our findings were also validated with bulk RNAseq.
-
02 GSE183852 对45例人类左心室心尖透壁组织样本进行单细胞和单核RNA测序,其中单细胞样本n=7(2例供体,5例扩张型心肌病患者),单核样本n=38(25例供体,13例扩张型心肌病患者)。单细胞样本经新鲜酶解处理,单核样本冷冻保存于液氮后存于-80℃,机械匀浆获取。通过整合分析两种测序数据,比较健康与扩张型心肌病状态下的细胞组成及转录特征。
设计对45例人类左心室心尖透壁组织样本进行单细胞和单核RNA测序,其中单细胞样本n=7(2例供体,5例扩张型心肌病患者),单核样本n=38(25例供体,13例扩张型心肌病患者)。单细胞样本经新鲜酶解处理,单核样本冷冻保存于液氮后存于-80℃,机械匀浆获取。通过整合分析两种测序数据,比较健康与扩张型心肌病状态下的细胞组成及转录特征。
摘要Heart failure represents a major cause of morbidity and mortality worldwide. Single cell transcriptomics have revolutionized our understanding of cell composition and associated gene expression across human tissues. Through integrated analysis of single cell and single nucleus RNA sequencing data generated from 45 individuals, we define the cell composition of the healthy and failing human heart. We identify cell specific transcriptional signatures of heart failure and reveal the emergence of disease associated cell states. Intriguingly, cardiomyocytes converge towards a common disease associated cell state, while fibroblasts and myeloid cells undergo dramatic diversification. Endothelial cells and pericytes display global transcriptional shifts without changes in cell complexity. Collectively, our findings provide a comprehensive analysis of the cellular and transcriptomic landscape of human heart failure, identify cell type specific transcriptional programs and states associated with disease, and establish a valuable resource for the investigation of human heart failure.
-
03 GSE292067 对人类左心室心肌组织进行单核RNA测序,比较doxorubicin心肌病(DoxCM)患者与非缺血性心肌病(NICM)患者及非失败供体的转录特征。
设计对人类左心室心肌组织进行单核RNA测序,比较doxorubicin心肌病(DoxCM)患者与非缺血性心肌病(NICM)患者及非失败供体的转录特征。
摘要Doxorubicin cardiomyopathy (DoxCM) remains a significant clinical problem, yet its underlying mechanisms remain incompletely understood. Identifying DoxCM mechanisms that can be translated into therapeutic interventions may improve patient outcomes. We performed single nuclear RNA-sequencing on left ventricular (LV) myocardial tissue from patients with DoxCM versus non-ischemic cardiomyopathy and non-failing donors. This approach aimed to elucidate the transcriptional changes associated with DoxCM. Additionally, we conducted immunostaining, flow cytometry, antibody neutralization, and cell depletion studies to validate our findings and define in vivo mechanisms.Compared to both donors and non-ischemic cardiomyopathy, LV myocardium from DoxCM patients exhibited increased periostin-positive (POSTN+) activated fibroblasts, down-regulation of genes involved in phagocytosis, and increased expression of the anti-phagocytic molecule CD47. Immunostaining of human cardiac sections and murine studies demonstrated increased POSTN+ cells and CD47 in DoxCM and in a murine breast cancer model. CD47 antibody neutralization both prevented and treated Dox-induced reduction in LV ejection fraction and fibrosis. Mechanistically, depletion of resident cardiac macrophages blocked the cardioprotective effects of CD47 neutralization and clearance of cardiac fibroblasts. Our data support CD47 as a disease-specific target and promising therapeutic approach for mitigating cardiac dysfunction in DoxCM
-
04 GSE326014 对人类右心室组织样本进行单核 RNA 测序,比较 arrhythmogenic right ventricular cardiomyopathy (ARVC) 患者与非进展性对照组的转录特征。
设计对人类右心室组织样本进行单核 RNA 测序,比较 arrhythmogenic right ventricular cardiomyopathy (ARVC) 患者与非进展性对照组的转录特征。
摘要Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic form of heart disease often caused by mutations in desmosomal proteins. We carried out single-nucleus RNA sequencing (snRNA-seq) on 11 non-failing and 8 ARVC patient right ventricular samples and transcriptionally profiled 139,347 nuclei. We identified over 4,400 differentially expressed protein coding genes between non-failing and ARVC samples across cell types. When compared to dilated, hypertrophic and ischemic cardiomyopathy, we found that end stage ARVC is transcriptionally similar to other forms of end stage heart failure. Despite broad transcriptional similarities, we identified seven cardiomyocyte genes and six fibroblast genes that were uniquely dysregulated in ARVC and validated PLXNA4 as a gene with uniquely increased expression in cardiomyocytes in ARVC compared to other cardiomyopathies. Overexpression of PLXNA4 in hiPSC-derived ventricular cardiomyocytes induced immune response gene expression, suppressed calcium signaling, and altered cardiomyocyte electrophysiology, suggesting PLXNA4 may contribute to these pathways in ARVC.
-
05 GSE298023 对非心衰供体及扩张型心衰(DCM)、缺血型心衰非瘢痕(ICM non-scar)和缺血型心衰瘢痕(ICM-scar)患者的人类心脏左心室组织进行单核RNA测序,比较不同心衰类型与非心衰样本间纤维母细胞的转录状态差异。样本按批次处理,包含4个非心衰、5个DCM、5个ICM non-scar及5个ICM-scar共18个GSM记录,采用10x技术分批测序。
设计对非心衰供体及扩张型心衰(DCM)、缺血型心衰非瘢痕(ICM non-scar)和缺血型心衰瘢痕(ICM-scar)患者的人类心脏左心室组织进行单核RNA测序,比较不同心衰类型与非心衰样本间纤维母细胞的转录状态差异。样本按批次处理,包含4个非心衰、5个DCM、5个ICM non-scar及5个ICM-scar共18个GSM记录,采用10x技术分批测序。
摘要Cardiac fibrosis is a major contributor to heart failure (HF), yet its therapeutic targeting remains limited due to the complexity of fibrosis types and distributions. This study investigates fibroblast heterogeneity and spatial organization in the left ventricle of human hearts from non-failing donors and HF patients with ischemic or dilated cardiomyopathy. Using single-nucleus RNA sequencing and spatial transcriptomics, distinct fibroblast subpopulations were identified, with resident fibroblasts being depleted in HF and replaced by disease-associated states. Differences in activation ligands, transcriptional trajectories, and spatial localization revealed divergent fibroblast transitions between scar and interstitial fibrosis, and between HF subtypes. These results provide insight into fibroblast dynamics and offer potential targets to modulate fibrosis in heart failure.
-
06 GSE138262 对hypertrophic cardiomyopathy患者的左心室心肌组织进行单细胞RNA测序,分析心肌细胞基因表达亚群,比较不同亚群间的基因表达差异。
设计对hypertrophic cardiomyopathy患者的左心室心肌组织进行单细胞RNA测序,分析心肌细胞基因表达亚群,比较不同亚群间的基因表达差异。
摘要Background – Hypertrophic cardiomyopathy (HCM) is a common genetic cardiac disorder that is characterized by the presence of left ventricular hypertrophy with histological evidence of myocyte disarray and fibrosis. Pathologic DNA variants in sarcomeric genes are seen in 50–60% of families, but the mechanistic origins of hypertrophy and disarray remain poorly understood. More molecular insights could contribute to a better understanding of these origins and improve therapeutic strategies for HCM. Methods – To identify gene expression patterns relevant to HCM pathology, we quantified intercellular heterogeneity in cardiomyocyte gene expression by performing single-cell RNA sequencing (scRNA-seq) on myectomy tissue from HCM patients. Results – Septal myectomy samples provide a unique opportunity to access diseased human heart tissue for scRNA-seq. We analysed gene expression of individual cardiomyocytes for three HCM patients, who each showed a similar presence of cardiomyocyte subpopulations. This similarity indicated these subpopulations emerge from biological processes, and not from experimental variability. Moreover, our data revealed functional links between genes important to HCM. A subpopulation characterized by elevated titin (TTN) expression showed increased expression of genes involved in muscle contraction and development. A subpopulation of Natriuretic Peptide A (NPPA)-enriched cells showed elevated expression of Natriuretic Peptide B (NPPB). Further analysis of gene co-expression revealed five groups of genes with tightly correlated expression (regulons), one consisting of mostly sarcomeric genes and another containing some well-known stress markers. These correlations were confirmed in 97 additional HCM myectomy samples and allowed us to de novo identify transcription factors related to sarcomeric gene expression and stress. Finally, using forward scatter, we charted functional implications of regulon expression and showed a link between the stress-marker regulon and cell size. Histology samples independently confirmed that regulon member skeletal alpha actin (ACTA1) correlates with cell size. Conclusion – We have shown that single-cell sequencing on myectomy samples from HCM patients identified new functional links between genes, transcription factors, and a functional link between genes and cell size. This highlights the relevance of cardiomyocyte heterogeneity, and additionally provides a wealth of novel insights into molecular events at the base of HCM, which potentially contribute to understanding disease progression.
-
07 GSE270258 将 16 例终末期扩张型心肌病 (DCM) 患者的心脏组织样本分为 4 组:ACR 组 (上午采样 6 am-10 am 和下午采样 2 pm-6 pm 各 4 例) 与 NCR 组 (上午采样 6 am-10 am 和下午采样 2 pm-6 pm 各 4 例),基于主动脉夹闭时间定义采样时段。采用单核 RNA 测序分析转录特征,比较 ACR 与 NCR 组在不同采样时段的基因表达差异。
设计将 16 例终末期扩张型心肌病 (DCM) 患者的心脏组织样本分为 4 组:ACR 组 (上午采样 6 am-10 am 和下午采样 2 pm-6 pm 各 4 例) 与 NCR 组 (上午采样 6 am-10 am 和下午采样 2 pm-6 pm 各 4 例),基于主动脉夹闭时间定义采样时段。采用单核 RNA 测序分析转录特征,比较 ACR 与 NCR 组在不同采样时段的基因表达差异。
摘要Dilated cardiomyopathy (DCM) has etiological and pathophysiological heterogeneity. Abnormal circadian rhythm (ACR) is related to the development of DCM in animal models, but exploration based on clinical samples is lacking. Sleep apnea (SA) is the most common disease related to ACR, and we chose SA as the study object to explore ACR-DCM. We included a DCM cohort and divided it into SA (n=76) and without SA group (n=29). RT-qPCR was used to determine the change of rhythm gene expression pattern. We used single-nucleus RNA sequencing (snRNA-seq) to explore the abnormal transcriptional patterns in the ACR group, and we verified the findings by pathological staining, atomic force microscopy (AFM), and Rev-erbα/β knockout (KO) mice analysis. DCM patients with SA showed decreased amplitude of rhythm gene expression. SA group showed more severe dilation of left heart chambers. From snRNA-seq, ACR-DCM lost the morning transcriptional patterns, detailly, actin cytoskeleton organization of cardiomyocytes (CMs) disrupted and hypertrophy aggravated, and the proportion of activated fibroblasts (Fibs) decreased with the reduction of fibrotic area ratio. The results of pathological staining, mechanical experiments, and transcriptional feature of Rev-erbα/β KO mice supported the above findings. The severe dilation of the left ventricular (LV) wall in DCM patients with SA was associated with a decrease in structural strength, and phenotypic changes of CMs and Fibs were involved in this process. ACR-DCM was histopathologically characterized by a fluffy ventricular wall.
-
08 GSE285315 对接受左心室辅助装置(LVAD)植入的儿童扩张型心肌病(DCM)患者左心室心肌组织进行单细胞RNA测序和染色质可及性分析,将患者分为左心室功能恢复组(R)和未恢复组(NR),分别定义为成功移除LVAD并维持药物治疗稳定状态或需移植/死亡。采用单核RNA测序(snRNA)和ATAC-seq技术检测六例亚病例(每组三例),通过组织学及血清学检测验证候选基因与通路。比较两组心肌细胞中NPPB、MYL7、PCDH9等基因表达及染色质可及性差异,分析凋亡相关通路变化。
设计对接受左心室辅助装置(LVAD)植入的儿童扩张型心肌病(DCM)患者左心室心肌组织进行单细胞RNA测序和染色质可及性分析,将患者分为左心室功能恢复组(R)和未恢复组(NR),分别定义为成功移除LVAD并维持药物治疗稳定状态或需移植/死亡。采用单核RNA测序(snRNA)和ATAC-seq技术检测六例亚病例(每组三例),通过组织学及血清学检测验证候选基因与通路。比较两组心肌细胞中NPPB、MYL7、PCDH9等基因表达及染色质可及性差异,分析凋亡相关通路变化。
摘要This study investigated factors associated with left ventricular (LV) recovery in pediatric dilated cardiomyopathy (DCM) following left ventricular assist device (LVAD) implantation, using single-cell multiomics analysis. Twenty-five pediatric DCM patients who underwent bridge-to-transplant LVAD (BTT-LVAD) implantation at our institution were categorized as either recovery (R) cases, defined by successful LVAD explantation with sustained stability on medical therapy, or non-recovery (NR) cases, defined by the need for transplantation or death. Single-nucleus RNA (snRNA) sequencing and chromatin accessibility analyses were conducted on six subcases (three from each group). Candidate genes and pathways identified were further validated through histological and serological assessments in all cases. Pseudobulk analysis revealed higher expression of NPPB, MYL7, and PCDH9 in cardiomyocytes from the R group, with NPPB exhibiting the highest baseline expression and corresponding changes in chromatin accessibility. Gene Ontology analysis highlighted pathways regulating apoptosis. Serum BNP, a protein product of NPPB, was significantly elevated in the R group at the time of LVAD implantation and correlated with a higher proportion of non-apoptotic cells.
-
09 GSE185100 对人类胎儿(19-20周,n=3)、非疾病(4-14年,n=3)及早期发病DCM(5-10年,n=4)左心室心肌组织进行单核RNA测序,分析各组间细胞组成及转录特征差异。将胎儿、非疾病和DCM样本的左心室心肌组织分别提取单核,按年龄分组处理,采用10x Chromium单核核糖核酸测序技术检测,比较不同发育阶段与疾病状态下的细胞转录组变化。
设计对人类胎儿(19-20周,n=3)、非疾病(4-14年,n=3)及早期发病DCM(5-10年,n=4)左心室心肌组织进行单核RNA测序,分析各组间细胞组成及转录特征差异。将胎儿、非疾病和DCM样本的左心室心肌组织分别提取单核,按年龄分组处理,采用10x Chromium单核核糖核酸测序技术检测,比较不同发育阶段与疾病状态下的细胞转录组变化。
摘要It is hypothesized that the postnatal heart adopts a fetal-like transcriptional state in response to cardiac stress. Here, we analyse the transcriptome of 74,451 nuclei from fetal, non-diseased and early-onset DCM samples, which revealed 7 broad cell clusters across fetal, ND and DCM samples. We find that there are no statistically significant shifts in cellular composition between DCM and ND hearts. Also, pseudo-bulk profiling revealed that transcriptional pathways perturbed in DCM are predominantly associated with cardiomyocytes, fibroblasts and immune cells. We advance the hypothesis that only a small subset (<10%) of fetal genes is re-engaged in both cardiomyocyte and cardiac fibroblast of DCM. This study provides a framework to identify critical gene expression networks that underpin disease pathogenesis independent of genetic aetiology.
-
10 GSE121893 研究对象为人类心脏组织,材料包括冠状动脉粥样硬化性心脏病(C1、C2)、扩张型心肌病(D1、D2、D5、D4)及正常样本(N13、N14)。通过单细胞测序技术,提取左心房和左心室混合样本中的细胞,分选不同细胞类型(内皮细胞、平滑肌细胞等)。采用不同消化酶处理以富集心肌细胞或非心肌细胞,生成细胞间相互作用网络,并比较不同疾病状态下细胞组成及相互作用的变化。
设计研究对象为人类心脏组织,材料包括冠状动脉粥样硬化性心脏病(C1、C2)、扩张型心肌病(D1、D2、D5、D4)及正常样本(N13、N14)。通过单细胞测序技术,提取左心房和左心室混合样本中的细胞,分选不同细胞类型(内皮细胞、平滑肌细胞等)。采用不同消化酶处理以富集心肌细胞或非心肌细胞,生成细胞间相互作用网络,并比较不同疾病状态下细胞组成及相互作用的变化。
摘要We studied the cell compositon of two types of human heart disease (coronary atherosclerotic heart disease and dilated cardiomyopathy) by single-cell sequencing. Distinct subgroups of cardiac muscle, fibroblast cell and endothelial cell were detected. We generated a cell-cell interaction network using specific expressed ligands and receptors of cells. And we also observed the change of interaction and cell transformation with age.
-
11 GSE302337 对人类心力衰竭患者和心脏功能正常对照组的左心室心肌组织进行单核RNA测序,比较两组心脏成纤维细胞的转录特征。样本来自四名接受左心室辅助装置植入的心力衰竭患者和两名心脏功能正常但进行尸检的患者,共6个样本。每个样本制备5000个核,使用Chromium Controller进行单核RNA测序,检测方式为RNA-Seq,以分析心脏成纤维细胞的基因表达差异。
设计对人类心力衰竭患者和心脏功能正常对照组的左心室心肌组织进行单核RNA测序,比较两组心脏成纤维细胞的转录特征。样本来自四名接受左心室辅助装置植入的心力衰竭患者和两名心脏功能正常但进行尸检的患者,共6个样本。每个样本制备5000个核,使用Chromium Controller进行单核RNA测序,检测方式为RNA-Seq,以分析心脏成纤维细胞的基因表达差异。
摘要Heart failure (HF) is a major global problem with increasing numbers of patients and deaths in many countries. Existing studies on HF have focused primarily on cardiomyocytes, with few studies targeting non-cardiomyocytes. This study focused on cardiac fibroblasts (CFs) as a cause of HF. Single-cell RNA sequencing of mouse hearts revealed six distinct subclusters of CFs at various stages after pressure overload, with one subcluster being specific to the HF stage. The transcription factor c-Myc is specifically expressed in HF-specific CFs. CFs-specific deletion of c-Myc ameliorates pressure overload-induced cardiac dysfunction without affecting fibrosis. The chemokine Cxcl1 is highly expressed in HF-specific CFs and downregulated in CFs-specific c-Myc knockout mice. Chromatin immunoprecipitation analysis revealed that c-Myc binds to the promoter region of Cxcl1 in CFs. Cxcr2, the receptor for Cxcl1, is expressed in cardiomyocytes, and blockade of the Cxcl1-Cxcr2 signalling pathway prevents pressure overload-induced cardiac dysfunction. The addition of CXCL1 reduces the contractility of cardiomyocytes of neonatal rats and human iPS-derived cardiomyocyte organoids. Human CFs from failing hearts expressed c-MYC and CXCL1, while CFs from control hearts did not. These findings suggest that HF-specific CFs play an important role in inducing HF by upregulating c-Myc and Cxcl1 and that CFs could be a novel therapeutic target for HF.
-
12 GSE316567 对人类左心室组织样本进行单核 RNA 测序,比较健康供体与非缺血性心肌病患者样本的转录组特征。使用 10x Genomics Chromium 3′ v4、Chromium 5′ v3 和 Takara Bio ICELL8 cx 平台分别制备文库,检测核捕获效率、文库复杂度、转录灵敏度、RNA 类型覆盖及细胞类型分辨率,所有样本均通过流式细胞分选 DRAQ5+ 核并调整至 1,000 核/μl 浓度后进行测序。
设计对人类左心室组织样本进行单核 RNA 测序,比较健康供体与非缺血性心肌病患者样本的转录组特征。使用 10x Genomics Chromium 3′ v4、Chromium 5′ v3 和 Takara Bio ICELL8 cx 平台分别制备文库,检测核捕获效率、文库复杂度、转录灵敏度、RNA 类型覆盖及细胞类型分辨率,所有样本均通过流式细胞分选 DRAQ5+ 核并调整至 1,000 核/μl 浓度后进行测序。
摘要Single-nucleus RNA sequencing (snRNA-seq) enables transcriptomic profiling of complex tissues such as the heart, where dissociation into intact single cells is challenging. Among commercially available snRNA-seq platforms, 10x Genomics Chromium and Takara Bio’s ICELL8 cx represent technically distinct approaches, yet systematic comparisons in cardiac tissue are limited. Here, we benchmarked the 3′ Chromium, 5′ Chromium, and ICELL8 cx platforms using nuclei isolated from mouse and human heart tissues, including healthy donors and patients with non-ischemic cardiomyopathy. We assessed nuclei capture efficiency, library complexity, transcript detection sensitivity, RNA biotype coverage, ambient RNA contamination, and cell-type resolution. The Chromium platforms achieved higher nuclear throughput with robust capture efficiency and low ambient RNA contamination, whereas ICELL8 cx provided deeper transcriptomic coverage per nucleus, detecting a broader range of RNA biotypes, including low-abundance non-coding RNAs, albeit with lower nuclei yield. All platforms consistently resolved major cardiac cell populations. Together, these results inform selection of snRNA-seq workflows for cardiac tissue studies, highlighting trade-offs between cellular throughput and transcriptomic depth.
人源bulk 转录组
Human · Bulk RNA-seq
-
01 GSE5406 采集进行性缺血性或特发性心肌病患者心脏移植时的左心室心肌组织及未使用供体心脏的LV组织,采用液氮冷冻保存并提取总RNA,通过微阵列技术检测基因表达,比较疾病组与非失败对照组的转录组差异。
设计采集进行性缺血性或特发性心肌病患者心脏移植时的左心室心肌组织及未使用供体心脏的LV组织,采用液氮冷冻保存并提取总RNA,通过微阵列技术检测基因表达,比较疾病组与非失败对照组的转录组差异。
摘要Left ventricular myocardium was snap-frozen at time of cardiac transplantation from patients with advanced idiopathic or ischemic cardiomyopathy, or at time of harvest from unused donor heart that serve as a nonfailing control. No subjects received mechanical support devices. Keywords: disease state analysis (case:control)
-
02 GSE191083 对人类心脏和血液组织样本进行转录组与甲基化组联合分析,包含非慢性恰加斯病对照组、扩张型心肌病组和慢性恰加斯病心肌病组。心脏组织采用RLT裂解液提取总RNA,血液样本使用QIAamp DNA Blood Max Kit提取基因组DNA,经bisulfite转化后进行甲基化检测。所有样本通过RNA-Seq和Infinium Human Methylation EPIC Bead Chip平台分析,比较不同疾病状态下基因表达与甲基化特征差异。
设计对人类心脏和血液组织样本进行转录组与甲基化组联合分析,包含非慢性恰加斯病对照组、扩张型心肌病组和慢性恰加斯病心肌病组。心脏组织采用RLT裂解液提取总RNA,血液样本使用QIAamp DNA Blood Max Kit提取基因组DNA,经bisulfite转化后进行甲基化检测。所有样本通过RNA-Seq和Infinium Human Methylation EPIC Bead Chip平台分析,比较不同疾病状态下基因表达与甲基化特征差异。
摘要This SuperSeries is composed of the SubSeries listed below.
-
03 GSE165303 对人类非心力衰竭和心力衰竭(DCM)心肌组织以及人类诱导多能干细胞(iPSC)来源的心肌细胞进行 HiChIP、Hi-C、ATAC-seq、RNA-seq 和 ChIP-seq 测定,比较非心力衰竭与心力衰竭心肌组织的三维染色质结构、染色质可及性、转录因子 HAND1 的结合情况及基因表达差异,并分析 HAND1 过表达对 iPSC 来源心肌细胞表型的影响。
设计对人类非心力衰竭和心力衰竭(DCM)心肌组织以及人类诱导多能干细胞(iPSC)来源的心肌细胞进行 HiChIP、Hi-C、ATAC-seq、RNA-seq 和 ChIP-seq 测定,比较非心力衰竭与心力衰竭心肌组织的三维染色质结构、染色质可及性、转录因子 HAND1 的结合情况及基因表达差异,并分析 HAND1 过表达对 iPSC 来源心肌细胞表型的影响。
摘要Here we generated the first reference 3D chromatin contact maps from 101 biobanked human heart tissue samples through HiChIP (H3K27ac), in situ Hi-C, ChIP-seq, ATAC-seq and RNA-seq profiling. We discovered that the active regulatory elements and their connectome were extensively reprogrammed in DCM and contributed to transcription dysregulation implicated for DCM development. Higher-order chromatin structures indicated that the overall genome architecture was largely invariant in DCM and chromatin accessibility did not alter DCM-specific H3K27ac loops. This provided insight to the mechanistic hierarchies between higher-order chromatin structures, cis-regulatory elements and differential chromatin accessibilities in DCM, suggesting the importance of sequence-specific transcription factors. Intriguingly, we uncovered that the DCM-specific H3K27ac loops anchors exhibited a strong enrichment for Heart And Neural Crest Derivatives Expressed 1 (HAND1), a key transcription factor involved in early cardiogenesis. In line with this, its protein expression was upregulated in human DCM hearts and mouse failing hearts. Functional analyses by ectopic overexpression of HAND1 in human iPSC-derived cardiomyocytes induced cell hypertrophy and abnormal electrophysiology. Moreover, cardiomyocyte-specific overexpression of HAND1 in the mouse heart resulted in cardiomyocyte enlargement, increased heart weight/body weight ratio and dilated left ventricle. Echocardiography showed that cardiomyocyte-specific Hand1 overexpression in the mouse heart led to cardiac dysfunction and remodeling. Thus, aberrant activation of HAND1 in adult cardiomyocytes recapitulated the phenotypes observed in human DCM and indicated the involvement of a partial reactivation of a developmentally earlier cell identity program in the disease.
-
04 GSE36961 对肥厚型心肌病患者和对照捐赠者的手术切除心脏组织进行转录组分析,比较两组的基因表达差异。
设计对肥厚型心肌病患者和对照捐赠者的手术切除心脏组织进行转录组分析,比较两组的基因表达差异。
摘要Using a high-throughput gene expression profiling technology, we have been able to develop new hypotheses regarding the molecular pathogenic mechanisms of human hypertrophic cardiomyopathy (HCM). It is hoped that these hypotheses, among others generated by this data, will fuel future research endeavors that will uncover novel biomarkers, prognostic indicators, and therapeutic targets to improve our ability to diagnose, counsel, and treat patients with this highly heterogeneous and potentially life-threatening condition.
-
05 GSE19303 对扩张型心肌病(DCM)患者在免疫吸附联合免疫球蛋白替代治疗前后的左心室射血分数(LVEF)和左心室舒张末径(LVDD)进行检测,采集心内膜活检样本进行基因表达和蛋白质组分析,比较治疗应答者与非应答者在分子水平上的差异。
设计对扩张型心肌病(DCM)患者在免疫吸附联合免疫球蛋白替代治疗前后的左心室射血分数(LVEF)和左心室舒张末径(LVDD)进行检测,采集心内膜活检样本进行基因表达和蛋白质组分析,比较治疗应答者与非应答者在分子水平上的差异。
摘要Immunoadsorption with subsequent immunoglobulin substitution (IA/IgG) represents a therapeutic approach for patients with dilated cardiomyopathy (DCM). Here, we studied which molecular cardiac alterations are initiated after this treatment. Transcription profiling of endomyocardial biopsies with Affymetrix whole genome arrays was performed on 33 paired samples of DCM patients collected before and six months after IA/IgG. Therapy-related effects on myocardial protein levels were analysed by label free proteome profiling for a subset of 23 DCM patients. Data were analysed regarding therapy-associated differences in gene expression and protein levels by comparing responders (defined by improvement of left ventricular ejection fraction ≥ 20% relative and ≥5% absolute) and non-responders. Responders to IA/IgG showed a decrease in serum N-terminal proBNP levels in comparison to baseline which was accompanied by a decreased expression of heart failure markers such as angiotensin converting enzyme 2 or periostin. However, despite clinical improvement even in responders IA/IgG did not trigger general inversion of DCM associated molecular alterations in myocardial tissue. Transcriptome profiling revealed reduced gene expression for connective tissue growth factor, fibronectin, and collagen type I in responders. In contrast, in non-responders after IA/IgG, for fibrosis associated genes and proteins showed elevated levels whereas values were reduced or maintained in responders. Thus, improvement of LV function after IA/IgG seems to be related to a reduced gene expression of heart failure markers and pro-fibrotic molecules as well as reduced fibrosis progression.
-
06 GSE46224 对人类左心室心尖组织进行RNA-Seq和miRNA-Seq测序,比较非心肌病(NF)、缺血性心肌病(ICM)、非缺血性心肌病(NICM)及接受LVAD治疗的ICM+LVAD、NICM+LVAD组的转录组差异。样本经RNAlater保存后提取总RNA,采用poly-A选择和大小分选策略构建文库,检测对象包含非编码RNA及小RNA。
-
07 GSE116250 对64例人类左心室组织样本进行polyA富集的RNA-seq,样本分为非心衰供体(14例)、扩张型心肌病(37例)和缺血型心肌病(13例)。非心衰样本来自无法移植的器官捐献者,心衰样本来自心脏移植患者。检测基因表达差异,比较各疾病组与非心衰对照组的转录特征。
-
08 GSE245825 对58例扩张型心肌病(DCM)患者的右心室间隔组织进行RNA测序,与12例非心功能衰竭的左心室组织样本进行转录组比较。所有DCM样本均来自GSE245825数据集,对照组数据源自GSE11625公开数据集。
设计对58例扩张型心肌病(DCM)患者的右心室间隔组织进行RNA测序,与12例非心功能衰竭的左心室组织样本进行转录组比较。所有DCM样本均来自GSE245825数据集,对照组数据源自GSE11625公开数据集。
摘要Dilated cardiomyopathy (DCM) represents a leading cause of heart failure among younger adults. Despite endomyocardial biopsy (EMB) transcriptome enriching our understanding of DCM, the link between its gene expression and phenotype remains unclear. RNA-seq analysis of 58 DCM samples and 12 publicly available control samples unveiled about 25,000 transcripts. A principal component analysis highlighted a distinct DCM-control separation. WGCNA revealed four transcriptome modules strongly associated with DCM. The purple module, which is the DCM-related module, was enriched with fibrosis-related genes and showed FSTL3 as a pivotal DCM-associated gene.
-
09 GSE120895 对47例扩张型心肌病(DCM)患者(左室射血分数LVEF<45%且符合纽约心脏协会II-III级标准)和8例正常LVEF个体的人类心内膜活检样本进行基因表达分析,比较两组间基因表达模式与心脏形态参数(左室舒张末直径指数LVEDDI)、射血分数(LVEF)及血清心肽激素N末端脑钠肽前体(NT-proBNP)水平的相关性。
设计对47例扩张型心肌病(DCM)患者(左室射血分数LVEF<45%且符合纽约心脏协会II-III级标准)和8例正常LVEF个体的人类心内膜活检样本进行基因表达分析,比较两组间基因表达模式与心脏形态参数(左室舒张末直径指数LVEDDI)、射血分数(LVEF)及血清心肽激素N末端脑钠肽前体(NT-proBNP)水平的相关性。
摘要To gain new insights into the complex pathophysiology of dilated cardiomyopathy (DCM) we performed a quantitative approach to identify genes with expression patterns that linearly correlate with parameters of cardiac morphology (left ventricular end-diastolic diameter indexed by body surface are (LVEDDI), systolic function (LV ejection fraction (LVEF)), and serum levels of cardiac peptide hormone N-terminal pro-brain natriuretic peptide (NT-proBNP) in human endomyocardial biopsies of 47 DCM patients and 8 individuals with normal LVEF. A set of genes was identified as common heart failure markers characterized by correlation of their expression with cardiac morphology, systolic function and NT-proBNP. Among them are already known genes encoding e.g. the natriuretic peptide hormones NPPA and NPPB and its converting enzyme corin, but also potential new HF markers like EP300 antisense RNA1 and dimethylarginine dimethylaminohydrolase 1 (DDAH1) along with other genes with so far unknown relation to heart function. In contrast, the expression of other genes including the Ca2+ flux regulating genes phospholamban (PLN), sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA), and extracellular matrix proteins showed significant correlation with LVEF and LVEDDI only. Those genes seem to reflect more specifically pathological alterations of systolic function and morphology in DCM hearts.
-
10 GSE2656 对不同病因的心力衰竭(HF)患者左心室(LV)与非疾病供体左心室进行基因表达比较,采用心血管特异性基因芯片(CardioChip)检测,采集样本经液氮研磨后提取总RNA,使用Agilent 2100 Bioanalyzer检测RNA纯度与完整性,以人类通用参考RNA为基准归一化数据,通过GeneSpring 6.1软件进行荧光强度量化分析,识别各HF组与供体组间差异表达基因并执行层次聚类分析。
设计对不同病因的心力衰竭(HF)患者左心室(LV)与非疾病供体左心室进行基因表达比较,采用心血管特异性基因芯片(CardioChip)检测,采集样本经液氮研磨后提取总RNA,使用Agilent 2100 Bioanalyzer检测RNA纯度与完整性,以人类通用参考RNA为基准归一化数据,通过GeneSpring 6.1软件进行荧光强度量化分析,识别各HF组与供体组间差异表达基因并执行层次聚类分析。
摘要The goal of this experiment was to identify gene expression changes that are common in different heart failure (HF) types or specific to an etiology of HF. HF groups studied include doxorubicin induced cardiomyopathy, familial dilated cardiomyopathy, hypertrophic cardiomyopathy, idiopathic dilated cardiomyopathy, ischemic heart disease, peripartum cardiomyopathy, and viral induced cardiomyopathy. Non-diseased left ventricles (LV) were obtained from donor hearts not used for transplantation (these were considered to be unsuitable for transplantation for a variety of reasons including the lack of a tissue-compatible recipient). Failing LV were obtained from patients undergoing heart transplantation. Transmural sections of LV anterior free wall were trimmed of fat, dissected into 1-1.5 gm pieces, and immediately frozen in the operating theater. 100-200 mg of frozen transmural LV was ground to a fine powder in liquid nitrogen using a mortar and pestle. Then total RNA was isolated by a method described by Wei and Khan (A Molecular Cloning Manual). The purity of the RNA extract was assessed by measuring the absorbance at 260 nm and 280 nm. Its quantity and integrity was then examined using RNA Nano Chips on a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). 10 ?g of RNA extracts and a universal human reference RNA (Stratagene, La Jolla, CA, USA) were reverse transcribed with Cy3-dUTP and Cy5-dUTP, respectively, to produce labeled cDNA probes using Thermoscript reverse transcriptase according Hwang JJ et. al. (Physiological Genomics 10: 31-44, 2002). Raw scanned images were processed using ScanAlyze version 2.50 (Michael Eisen, Stanford University, CA, USA). Cy3 and Cy5 scans were superimposed, local backgrounds were subtracted, and the fluorescence intensities of each spot were quantified. All further analyses of CardioChips were done using GeneSpring version 6.1 (Silicon Genetics, Redwood City, CA, USA). The data from each array was normalized first to the reference RNA and then a LOWESS curve was fit to the log-intensity versus log-ratio plot for each array and for each gene across all experiments. 40.0% of the data was used to calculate the LOWESS fit at each point. Differentially expressed genes in each HF group compared to donor hearts were identified by a one-way ANOVA test (P <0.05) with the benjamini and hochberg multiple testing corrections and we selected those genes with an average difference greater than 1.5 fold. A hierarchical clustering analysis was performed using pearson correlation with the separation ratio of 1.0 and minimum distance of 0.001 as similarity measure. Using a cardiovascular-specific gene array (CardioChip) of 42 heart failure (HF) patients from a wide range of etiology groups and 8 non-failing donors, we have identified down-regulation of LIM domain protein which may be an important pathway for the clinical progression of HF. We identified six genes, encoding LIM domain and Homer proteins, that are down-regulated in terminally failing hearts. The LIM and cysteine rich domain 1 (LMCD1) gene, in particular, was significantly down-regulated in all HF samples. This novel finding suggests that the LMCD 1 is a universal biomarker for end-stage HF. Other LIM domain genes were also down-regulated but only in non-familial dilated forms of cardiomyopathy. This is probably due to the fact that down-regulation of LIM protein expression may disrupt the cytoskeletal architecture, leading to dilated cardiomyopathy. In addition to identifying the LIM domain genes as possible regulatory genes involved in HF, we also demonstrated that the gene expression profile was able to classify multiple HF patients groups. This paper is the first to examine viral-induced cardiomyopathy, doxorubicin toxicity cardiomyopathy and perimartum cardiomyopathy and to perform the clustering analysis of those HF types providing new insights into human HF. Keywords: other
-
11 GSE17800 对40例扩张型心肌病(DCM)患者在免疫吸附/免疫球蛋白(IA/IgG)治疗前的内膜心肌活检(EMB)样本进行转录组分析,并与8例正常左室射血分数(LVEF)的对照组样本进行比较。研究对象为人类DCM患者和对照组,检测方式为Affymetrix HGU 133 Plus 2.0芯片进行基因表达分析,主要比较DCM患者与对照组的基因表达差异。
设计对40例扩张型心肌病(DCM)患者在免疫吸附/免疫球蛋白(IA/IgG)治疗前的内膜心肌活检(EMB)样本进行转录组分析,并与8例正常左室射血分数(LVEF)的对照组样本进行比较。研究对象为人类DCM患者和对照组,检测方式为Affymetrix HGU 133 Plus 2.0芯片进行基因表达分析,主要比较DCM患者与对照组的基因表达差异。
摘要Background: Immunoadsorption with subsequent IgG substitution (IA/IgG) represents a novel therapeutic approach in treatment of dilated cardiomyopathy (DCM) which leads to improvement of left ventricular ejection fraction (LVEF). However, response to this therapeutic intervention shows wide inter-individual variability. In this pilot study, we tested the value of clinical, biochemical and molecular parameters for prediction of the response of patients with DCM to IA/IgG. Methods & Results: Forty DCM patients underwent endomyocardial biopsies (EMBs) before IA/IgG. In 8 patients with normal LVEF (controls) EMB were obtained for clinical reasons. Clinical parameters, negative inotropic activity (NIA) of antibodies on isolated rat cardiomyocytes and gene expression profiles of EMBs were analyzed. DCM patients displaying improvement of LVEF (≥ 20% relative and ≥ 5% absolute) six month after IA/IgG were considered responders. Compared to non-responders (n=16), responders (n=24) displayed shorter disease duration (p=0.006), smaller LV internal diameter in diastole (LVIDd) (p=0.019) and stronger NIA of antibodies. Antibodies obtained from controls were devoid of NIA. Myocardial gene expression patterns were different in responders and non-responders for genes of oxidative phosphorylation, mitochondrial dysfunction, hypertrophy, and ubiquitin proteasome pathway. Integration of scores of NIA and expression levels of four genes allowed robust discrimination of responders from non-responders at baseline (sensitivity of 100 % (95% CI, 85.8%-100%); specificity up to 100% (95 % CI, 79.4%-100%, cut-off value: -0.28), and was superior to scores derived from antibodies, gene expression or clinical parameters only. Conclusion: Combined assessment of NIA of antibodies and gene expression patterns of DCM patients at baseline predicts response to IA/IgG therapy and may enable appropriate selection of patients who benefit from this therapeutic intervention.
-
12 GSE160997 对18例HCM患者和5例健康对照的左室游离壁及前壁组织进行RNA测序,同时对HCM患者的相同组织进行全外显子组测序,比较两组间基因表达差异。
设计对18例HCM患者和5例健康对照的左室游离壁及前壁组织进行RNA测序,同时对HCM患者的相同组织进行全外显子组测序,比较两组间基因表达差异。
摘要This study is to examine gene expression profiles in 18 HCM patients and compare them with those in 5 healthy controls. The hypothesis tested here is whether patient individual-level transcriptome data integrated with the human interactom can implicate the heterogenity of HCM phenotypes.In this study, we also analyze DNA whole-exome sequencing (WES) data from 18 patients.
-
13 GSE43435 对人类扩张型心肌病(DCM)与非心衰(NF)患者左心室组织的总RNA及全基因组DNA进行表观遗传甲基化和基因表达分析,比较两种疾病状态下样本的差异。将DCM组与NF组的总RNA分别提取并合成cDNA,采用Roche Nimblegen 2.1M Deluxe Promoter Arrays检测甲基化状态,同时使用Expression arrays分析基因表达,所有样本均来自心脏移植或非心衰控制患者,经液氮快速冷冻保存。
设计对人类扩张型心肌病(DCM)与非心衰(NF)患者左心室组织的总RNA及全基因组DNA进行表观遗传甲基化和基因表达分析,比较两种疾病状态下样本的差异。将DCM组与NF组的总RNA分别提取并合成cDNA,采用Roche Nimblegen 2.1M Deluxe Promoter Arrays检测甲基化状态,同时使用Expression arrays分析基因表达,所有样本均来自心脏移植或非心衰控制患者,经液氮快速冷冻保存。
摘要A comparison of epigenetic nuclear DNA methylation and gene expression changes between human dialated cardiomypathy left ventricle samples and non-failing cardiac left ventricule samples This study addresses how depletion of huaman cardiac left ventricle mitochondrial DNA and epigentic nuclear DNA methylation promote cardiac dysfunction in human dilated cardiomyopathy.
-
15 GSE29819 对6例人类ARVC患者左心室和右心室组织、7例扩张型心肌病(DCM)患者左心室和右心室组织、以及6例非失败供体心脏(NF)左心室和右心室组织进行基因表达分析,采用Affymetrix HG-U133 Plus 2.0芯片检测,比较ARVC与NF、DCM与NF的转录组差异,并分析ARVC患者左心室与右心室基因表达模式。
设计对6例人类ARVC患者左心室和右心室组织、7例扩张型心肌病(DCM)患者左心室和右心室组织、以及6例非失败供体心脏(NF)左心室和右心室组织进行基因表达分析,采用Affymetrix HG-U133 Plus 2.0芯片检测,比较ARVC与NF、DCM与NF的转录组差异,并分析ARVC患者左心室与右心室基因表达模式。
摘要Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy primarily of the right ventricle characterized through fibrofatty replacement of cardiomyocytes. The genetic etiology in ARVC patients is most commonly caused by dominant inheritance and high genetic heterogeneity. Though histological examinations of ARVC affected human myocardium reveals fibrolipomatous replacement, the molecular mechanisms leading to loss of cardiomyocytes are largely unknown. We therefore analyzed the transcriptomes of 6 ARVC specimen derived from heart transplantation candidates and compared our findings to 6 non-failing donor hearts (NF) which could not be transplanted for technical reasons. In addition, we compared our findings to 7 hearts from patients with idiopathic dilated cardiomyopathy. From each heart left (LV) and right ventricular (RV) myocardial samples were analyzed by Affymetrix HG-U133 Plus 2.0 arrays, adding up to six sample groups. Unsupervised cluster analyses of the six sample groups revealed a clear separation of NF and cardiomyopathy samples. However, in contrast to the other samples, unsupervised cluster analyses revealed no distinct expression pattern in LV and RV samples from ARVC-hearts. We further identified differentially expressed transcripts using t-tests and found transcripts separating diseased and NF ventricular myocardium. Of note, in failing myocardium only about 15-16% of the genes are commonly regulated compared to NF samples. In addition both cardiomyopathies are clearly distinct on the transcriptome level. Comparison of the expression patterns between the failing RV and LV using a paired t-test revealed a lack of major differences between LV and RV gene expression in ARVC hearts.
-
16 GSE130036 对人类心肌组织进行strand-specific RNA-seq,分析28例hypertrophic cardiomyopathy患者与9例健康供体的转录组差异。
设计对人类心肌组织进行strand-specific RNA-seq,分析28例hypertrophic cardiomyopathy患者与9例健康供体的转录组差异。
摘要Hypertrophic cardiomyopathy (HCM) represents one of the most common heritable heart diseases. However, the signalling pathways and regulatory networks underlying the pathogenesis of HCM remain largely unknown. Here, we present a strand-specific RNA-seq dataset for both coding and lncRNA profiling in myocardial tissues from 28 HCM patients and 9 healthy donors. This dataset constitutes a valuable resource for the community to examine the dysregulated coding and lncRNA genes in HCM versus normal conditions.
-
17 GSE278521 对非缺血性扩张型心肌病患者的心内膜活检组织进行bulk RNA测序,样本采集于疾病诊断后9个月(四分位数范围4-26个月)。根据心内膜活检中CD3+ T细胞数量(≥7个/mm²)和CD45+白细胞数量(≥14个/mm²)划分高炎症组与低炎症组(低炎症组定义为CD3+ T细胞<3个/mm²且CD45+白细胞<5个/mm²),比较两组间基因表达差异。
设计对非缺血性扩张型心肌病患者的心内膜活检组织进行bulk RNA测序,样本采集于疾病诊断后9个月(四分位数范围4-26个月)。根据心内膜活检中CD3+ T细胞数量(≥7个/mm²)和CD45+白细胞数量(≥14个/mm²)划分高炎症组与低炎症组(低炎症组定义为CD3+ T细胞<3个/mm²且CD45+白细胞<5个/mm²),比较两组间基因表达差异。
摘要Dilated cardiomyopathy (DCM) is often driven by myocarditis, however, the underlying immune mechanism remains unknown. We performed bulk-RNA sequencing of endomyocardial biopsies taken 9 months (interquartile range 4-26 months) from DCM diagnosis and we found that in patients with high cardiac inflammation (at least 7 CD3+ T-cells per mm2 or at least 14 CD45+ leukocyte per mm2 endomyocardial biopsy) Perforin-1, Granzyme-A, Granzyme-H, and Interleukin-17 receptor subunit C were more often expressed compared to patients with low cardiac inflammation (less than 3 CD3+ T-cells per mm2 and less than 5 CD45+ leukocytes per mm2 endomyocardial biopsy).
-
18 GSE55296 对患有缺血性或扩张性心肌病的人类心衰患者及健康对照的左心室组织进行RNA测序,比较三组间转录组差异。研究共包含13例缺血性心肌病样本、13例扩张性心肌病样本和10例健康对照样本。
设计对患有缺血性或扩张性心肌病的人类心衰患者及健康对照的左心室组织进行RNA测序,比较三组间转录组差异。研究共包含13例缺血性心肌病样本、13例扩张性心肌病样本和10例健康对照样本。
摘要The goal of this study is to compare the transcriptome of heart failure patients (with ischemic or dilated cardiomyopathy) undergoing heart transplantation compared with healthy controls.
GEO 直达 PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed PubMed
-
19 GSE194394 研究对象为心力衰竭患者和小鼠模型,采集尸源心脏组织总RNA,分析不同处理时间(4小时和4天)及药物(phenylephrine、isoproterenol)处理组与对照组的转录组变化,比较人类非心力衰竭与心力衰竭样本的差异。动物实验中,8周龄C57/Bl6小鼠在4小时或4天后接受药物处理,对照组为未处理组,同时包括DMSO、colchicine和tax处理的正对照。人体实验分为非心力衰竭(12例)和心力衰竭(23例)组,检测总RNA的表达情况,比较不同组别间的差异。
设计研究对象为心力衰竭患者和小鼠模型,采集尸源心脏组织总RNA,分析不同处理时间(4小时和4天)及药物(phenylephrine、isoproterenol)处理组与对照组的转录组变化,比较人类非心力衰竭与心力衰竭样本的差异。动物实验中,8周龄C57/Bl6小鼠在4小时或4天后接受药物处理,对照组为未处理组,同时包括DMSO、colchicine和tax处理的正对照。人体实验分为非心力衰竭(12例)和心力衰竭(23例)组,检测总RNA的表达情况,比较不同组别间的差异。
摘要A proliferated and post-translationally modified microtubule network underlies cellular growth in cardiac hypertrophy and contributes to contractile dysfunction in heart failure. Yet how the heart achieves this modified network is poorly understood. Determining how the “tubulin code” – the permutations of tubulin isoforms and post-translational modifications - is rewritten upon cardiac stress may provide new targets to modulate cardiac remodeling. Further, while tubulin can autoregulate its own expression, it is unknown if autoregulation is operant in the heart or tuned in response to stress. Here we use heart failure patient samples and murine models of cardiac remodeling to interrogate transcriptional, autoregulatory, and post-translational mechanisms that contribute to microtubule network remodeling at different stages of heart disease. We find that autoregulation is operant across tubulin isoforms in the heart and leads to an apparent disconnect in tubulin mRNA and protein levels in heart failure. We also find that within 4 hours of a hypertrophic stimulus and prior to cardiac growth, microtubule detyrosination is rapidly induced to help stabilize the network. This occurs concomitant with rapid transcriptional and autoregulatory activation of specific tubulin isoforms and microtubule motors. Upon continued hypertrophic stimulation, there is an increase in post-translationally modified microtubule tracks and anterograde motors to support cardiac growth, while total tubulin content increases through progressive transcriptional and autoregulatory induction of tubulin isoforms. Our work provides a new model for how the tubulin code is rapidly rewritten to establish a proliferated, stable microtubule network that drives cardiac remodeling, and provides the first evidence of tunable tubulin autoregulation during pathological progression.
-
20 GSE81338 对人类扩张型心肌病患者左心室和右心室组织的DNA甲基组(Infinium 450K HumanMethylation BeadChip)及转录组(Infinium HT-12 v4)进行分析,比较左右心室的甲基化和基因表达差异。
设计对人类扩张型心肌病患者左心室和右心室组织的DNA甲基组(Infinium 450K HumanMethylation BeadChip)及转录组(Infinium HT-12 v4)进行分析,比较左右心室的甲基化和基因表达差异。
摘要Alterations in DNA methylation and gene expression have been implicated in the development of human dilated cardiomyopathy (DCM). In this study, we analyzed DNA methylomes (Infinium 450K HumanMethylation BeadChip) and transcriptomes (Infinium HT-12 v4) to characterize differentially methylated probes (DMPs) and differentially expressed genes (DEGs) between the left and right ventricles of human DCM.
-
21 GSE9800 对dilated cardiomyopathy (DCM)患者、特定心肌病患者及非疾病对照心脏的cardiac muscle组织进行全基因组表达分析,采用Human 1A ver.2微阵列平台检测基因表达差异,比较DCM组与非疾病对照组、特定心肌病组与非疾病对照组的基因表达特征。
设计对dilated cardiomyopathy (DCM)患者、特定心肌病患者及非疾病对照心脏的cardiac muscle组织进行全基因组表达分析,采用Human 1A ver.2微阵列平台检测基因表达差异,比较DCM组与非疾病对照组、特定心肌病组与非疾病对照组的基因表达特征。
摘要There is an emerging hypothesis that dilated cardiomyopathy (DCM) is a manifestation of end-stage heart failure (ESHF) resulting from “final common pathway” despite heterogeneous primary etiologies. We performed genome-wide expression profiling by means of high-density oligonucleotide microarrays using cardiac muscles from patients with DCM or specific cardiomyopathy as well as non-disease control hearts. Differentially expressed genes between ESHF and non-disease samples should include both genes reactive to heart failure (HF) and those responsible for ESHF. With the aid of samples with acute HF without DCM and those with DCM without HF (corrected with left ventricular assist device), we successfully distinguished ESHF genes from HF genes. Our findings implicate that transcriptional signature of cardiac muscle can be potentially applied as a diagnostic or prognostic tool for severe HF. Keywords: disease state analysis
-
22 GSE146621 对携带 TTNtv、RBM20、MYH7 或 LMNA 基因突变的扩张型心肌病(DCM)患者心脏活检组织进行 RNA-Seq 分析,比较不同遗传背景患者的转录组差异。
设计对携带 TTNtv、RBM20、MYH7 或 LMNA 基因突变的扩张型心肌病(DCM)患者心脏活检组织进行 RNA-Seq 分析,比较不同遗传背景患者的转录组差异。
摘要RNA profiles strongly differ in TTNtv and LMNA-mutated DCM patients, despite clinical similarities as other pathogenic variant carriers such as RBM20 and MYH7, suggesting a specific genetic effect on the cardiac transcriptome in addition to the effect of the clinical component.
-
23 GSE42955 将人类左心室心尖部跨壁样本分为缺血性心肌病组(n=12)、扩张性心肌病组(n=12)和正常心脏组(n=5),采用微阵列技术检测总RNA基因表达,比较三组间心肌组织基因表达差异。样本在冠脉循环中断后4°C保存最多6小时,随后存于-80°C直至RNA提取。
设计将人类左心室心尖部跨壁样本分为缺血性心肌病组(n=12)、扩张性心肌病组(n=12)和正常心脏组(n=5),采用微阵列技术检测总RNA基因表达,比较三组间心肌组织基因表达差异。样本在冠脉循环中断后4°C保存最多6小时,随后存于-80°C直至RNA提取。
摘要Global gene expression is altered in heart failure. This syndrome can be caused by cardiovascular diseases, including dilated cardiomyopathy (DCM), ischemic cardiomyopathy (ICM), hypertrophic cardiomyopathy, viral or toxic myocarditis, hypertension, and valvular diseases. We used microarrays to evaluate the impact of heart failure on human nucleocytoplasmic transport-related genes examining simultaneoulsly both dilated and ischemic human cardiomyopathies compared to normal hearts.
-
24 GSE3586 对扩张型心肌病(DCM)患者和非心衰患者的心肌活检样本进行微阵列表达分析,比较两组基因表达差异。
设计对扩张型心肌病(DCM)患者和非心衰患者的心肌活检样本进行微阵列表达分析,比较两组基因表达差异。
摘要Dilated cardiomyopathy (DCM) is a common cause of heart failure and a leading cause of cardiac transplantation in western countries. The robust predictive expression profile of cardiomyopathic and NF hearts as well as the functional classification can help to identify promising candidates for DCM and may improve the early diagnosis of cardiomyopathy. Keywords: disease state analysis
-
25 GSE2014 对9例终末期心肌病(CAD)患者和11例冠状动脉疾病(CAD)患者的总RNA进行微阵列分析,与4例正常非病变心脏的混合总RNA进行比较。
设计对9例终末期心肌病(CAD)患者和11例冠状动脉疾病(CAD)患者的总RNA进行微阵列分析,与4例正常非病变心脏的混合总RNA进行比较。
摘要RNA form the heart a goupe of 9 patients with end stage cardiomyopathy (CAD) and 11 patiensts with coronary artery disease (CAD) was hybridized against pooled RNA form 4 normal nonfailing hearts. Keywords: repeat sample
-
26 GSE230585 对因cMyBP-C截断突变导致的肥厚型心肌病患者(n=6)、主动脉瓣狭窄患者(n=5)及健康供体(n=5)的左心室心脏组织进行RNA测序,比较截断突变患者与供体或主动脉瓣狭窄患者的基因表达差异。
设计对因cMyBP-C截断突变导致的肥厚型心肌病患者(n=6)、主动脉瓣狭窄患者(n=5)及健康供体(n=5)的左心室心脏组织进行RNA测序,比较截断突变患者与供体或主动脉瓣狭窄患者的基因表达差异。
摘要Hypertrophic cardiomyopathy (HCM) is often associated with heterozygous mutations in sarcomeric genes. One of the most commonly affected genes encodes for myosin binding protein C (cMyBP-C, MYBPC3). Interestingly, most mutations in MYBPC3 lead to premature termination codons which could result in truncated fragments of cMyBP-C. However, truncated cMyBP-C has not been detect, but rather a reduction of total wildtype cMyBP-C. Nonsense mediated mRNA decay of mutated MYBPC3-mRNA was often hypothesized as cause for the reduced MYBPC3-expression, however it has not been shown in human patients. Therefore, we performed RNA-sequencing of MYBPC3trunc patients, AS-patients and donors, to detect if expression of regulatory proteins of the NMD is altered in the MYBPC3trunc patients. By gene set enrichment analysis (GSEA) of the presented data, we found expression of NMD components to be enriched in the MYBPC3trunc patients, which was furthermore associated with upregulation of UP-frameshift protein (UPF3B, UPF3B) which is a regulator of NMD.
-
27 GSE243406 对四例因容积超负荷导致的扩张型心肌病(DCM)患者和四例缺血型 DCM 患者的心肌活检样本进行 mRNA 和 miRNA 测序,比较两组间基因和 miRNA 的表达差异。
设计对四例因容积超负荷导致的扩张型心肌病(DCM)患者和四例缺血型 DCM 患者的心肌活检样本进行 mRNA 和 miRNA 测序,比较两组间基因和 miRNA 的表达差异。
摘要Dilated cardiomyopathy (DCM) entails a broad group of diseases, acquired or genetic, that share a similar phenotype. The understanding of gene-specific pathogenetic mechanisms and the determination of the functional effects of each variant may tailor different therapeutic strategies. MicroRNAs (miRNAs) are short sequences of non-coding RNA that play an important role in the development of several cardiovascular diseases, including DCM. Here, we applied mRNA and small RNA sequencing to identify the gene and miRNA signature from myocardial biopsies from four patients with DCM caused by volume overload (VCM) and four with ischemic DCM (ICM). Analysis showed five miRNAs and 112 mRNAs dysregulated in VCM vs ICM. Differentially expressed genes were positively enriched for extracellular matrix (ECM), mitochondria respiration-related, cardiac muscle contraction and fatty acid pathways in VCM vs ICM, and negatively enriched for immune response-related pathways, JAK-STAT and NF-kappa B signaling pathways in VCM vs ICM. miRNA-mRNA interaction analysis revealed four negatively correlated miRNA-target transcript pairs, miR-218-5p-DDX6, miR-218-5p-TT39C, miR-218-5p-SEMA4A and miR-494-3p-SGMS2. qRT-PCR validation showed a strong correlation between RNA-seq and qRT-PCR for these genes and miRNAs. These findings suggest that transcriptome signatures may distinguish distinct etiologies of DCM shedding light on underlying biological differences between VCM and ICM.
-
29 GSE206978 对8例 hypertrophic cardiomyopathy 患者和5例 aortic stenosis 患者的左心室心肌组织进行RNA-seq分析,比较两组基因表达差异。
设计对8例 hypertrophic cardiomyopathy 患者和5例 aortic stenosis 患者的左心室心肌组织进行RNA-seq分析,比较两组基因表达差异。
摘要Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease, and its pathogenesis is still being intensively studied to explain the reasons of significant genetic and phenotypic heterogeneity of the disease. To search for possible HCM modifier genes involved in the HCM development we first attempted to analyze gene expression profile coupled with DNA methylation profile in the hypertrophied myocardium of HCM patients; the control group consisted of patients with aortic stenosis. The transcriptome analysis identified significant differences in levels of 193 genes, most of which were underexpressed in HCM. The methylome analysis revealed 1755 nominally significant differentially methylated positions (DMPs), mostly hypomethylated in HCM. The clear differences in DNA methylation profiles between the studied groups indicate the involvement of this process in the formation of primary left ventricle hypertrophy in HCM. Based on gene ontology enrichment analysis, the majority of biological processes, overrepresented by both differentially expressed genes (DEGs) and DMP-containing genes, are involved in the regulation of locomotion and muscle structure development. The intersection of 193 DEGs and 978 DMP-containing genes pinpointed eight genes, expression of which differed between studied groups and correlated with methylation levels of the neighboring DMPs. Half of these genes (AUTS2, GIGYF1, PRRT1, and SLC17A7) were found underexpressed in HCM and involved in neurogenesis and synapse functioning. Our data suggesting the possible involvement of innervation-associated genes in HCM provide additional insights in the disease pathogenesis and expand the field of further research.
-
30 GSE68316 对肥厚型心肌病患者与无疾病个体的心肌组织进行微阵列分析,比较两组间长非编码RNA和信使RNA的表达差异。
-
31 GSE188238 对 Noonan 综合征相关心肌病(NS-CM)和肥厚型心肌病(HCM)患者的左心室心肌组织进行基因表达分析,同时结合患者来源的 PTPN11N308S/+ 诱导多能干细胞分化的心肌细胞疾病建模,比较 NS-CM 与 HCM 的基因表达差异及与正常心脏的对照。
设计对 Noonan 综合征相关心肌病(NS-CM)和肥厚型心肌病(HCM)患者的左心室心肌组织进行基因表达分析,同时结合患者来源的 PTPN11N308S/+ 诱导多能干细胞分化的心肌细胞疾病建模,比较 NS-CM 与 HCM 的基因表达差异及与正常心脏的对照。
摘要Childhood-onset myocardial hypertrophy and cardiomyopathic changes are associated with significant morbidity and mortality early in life, particularly in patients with Noonan syndrome, a multisystemic genetic disorder caused by autosomal dominant mutations in genes of the Ras-MAPK pathway. Although the cardiomyopathy associated with Noonan syndrome (NS-CM) shares certain cardiac features with the hypertrophic cardiomyopathy caused by mutations in sarcomeric proteins (HCM), such as pathological myocardial remodeling, ventricular dysfunction and increased risk for malignant arrhythmias, the clinical course of NS-CM significantly differs from HCM. This suggests a distinct pathophysiology that remains to be elucidated. Here, by analysis of sarcomeric myosin conformational states, histopathology and gene expression in left ventricular myocardial tissue from NS-CM, HCM and normal hearts complemented with disease modeling in cardiomyocytes differentiated from patient-derived PTPN11N308S/+ induced pluripotent stem cells, we demonstrate distinct disease phenotypes between NS-CM and HCM and uncover cell cycle defects as a potential driver of NS-CM.
-
32 GSE120836 对5例对照组和5例扩张型心肌病(DCM)患者的人类心脏样本进行ChIP-Seq、RRBS和RNA-Seq分析,研究Lamin A/C蛋白相关核域(LADs)的基因组重排特征及其与CpG甲基化、基因表达的关联。采集分离的心肌细胞,采用RNA-Seq检测基因表达,RRBS分析DNA甲基化,ChIP-Seq定位LMNA结合位点,比较DCM组与对照组在LADs分布、甲基化模式及转录特征的差异。
设计对5例对照组和5例扩张型心肌病(DCM)患者的人类心脏样本进行ChIP-Seq、RRBS和RNA-Seq分析,研究Lamin A/C蛋白相关核域(LADs)的基因组重排特征及其与CpG甲基化、基因表达的关联。采集分离的心肌细胞,采用RNA-Seq检测基因表达,RRBS分析DNA甲基化,ChIP-Seq定位LMNA结合位点,比较DCM组与对照组在LADs分布、甲基化模式及转录特征的差异。
摘要Mutations in the LMNA gene causes set of disorders collectively referred to as laminopathies that include dilated cardiomyopathy. Lamin A/C proteins a components of nuclear lamina forms distinct nuclear domains called lamina associated domains (LADs). The roles of LADs in DCM is not known. To identify LADs and characterize their associations with CpG methylation and gene expression in human cardiac myocytes isolated from patients with DCM and controls we performed Chromatin immunoprecipitation-sequencing (ChIP-Seq), reduced representative bisulfite sequencing (RRBS), and RNA-sequencing (RNA-Seq) in 5 control and 5 DCM hearts with defined pathogenic variants in the LMNA gene. LADs are redistributed in DCM, are associated with CpG methylation and suppressed transcription, contributing to the pathogenesis of DCM in laminopathies.
-
33 GSE191120 对肥厚型心肌病患者与健康对照的左心室室间隔组织进行全转录组测序,采集总RNA并构建cDNA文库,同时通过定量实时PCR验证环状RNA表达,比较两组间环状RNA与mRNA的表达差异。
设计对肥厚型心肌病患者与健康对照的左心室室间隔组织进行全转录组测序,采集总RNA并构建cDNA文库,同时通过定量实时PCR验证环状RNA表达,比较两组间环状RNA与mRNA的表达差异。
摘要In the present study, we performed the whole transcriptome resequencing in left ventricular samples from HCM patients and healthy controls. Quantitative real-time PCR (qRT-PCR) was used to validate circRNA expression. By analysing the differentially expressed circRNAs and mRNAs, we constructed the ceRNA networks based on ceRNA theory. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed of target mRNAs of differentially expressed circRNA.
-
34 GSE156869 对3例人类家族性ACM患者和5例健康对照的右心室心内膜活检样本进行RNA测序,比较两组间TRs在Hippo/cWNT通路中的表达差异。
设计对3例人类家族性ACM患者和5例健康对照的右心室心内膜活检样本进行RNA测序,比较两组间TRs在Hippo/cWNT通路中的表达差异。
摘要The RNA-Seq studies performed in the endomyocardial biopsy samples from human patients with defined truncating mutations in the DSP gene and normal right ventricular size and function, identified dysregulation of over two-dozen TRs, including the Hippo/cWNT pathways, early in the course of ACM. The findings of the RNA-Seq were corroborated by immunoblotting and immunofluorescence studies showing reduced protein levels of the TRs of the Hippo/cWNT pathways in the ACM hearts. Dysregulation of these pathways early and prior to the onset of cardiac dysfunction suggest their pathogenic role in ACM.
-
35 GSE273295 对健康对照组和心肌病患者的心肌组织进行mRNA和small RNA测序,比较两组间差异表达基因及miRNA的表达情况,分析其在疾病发病机制中的作用。按总单位数与组数估计,每组包含4个样本。
设计对健康对照组和心肌病患者的心肌组织进行mRNA和small RNA测序,比较两组间差异表达基因及miRNA的表达情况,分析其在疾病发病机制中的作用。按总单位数与组数估计,每组包含4个样本。
摘要Arrhythmogenic cardiomyopathy is an inherited entity characterized by irregular cell-cell adhesion, cardiomyocyte death, fibro-fatty replacement of ventricular myocytes, leading to malignant ventricular arrythmias, contractile dysfunction and sudden cardiac death. Pathogenic variants in genes that encode desmosome are the predominant cause of arrhythmogenic cardiomyopathy. Moreover, signalling pathways such as Wnt/ß-catenin and transforming growth factor-β have been involved in the disease progression. However, still little is known about the molecular pathophysiological mechanisms that underlie arrhythmogenic cardiomyopathy pathogenesis. We used mRNA and small RNA sequencing to analyse the transcriptome of health and arrhythmogenic cardiomyopathy autopsied human hearts. Our results showed 697 differentially expressed genes, and eight differentially expressed miRNAs. Functional enrichment revealed mitochondrial respiratory-related pathways, impaired response to oxidative stress, apoptotic signalling pathway, inflammatory response-related and extracellular matrix response pathways. Furthermore, analysis of miRNA-mRNA interactome identified eleven negatively correlated miRNA-target pairs for arrhythmogenic cardiomyopathy. Our finding revealed novel arrhythmogenic cardiomyopathy-related miRNAs with important regulatory function in disease pathogenesis highlighting their value as potential key targets for therapeutic approaches.
-
36 GSE71613 对终末期心力衰竭患者和健康人的心脏组织进行RNA-Seq测序,比较不同诊断组之间的转录组差异。
设计对终末期心力衰竭患者和健康人的心脏组织进行RNA-Seq测序,比较不同诊断组之间的转录组差异。
摘要The knowledge of an expression network signature in end-stage heart failure (HF) diseased hearts may offer important insights into the complex pathogenesis of advanced cardiac failure, as well as it may provide potential targets for therapeutic intervention. In this study, the NGS sequencing of RNA (RNA-Seq) method was employed to obtain the whole transcriptome of cardiac tissues from transplant recipients with advanced stage of HF. The analysis of RNA-Seq data presents novel challenges and many methods have been developed for the purpose of mapping reads to genomic features and quantifying gene expression. The main goal of this work was to identify, characterize and catalogue all the transcripts expressed within cardiac tissue and to quantify the differential expression of transcripts in both physio- and pathological conditions through whole transcriptome analyses. Expression levels, differential splicing, allele-specific expression, RNA editing and fusion transcripts constitute important information when comparing samples for disease related studies. Analysis methods for RNA-Seq data are continuing to evolve. Thus, in order to find the best solution for filter generated list of differentially expressed genes, an informatic approach of NOISeq BIO method has been applied in this RNA-Seq analysis. Most of the genes obtained by filtering differentially expressed gene list, have been experimentally validated by Real time RT-PCR. Noteworthy, these findings provide valuable resources for further studies of the molecular mechanisms involved in heart ischemic response thus leading to potential novel biomarkers and targets for therapeutic intervention in the onset and progression of cardiomyopathies.
人源·鼠源单细胞
Human · Mouse · Single-cell
-
01 GSE190977 对Lmna Q353R突变小鼠与野生型小鼠心脏组织进行单细胞RNA测序和ATAC测序,比较不同胚胎发育阶段(E13.5和E17.5)突变型与野生型小鼠的转录组和染色质可及性差异,同时分析TEAD1靶基因表达情况。
设计对Lmna Q353R突变小鼠与野生型小鼠心脏组织进行单细胞RNA测序和ATAC测序,比较不同胚胎发育阶段(E13.5和E17.5)突变型与野生型小鼠的转录组和染色质可及性差异,同时分析TEAD1靶基因表达情况。
摘要• Mutations in the LMNA gene encoding Lamin A and C (Lamin A/C), major components of the nuclear lamina, cause laminopathies including dilated cardiomyopathy (DCM), but the underlying molecular mechanisms have not been fully elucidated. Here, by leveraging single-cell RNA-seq, ATAC-seq, protein array, and electron microscopy analysis, we show that insufficient structural maturation of cardiomyocytes owing to trapping of transcription factor TEAD1 by mutant Lamin A/C at the nuclear membrane underlies the pathogenesis of Q353R- LMNA-related DCM. Inhibition of the Hippo pathway rescued the dysregulation of cardiac developmental genes by TEAD1 in LMNA-mutant cardiomyocytes. Single-cell RNA-seq of cardiac tissues from DCM patients with the LMNA mutation confirmed the dysregulated expression of TEAD1 target genes. Our results propose an intervention for transcriptional dysregulation as a potential treatment of LMNA-related DCM.
-
02 GSE255296 对MYBPC3相关肥厚型心肌病患者及对照的单细胞转录组分析,涵盖人类、猫和小鼠心脏组织。人类样本为室间隔心肌切除术组织,猫样本来自左心室流出道阻塞患者及器官捐献者对照,小鼠样本为携带截断型myosin binding protein C3的敲入模型与野生型对照,采用snRNA-seq技术检测核RNA表达,比较不同物种和基因型间的转录差异。
设计对MYBPC3相关肥厚型心肌病患者及对照的单细胞转录组分析,涵盖人类、猫和小鼠心脏组织。人类样本为室间隔心肌切除术组织,猫样本来自左心室流出道阻塞患者及器官捐献者对照,小鼠样本为携带截断型myosin binding protein C3的敲入模型与野生型对照,采用snRNA-seq技术检测核RNA表达,比较不同物种和基因型间的转录差异。
摘要Single RNA sequencing analysis of myosin binding protein C3 (mybpc-3) associated Hypertrophic Cardiomyopathy to identify single cell gene expression changes across common pathological mechanisms and species-specific distinctions in human, feline, and murine heart tissues.
-
03 GSE242821 研究对象为小鼠和人类心脏组织中的心肌细胞,分组包括对照组(control)、Atf3 knockdown组、Atf3 WT与Ndufs6 knockdown组合组、Atf3 knockout与Ndufs6 knockdown组合组,同时涉及不同疾病状态(control和mitochondrial cardiomyopathy模型)及年龄分层(8周、12周、17周、young)。检测方式为RNA-Seq,采用UMI-tools提取条形码和UMI,HISAT2比对至GRCm38参考基因组,featureCounts统计基因表达量。主要比较不同基因型在疾病状态下的转录组差异及年龄相关变化。
设计研究对象为小鼠和人类心脏组织中的心肌细胞,分组包括对照组(control)、Atf3 knockdown组、Atf3 WT与Ndufs6 knockdown组合组、Atf3 knockout与Ndufs6 knockdown组合组,同时涉及不同疾病状态(control和mitochondrial cardiomyopathy模型)及年龄分层(8周、12周、17周、young)。检测方式为RNA-Seq,采用UMI-tools提取条形码和UMI,HISAT2比对至GRCm38参考基因组,featureCounts统计基因表达量。主要比较不同基因型在疾病状态下的转录组差异及年龄相关变化。
摘要This SuperSeries is composed of the SubSeries listed below.
人源·鼠源bulk 转录组
Human · Mouse · Bulk RNA-seq
-
01 GSE133054 对小鼠和人类心脏组织进行 bulk RNA-seq,包含正常心肌组织、肥厚型心肌病组织、心力衰竭组织及 TAC 心脏组织样本,同时进行小鼠左心室单细胞 RNA-seq。检测方式为 polyA RNA 测序,采用 cDNA 文库策略,通过 SMARTScribeTM 反转录缓冲液和 SeqAmpTM PCR 缓冲液体系制备文库。主要比较正常心肌与疾病状态(肥厚型心肌病、心力衰竭)的基因表达差异,以及 TAC 处理不同时间点(2W、5W、8W、11W)的组织变化。样本按年龄混池处理,包含 16 周龄和 20 周龄小鼠混池样本。
设计对小鼠和人类心脏组织进行 bulk RNA-seq,包含正常心肌组织、肥厚型心肌病组织、心力衰竭组织及 TAC 心脏组织样本,同时进行小鼠左心室单细胞 RNA-seq。检测方式为 polyA RNA 测序,采用 cDNA 文库策略,通过 SMARTScribeTM 反转录缓冲液和 SeqAmpTM PCR 缓冲液体系制备文库。主要比较正常心肌与疾病状态(肥厚型心肌病、心力衰竭)的基因表达差异,以及 TAC 处理不同时间点(2W、5W、8W、11W)的组织变化。样本按年龄混池处理,包含 16 周龄和 20 周龄小鼠混池样本。
摘要We deposit the data of single-cell and bulk-cell rna-seq of normal mouse heart. In addition, we conducted bulk rna-seq in human sample and found that many of the heart remodelling-associated genes we discovered show conserved expression pattern in human hypertrophy and heart failure stage.
-
02 GSE271871 对携带 LMOD2 突变的小鼠和人类诱导多能干细胞来源的心肌细胞(hiPSC-CMs)进行 RNA-Seq 测序,比较不同基因型(wildtype、Lmod2KO、LMOD2-/-、LMOD2+/+、LMOD2 -/+、Lmod2 W405*)的基因表达差异。样本来源包括小鼠左心室(LV)组织和 hiPSC-CMs,采用 TRIzol 试剂裂解并提取总 RNA,经 DNA 酶消化后进行测序。
设计对携带 LMOD2 突变的小鼠和人类诱导多能干细胞来源的心肌细胞(hiPSC-CMs)进行 RNA-Seq 测序,比较不同基因型(wildtype、Lmod2KO、LMOD2-/-、LMOD2+/+、LMOD2 -/+、Lmod2 W405*)的基因表达差异。样本来源包括小鼠左心室(LV)组织和 hiPSC-CMs,采用 TRIzol 试剂裂解并提取总 RNA,经 DNA 酶消化后进行测序。
摘要Neonatal dilated cardiomyopathy (DCM) is a poorly understood muscular disease of the heart. Several homozygous biallelic variants inLMOD2, the gene encoding the actin-binding protein Leiomodin 2, have been identified to result in severe DCM. Collectively, LMOD2-related cardiomyopathies present with cardiac dilation and decreased heart contractility, often resulting in neonatal death. Thus, it is evident that Lmod2 is essential to normal human cardiac muscle function. This study aimed to understand the underlying pathophysiology and signaling pathways related to the first reported LMOD2 variant (c.1193G>A, p.Trp398*). Using patient-specific human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and a mouse model harboring the homologous mutation to the patient, we discovered dysregulated actin-thin filament lengths, altered contractility and calcium handling properties, as well as alterations in the serum response factor (SRF)-dependent signaling pathway. These findings reveal that LMOD2 may be regulating SRF activity in an actin-dependent manner and provide a potential new strategy for the development of biologically active molecules to target LMOD2-related cardiomyopathies.
-
03 GSE215351 对小鼠心脏(whole ventricles)在8、16和24周龄时,比较野生型(WT)与Kdm8基因敲除的基因表达;同时,对iPSC-CMs进行转染处理,比较对照组与TBX15过表达的基因表达。采用RNA-seq检测,分析不同基因型和处理条件下的转录组差异。
设计对小鼠心脏(whole ventricles)在8、16和24周龄时,比较野生型(WT)与Kdm8基因敲除的基因表达;同时,对iPSC-CMs进行转染处理,比较对照组与TBX15过表达的基因表达。采用RNA-seq检测,分析不同基因型和处理条件下的转录组差异。
摘要Cardiac metabolism is deranged in heart failure, but underlying mechanisms remain unclear. Lysine demethylase 8 (Kdm8) represses gene expression in the embryo and controls metabolism in cancer. However, its function in cardiac homeostasis is unknown. We show that Kdm8 maintains a mitochondrial gene network active by repressing Tbx15 to prevent dilated cardiomyopathy leading to lethal heart failure. Deletion of Kdm8 in mouse cardiomyocytes increased H3K36me2 with activation of Tbx15 and repression of target genes in the NAD+ pathway before dilated cardiomyopathy initiates. Moreover, NAD+ supplementation prevented dilated cardiomyopathy in Kdm8 mutant mice and TBX15 overexpression blunted NAD+-activated cardiomyocyte respiration. Furthermore, KDM8 was downregulated in human hearts affected by dilated cardiomyopathy and higher TBX15 expression defines a subgroup of affected hearts with the strongest downregulation of genes encoding mitochondrial proteins. Thus, KDM8 represses TBX15 to maintain cardiac metabolism. Our results suggest that epigenetic dysregulation of metabolic gene networks initiates myocardium deterioration towards heart failure and could underlie heterogeneity of dilated cardiomyopathy.
-
04 GSE312561 对人类和小鼠左心室心肌组织进行RNA-Seq,比较妊娠相关心脏压力导致的基因表达变化。研究包含正常(NORMAL)样本、PPCM样本,以及小鼠产后正常(NT)与Ptrh2敲除(CKO)样本,检测总RNA表达差异以分析妊娠引发的心脏应激反应机制。
设计对人类和小鼠左心室心肌组织进行RNA-Seq,比较妊娠相关心脏压力导致的基因表达变化。研究包含正常(NORMAL)样本、PPCM样本,以及小鼠产后正常(NT)与Ptrh2敲除(CKO)样本,检测总RNA表达差异以分析妊娠引发的心脏应激反应机制。
摘要The peptidyl-tRNA hydrolase 2 (PTRH2, Bit-1; BIT1) gene plays a pro-survival role during development with loss of function gene mutations causing congenital infantile multisystem disease (IMNEPD). In wild-type female mice hearts, ptrh2 protein levels significantly increase during pregnancy and decrease postpartum, demonstrating a protective role in response to pregnancy-initiated cardiac stresses. Peripartum cardiomyopathy (PPCM) is due to dysregulated protective signaling in the pregnant heart. The genetic and molecular mechanisms underlying PPCM remain poorly defined with no specific therapies. Here, we engineered a cardiac-specific Ptrh2 knockout (Ptrh2-CKO) mouse and show these maternal mice develop left ventricular systolic dysfunction, exhibit high rates of postpartum heart failure, and model key features of human PPCM. Infusion of a caspase 3-specific inhibitor attenuated the PPCM phenotype. Collectively, our findings demonstrate Ptrh2 is a negative regulator of pregnancy-induced cardiac stresses by activating pro-survival signals and blocking apoptotic signals, suggesting Ptrh2 may be a therapeutic target for the treatment of PPCM
鼠源单细胞
Mouse · Single-cell
-
01 GSE228048 对16周龄野生型(WT)、Dsg2mut/mut和Dsg2mut/mut x Ccr2-/-小鼠的心脏组织进行单细胞RNA测序(snRNA-seq)和CITE-seq,比较不同基因型小鼠心脏组织中免疫信号通路与炎症细胞的差异。心脏组织样本按每组3只小鼠处理,通过酶解和过滤获取单细胞或单核,进行RNA提取和测序,分析心脏成纤维细胞和浸润性炎症细胞的基因表达及表型特征。
设计对16周龄野生型(WT)、Dsg2mut/mut和Dsg2mut/mut x Ccr2-/-小鼠的心脏组织进行单细胞RNA测序(snRNA-seq)和CITE-seq,比较不同基因型小鼠心脏组织中免疫信号通路与炎症细胞的差异。心脏组织样本按每组3只小鼠处理,通过酶解和过滤获取单细胞或单核,进行RNA提取和测序,分析心脏成纤维细胞和浸润性炎症细胞的基因表达及表型特征。
摘要Introduction: We have reported that iPSC-cardiac myocytes from patients with arrhythmogenic cardiomyopathy (ACM) mount an intense innate immune response under basal conditions in vitro. In addition, blocking innate immune signaling via NFκB prevents disease in a mouse model of ACM (Dsg2mut/mut mice). Here, we defined the relative pathogenic roles of immune signaling in cardiac myocytes vs. infiltrating inflammatory cells in Dsg2mut/mut mice. Methods: To define the role of immune signaling in cardiac myocytes, we bred Dsg2mut/mut mice with mice with cardiac myocyte-specific expression of a dominant-negative form of IκBα (DN-IκBα), which prevents nuclear translocation and, thereby, activation of NFκB signaling only in cardiac myocytes. To define the role of inflammatory cells in ACM, we focused on cells expressing C-C motif chemokine receptor-2 (CCR2+ cells), known to mediate adverse cardiac remodeling and fibrosis. We bred Dsg2mut/mut mice with germline deletion of Ccr2 mice (Ccr2-/- mice). We compared phenotypes in Dsg2mut/mut mice with double-mutant Dsg2mut/mut X DN-IκB and Dsg2mut/mut X Ccr2-/- lines. Results: Dsg2mut/mut mice develop marked myocardial fibrosis, reduced LV ejection fraction (EF) and many PVCs. These disease features were all normalized in Dsg2mut/mut X DN-IκB mice. Hearts of Dsg2mut/mut and Dsg2mut/mut X DN-IκB mice contained equal numbers of CD68+ macrophages, but Dsg2mut/mut hearts had many more CCR2+ cells. Cardiac myocyte expression of Tlr4 which activates NFκB, was increased in Dsg2mut/mut mice but not in Dsg2mut/mut X Ccr2-/- mice. Dsg2mut/mut X Ccr2-/- mice showed greatly reduced myocardial fibrosis and PVCs but LV EF was markedly depressed. This suggested that contractile dysfunction in ACM is due not only to loss of muscle but to immune signaling in viable cardiac myocytes as well. To test this hypothesis, we treated Dsg2mut/mut and Dsg2mut/mut X Ccr2-/- mice with the NFκB inhibitor Bay 11-7082. Before treatment, LV EFs were significantly reduced in both groups. Untreated Dsg2mut/mut mice had ongoing deterioration of LV function, whereas treated Dsg2mut/mut mice showed no further disease progression and actually had some improvement in contractile function. However, LV function in treated Dsg2mut/mut X Ccr2-/- mice was virtually normalized. Conclusions: NFκB signaling in cardiac myocytes drives myocardial injury, LV dysfunction and arrhythmias in Dsg2mut/mut mice. It also mobilizes CCR2+ cells to the heart, where they promote myocardial injury and arrhythmias. CCR2+ cells alter gene expression in cardiac myocytes. LV dysfunction in Dsg2mut/mut mice is caused not only by muscle loss but also by negative inotropic effects of inflammation mediated by NFκB in viable cardiac myocytes. These results have obvious implications for ACM patients and suggest that anti-inflammatory therapy may be beneficial even in patients with established disease.
-
02 GSE151084 对ACM小鼠模型中Wt1CreERT2:Rosa26mTmG和Wt1CreERT2:Rosa26mTmG:DspW/F两种基因型的epicardial derived cells进行单细胞RNA测序,比较其转录特征。样本通过Collagenase II消化心脏并流式分选获得,使用R26mT/mG双报告小鼠标记,共包含6个独立样本。
设计对ACM小鼠模型中Wt1CreERT2:Rosa26mTmG和Wt1CreERT2:Rosa26mTmG:DspW/F两种基因型的epicardial derived cells进行单细胞RNA测序,比较其转录特征。样本通过Collagenase II消化心脏并流式分选获得,使用R26mT/mG双报告小鼠标记,共包含6个独立样本。
摘要To delineate the role of the epicardium, the initial site of presentation of the ACM phenotype, the Dsp gene, encoding desmosome protein desmoplakin (DSP) was conditionally deleted in the mouse epicardial cells under the transcriptional regulation of Wilms tumor 1 (Wt1) locus. Single cell RNA sequencing (scRNA-Seq) of ~ 40,000 tagged epicardial-derived cells (EDCs), isolated using the dual reporter R26mT/mG mice, showed an increased number of EDCs expressing unique molecular identifiers of fibroblasts as well as a unique subset of epicardial-derived fibroblasts expressing pro-fibrotic genes in the Wt1-Cre: R26mT/mG: Dsp mice. Analysis of pseudo-bulk RNA-Seq data identified ~ 800 differentially expressed genes (DEGs), which were predominantly involved in epithelial-mesenchymal transition (EMT). The DEGs were the targets of TGFB1 among other trophic/mitotic factors, whose activation was verified by immunohistochemistry and quantification of transcript levels of selected TGBF1 pathway genes. Retro-mapping of the DEGs to the cell clusters, identified by scRNA-Seq, denoted epicardial-derived fibroblasts and to a lesser extent the epithelial cells as the main sources of paracrine factors in the myocardium of Wt1-Cre: R26mT/mG: Dsp mice.
-
03 GSE283722 将携带myosin R403Q突变的雄性小鼠与野生型小鼠分为三组:WT-CD、R403Q-CD和R403Q-EMPA,每组按总单位数与组数估计2只。所有小鼠均以对照饮食或添加empagliflozin(0.15 mg/g)的饮食喂养16周。采集12周龄小鼠的左心室组织,进行单核RNA测序,比较各组间基因表达差异。同时采用多核磁共振波谱(31P, 13C, 23Na MRS)和超声心动图评估代谢、结构和功能变化。
设计将携带myosin R403Q突变的雄性小鼠与野生型小鼠分为三组:WT-CD、R403Q-CD和R403Q-EMPA,每组按总单位数与组数估计2只。所有小鼠均以对照饮食或添加empagliflozin(0.15 mg/g)的饮食喂养16周。采集12周龄小鼠的左心室组织,进行单核RNA测序,比较各组间基因表达差异。同时采用多核磁共振波谱(31P, 13C, 23Na MRS)和超声心动图评估代谢、结构和功能变化。
摘要Background: Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder characterized by left ventricular hypertrophy (LVH), diastolic dysfunction, and impaired metabolic efficiency. This study investigates the therapeutic potential of the sodium-glucose cotransporter 2 inhibitor empagliflozin (EMPA) in ameliorating these pathological features in a mouse model carrying the myosin R403Q mutation. Methods: Male mice harboring the R403Q mutation were treated with EMPA for 16 weeks. We utilized multinuclear magnetic resonance spectroscopy (31P, 13C, 23Na MRS), alongside echocardiography, transcriptomic, proteomic, and phosphoproteomic profiling to assess metabolic, structural, and functional changes. Results: EMPA facilitated the coupling of glycolysis with glucose oxidation and normalized elevated intracellular sodium levels. Treatment resulted in a significant reduction in LVH and myocardial fibrosis as evidenced by echocardiography and histopathology. These structural improvements correlated with enhancements in mitochondrial ATP synthesis, fatty acid oxidation (FAO), and branched-chain amino acid (BCAA) catabolism. Furthermore, empagliflozin improved left ventricular diastolic function and contractile reserve, underscored by improved ATP production and reduced energy cost of contraction. Notably, these benefits were linked to downregulation of the mTOR signaling pathway and normalization of myocardial substrate metabolic fluxes. Conclusion: EMPA significantly mitigates structural and metabolic dysfunctions in a mouse model of HCM, underscoring its potential as a therapeutic agent for managing this condition. These findings suggest broader applicability of SGLT2 inhibitors in cardiovascular diseases, including those due to myocardial-specific mutations, warranting further clinical investigation.
-
04 GSE319519 将Lmna⁻/⁻小鼠心肌细胞核与野生型小鼠心肌细胞核分别进行单核RNA测序,比较AAV-Lmna/DJ8处理组与PBS对照组的转录组差异。新生小鼠于出生后第2天接受胸腔内注射AAV-Lmna/DJ8(3.3 × 1010 vg)或PBS,三周后采集左心室组织提取核进行测序,每组n=2。
设计将Lmna⁻/⁻小鼠心肌细胞核与野生型小鼠心肌细胞核分别进行单核RNA测序,比较AAV-Lmna/DJ8处理组与PBS对照组的转录组差异。新生小鼠于出生后第2天接受胸腔内注射AAV-Lmna/DJ8(3.3 × 1010 vg)或PBS,三周后采集左心室组织提取核进行测序,每组n=2。
摘要Mutations in LMNA, which encodes the nuclear envelope protein lamin A/C, cause laminopathies that frequently present as dilated cardiomyopathy (DCM). We investigated whether re-expression of lamin A in cardiomyocytes can rescue the severe phenotype of Lmna⁻/⁻ mice. An adeno-associated virus vector expressing wild-type Lmna (AAV-Lmna/DJ8) was administered intrathoracically to neonatal mice. Three weeks after injection, treated Lmna⁻/⁻ mice exhibited robust cardiac Lmna mRNA induction and nuclear localization of lamin A protein, reflecting efficient cardiotropic gene delivery. Compared with PBS treatment, AAV-Lmna/DJ8 treatment promoted body weight maintenance, improved left ventricular systolic function, and significantly prolonged survival in Lmna⁻/⁻ mice. To explore the underlying mechanisms, we performed single-nucleus RNA sequencing of cardiomyocytes from wild-type mice, PBS-treated Lmna⁻/⁻ mice, and AAV-Lmna/DJ8–treated Lmna⁻/⁻ mice. AAV-mediated lamin A re-expression shifted the cardiomyocyte transcriptome toward the wild-type profile, and restored oxidative phosphorylation–related gene programs, which were diminished in untreated Lmna⁻/⁻ mice. These findings demonstrate that targeted re-expression of Lmna ameliorates cardiac dysfunction in Lmna⁻/⁻ mice and highlight the therapeutic potential of LMNA gene replacement for laminopathy-associated cardiomyopathy.
鼠源bulk 转录组
Mouse · Bulk RNA-seq
-
01 GSE280991 对C57BL/6JEiJ、C57BL/6JEiJ Ant1-/-及C57BL/6JEiJ Ant1-/- ND6P25L小鼠(WT、ANT1、ANT1 ND6)进行批量RNA测序和单核RNA测序(snRNA-seq)分析,其心脏通过心包注射给予2.5x10^11 vg AAV2/9Des-Gfp-mAnt1或2.5x10^11 vg AAV2/9Des-Gfp处理,分别在感染后1、3、6、9和12个月采集心脏样本进行RNA分析。
设计对C57BL/6JEiJ、C57BL/6JEiJ Ant1-/-及C57BL/6JEiJ Ant1-/- ND6P25L小鼠(WT、ANT1、ANT1 ND6)进行批量RNA测序和单核RNA测序(snRNA-seq)分析,其心脏通过心包注射给予2.5x10^11 vg AAV2/9Des-Gfp-mAnt1或2.5x10^11 vg AAV2/9Des-Gfp处理,分别在感染后1、3、6、9和12个月采集心脏样本进行RNA分析。
摘要Primary mitochondrial disease (PMD) patients manifesting cardiomyopathy are twice as likely to die as other PMD patients. One PMD with cardiomyopathy is caused by null mutations in the heart-muscle isoform of the adenine nucleotide translocator (SLC25A4, ANT1) gene, the severity of the cardiomyopathy being mediated by the mitochondrial DNA (mtDNA). To optimize strategies for addressing mitochondrial cardiomyopathy, we generated an Ant1 null mouse and combined it with the ND6P25L mtDNA mutation to mimic the hypertrophic versus dilated cardiomyopathies observed in patients. Here, we transduce the neonatal Ant1-/- and Ant1-/-+ND6P25L mouse hearts with an AAV2/9-pDes-Gfp-mAnt1 cDNA vector. We show that restoration of just 10% of Ant1 gene expression was sufficient to ameliorate the cardiomyopathies in these mice. Proteomics and single-nucleus RNA sequencing reveal the reversal of dysregulated mitochondrial metabolic genes, including PGC1α, as well as cardiac contractile and extracellular matrix proteins. Hence, a modest increase in cardiac mitochondrial energetics can have profound benefits on cardiac function and is effective in treating mitochondrial cardiomyopathy.
-
02 GSE670 对小鼠左心室心肌组织进行微阵列分析,比较正常、心力衰竭(HF)及转基因救回(betaARKct)组的基因表达差异。研究包括早期和晚期HF小鼠,各组样本数为12,总样本数为53。检测方式为Affymetrix Mu11K芯片,RNA提取采用胍基异硫氰酸酯方法。
设计对小鼠左心室心肌组织进行微阵列分析,比较正常、心力衰竭(HF)及转基因救回(betaARKct)组的基因表达差异。研究包括早期和晚期HF小鼠,各组样本数为12,总样本数为53。检测方式为Affymetrix Mu11K芯片,RNA提取采用胍基异硫氰酸酯方法。
摘要Numerous murine models of heart failure (HF) have been described, many of which develop progressive deterioration of cardiac function. We have recently demonstrated that several of these can be "rescued" or prevented by transgenic cardiac expression of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARKct). To uncover genomic changes associated with cardiomyopathy and/or its phenotypic rescue by the betaARKct, oligonucleotide microarray analysis of left ventricular (LV) gene expression was performed in a total of 53 samples, including 12 each of Normal, HF, and Rescue. Multiple statistical analyses demonstrated significant differences between all groups, and further demonstrated that betaARKct Rescue returned gene expression toward that of Normal. In our statistical analyses, we found that the HF phenotype is blindly predictable based solely on gene expression profile. To investigate the progression of HF, LV gene expression was determined in young mice with mildly diminished cardiac function and in older mice with severely impaired cardiac function. Interestingly, mild and advanced HF mice shared similar gene expression profiles and, importantly, the mild HF mice were predicted as having a HF phenotype when blindly subjected to our predictive model described above. These data not only validate our predictive model, but further demonstrate that, in these mice, the HF gene expression profile appears to already be set in the early stages of HF progression. Thus, we have identified methodologies that have the potential to be used for predictive genomic profiling of cardiac phenotype, including cardiovascular disease. Keywords: other
-
03 GSE73771 对出生后小鼠心肌细胞进行基因表达与组蛋白修饰检测,比较心脏条件性 EED 敲除(CKO)与野生型(WT)小鼠在不同时间点的表型差异,分析 EED 缺失对 H3K27me3 和 H3K27ac 标记的影响,评估 HDAC 过表达对 CKO 心脏功能及基因表达的调控作用。
设计对出生后小鼠心肌细胞进行基因表达与组蛋白修饰检测,比较心脏条件性 EED 敲除(CKO)与野生型(WT)小鼠在不同时间点的表型差异,分析 EED 缺失对 H3K27me3 和 H3K27ac 标记的影响,评估 HDAC 过表达对 CKO 心脏功能及基因表达的调控作用。
摘要In proliferating cells, where most Polycomb repressive complex 2 (PRC2) studies have been performed, gene repression is associated with PRC2 trimethylation of H3K27 (H3K27me3). However, it is uncertain whether PCR2 writing of H3K27me3 is mechanistically required for gene silencing. Here we studied PRC2 function in postnatal mouse cardiomyocytes, where the paucity of cell division obviates bulk H3K27me3 rewriting after each cell cycle. EED (Embryonic Ectoderm Development) inactivation in the postnatal heart (Eed CKO ) caused lethal dilated cardiomyopathy. Surprisingly, gene upregulation in Eed CKO was not coupled with loss of H3K27me3. Rather, the activating histone mark H3K27ac increased. EED interacted with histone deacetylases (HDACs) and enhanced their catalytic activity. HDAC overexpression normalized Eed CKO heart function and expression of derepressed genes. Our results uncovered a non-canonical, H3K27me3-independent EED repressive mechanism that is essential for normal heart function. Our results further illustrate that organ dysfunction due to epigenetic dysregulation can be corrected by epigenetic rewiring.
-
04 GSE253225 将C57BL6小鼠分为5组:野生型(WT)与心脏特异性敲除(cKO-PKP2)小鼠,其中cKO组接受不同处理(HBSS对照、AAV9:mPkp2 3E13 vg/kg预防性给药、AAV9:mPkp2 1E14 vg/kg预防性给药、AAV9:mPkp2 1E14 vg/kg治疗性给药)。每只小鼠的右心室(RV)和左心室(LV)组织同时进行RNA测序,比较不同处理条件下基因表达差异。
设计将C57BL6小鼠分为5组:野生型(WT)与心脏特异性敲除(cKO-PKP2)小鼠,其中cKO组接受不同处理(HBSS对照、AAV9:mPkp2 3E13 vg/kg预防性给药、AAV9:mPkp2 1E14 vg/kg预防性给药、AAV9:mPkp2 1E14 vg/kg治疗性给药)。每只小鼠的右心室(RV)和左心室(LV)组织同时进行RNA测序,比较不同处理条件下基因表达差异。
摘要Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a familial cardiac disease associated with ventricular arrhythmias and an increased risk of sudden cardiac death. Currently, there are no approved treatments that address the underlying genetic cause of this disease, representing a significant unmet need. Mutations in Plakophilin-2 (PKP2), encoding a desmosomal protein, account for approximately 40% of ARVC cases and result in reduced gene expression. Methods: Our goal is to examine the feasibility and the efficacy of adeno-associated virus 9 (AAV9)-mediated restoration of PKP2 expression in a cardiac specific knock-out mouse model of Pkp2. Results: We show that a single dose of AAV9:PKP2 gene delivery prevents disease development before the onset of cardiomyopathy and attenuates disease progression after overt cardiomyopathy. Restoration of PKP2 expression leads to a significant extension of lifespan by restoring cellular structures of desmosomes and gap junctions, preventing or halting decline in left ventricular ejection fraction, preventing or reversing dilation of the right ventricle, ameliorating ventricular arrhythmia event frequency and severity, and preventing adverse fibrotic remodeling. RNA sequencing analyses show that restoration of PKP2 expression leads to highly coordinated and durable correction of PKP2-associated transcriptional networks beyond desmosomes, revealing a broad spectrum of biological perturbances behind ARVC disease etiology. Conclusions: We identify fundamental mechanisms of PKP2-associated ARVC beyond disruption of desmosome function. The observed PKP2 dose-function relationship indicates that cardiac-selective AAV9:PKP2 gene therapy may be a promising therapeutic approach to treat ARVC patients with PKP2 mutations.
-
05 GSE297707 将C57BL/6J小鼠按基因型(TG/nTG)和性别(雄性/雌性)分为8组,每组接受HIIT或sedentary处理,每组提取7-9个心脏样本进行bulk RNA-Seq分析,比较不同处理条件下基因表达差异及性别与基因型交互作用。
设计将C57BL/6J小鼠按基因型(TG/nTG)和性别(雄性/雌性)分为8组,每组接受HIIT或sedentary处理,每组提取7-9个心脏样本进行bulk RNA-Seq分析,比较不同处理条件下基因表达差异及性别与基因型交互作用。
摘要High intensity exercise (HIE) has become a prominent training modality used to ameliorate cardiac disease conditions. The effects of HIE training on Hypertrophic Cardiomyopathy (HCM) have not been previously studied in animal models or in patients, largely due to concerns about triggering sudden arrhythmic events. Employing a transgenic cardiac troponin (cTnT-160E or TG) preclinical murine model that closely recapitulates human HCM, we evaluated the effects of a High Intensity Interval Training (HIIT) protocol on cardiorespiratory capacity (i.e., peak oxygen consumption or pVO2), which is a significant prognostic indicator of disease trajectory. 14 month old TG male mice had lower peak VO2 than non-transgenic (NTG) male mice of the same age at baseline, but there was no difference in pVO2 in female TG compared to nTG mice. HIIT significantly improved pVO2 in both nTG female (18%) , nTG male (18%), TG female (16%) and TG male (12%) mice compared to sedentary controls. There were no changes in structure, function or LV mass as measured by echocardiography or post mortem analyses in any of the groups, and no effect of HIIT on cardiac fibrosis. HIIT led to significant increases in lean muscle mass in both nTG and TG male mice, and nTG female mice but not TG female mice. The results of our study provide foundational evidence that HIE can improve pVO2 in HCM without adverse effects on disease phenotype.
-
06 GSE17021 对小鼠心脏组织及子宫肌层在分化、疾病和发育重塑过程中的替代剪接模式进行表达谱分析,采用 Affymetrix AltMouseA Array 平台检测不同转基因状态和多西环素处理条件下的 RNA 修饰事件,比较转基因心脏(表达 G alpha q 或 Ro1 蛋白)与非转基因对照心脏、不同时间点(14 天、8 周、6 小时)的子宫肌层样本以及胚胎干细胞分化模型的转录异构体差异。
设计对小鼠心脏组织及子宫肌层在分化、疾病和发育重塑过程中的替代剪接模式进行表达谱分析,采用 Affymetrix AltMouseA Array 平台检测不同转基因状态和多西环素处理条件下的 RNA 修饰事件,比较转基因心脏(表达 G alpha q 或 Ro1 蛋白)与非转基因对照心脏、不同时间点(14 天、8 周、6 小时)的子宫肌层样本以及胚胎干细胞分化模型的转录异构体差异。
摘要Two major goals for regenerative medicine are to reproducibly transform adult somatic cells into a pluripotent state and to control their differentiation into specific cell fates. These goals could be furthered by obtaining a complete picture of the RNA isoforms produced by these cells due to alternative splicing (AS) and alternative promoter selection (APS). To investigate the roles of AS and APS, reciprocal exon-exon junctions were interrogated on a genome-wide scale in differentiating mouse embryonic stem cells (ESCs), mouse myometrium throughout gestation and cardiac remodeling with disease using a prototype Affymetrix microarray. Using a custom analysis package named AltAnalyze (http://www.AltAnalyze.org), we identified a large number of putative AS and APS events, the majority of which were predicted to alter protein sequence and domain composition. Over a dozen AS and APS events were validated in mouse ESCs with differentiation to embryoid bodies.
-
07 GSE152005 将PLNR9C转基因小鼠与野生型小鼠按8周、16周、20周年龄分组,分别给予JQ1或vehicle处理,采集心脏组织进行RNA-seq,比较不同基因型、年龄及处理组间的基因表达差异。
-
08 GSE343640 对Hutchinson-Gilford progeria综合征(HGPS)小鼠模型LMNAG608G/G608G及其同龄野生型对照小鼠进行RNA-seq分析,同时检测特定位点腺嘌呤碱基编辑(ABE)处理组与盐水处理对照组的转录组变化。采用TriZol提取总RNA并经DNA酶消化,检测对象为小鼠心脏组织,包含snRNA-seq和Bulk RNA-seq两种策略,比较不同基因型与处理条件下的心脏转录特征差异。
设计对Hutchinson-Gilford progeria综合征(HGPS)小鼠模型LMNAG608G/G608G及其同龄野生型对照小鼠进行RNA-seq分析,同时检测特定位点腺嘌呤碱基编辑(ABE)处理组与盐水处理对照组的转录组变化。采用TriZol提取总RNA并经DNA酶消化,检测对象为小鼠心脏组织,包含snRNA-seq和Bulk RNA-seq两种策略,比较不同基因型与处理条件下的心脏转录特征差异。
摘要Background: Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder characterized by rapid premature aging. Without treatment, accelerated atherosclerosis results in death from heart attack or stroke in the early teens. Recent echocardiographic study has also demonstrated a progressive cardiomyopathy in HGPS patients, characterized by diastolic dysfunction with preserved ejection fraction. We sought to define the cardiovascular phenotype and molecular mechanisms underlying progeria-associated cardiomyopathy in a humanized mouse model, and to determine whether these abnormalities can be corrected by in vivo adenine base editing. Methods: Cardiovascular phenotypes were extensively characterized in LMNAG608G/G608G progeria mice using echocardiography, vascular biomechanical testing, histopathology, transmission electron microscopy, snRNA-seq, RNA in situ hybridization, and plasma biomarker analyses. The effects of in vivo adenine base editing on pathological cardiac remodeling were subsequently evaluated. Results: LMNAG608G/G608G mice developed progressive left ventricular diastolic dysfunction with normal ejection fraction, accompanied by severe central arterial stiffening, impaired vasoreactivity, and reduced vascular distensibility. Histological and ultrastructural analyses of the heart revealed cardiomyocyte nuclear abnormalities, sarcomere disruption, mitochondrial defects, and increased myocardial collagen deposition. Transcriptomic profiling identified a signature of pathological myocardial remodeling, characterized by activation of proteostatic stress responses, suppression of contractile and calcium signaling pathways, enhanced extracellular matrix remodeling and inflammatory signaling, and reactivation of the fetal heart failure gene program. Robust upregulation of Nppa and Nppb, two established heart failure markers, was validated by RNA in situ hybridization and accompanied by significantly elevated circulating NT-proBNP levels. In vivo delivery of an AAV9-encapsulated adenine base editor achieved partial correction of the progeria mutation in the heart and partially reversed cardiomyocyte transcriptional alterations, pathological myocardial remodeling, fibrosis, and heart failure marker expression. Conclusions: A humanized mouse model of HGPS is associated with progressive atherosclerosis, as well as a progressive cardiomyopathy characterized by diastolic dysfunction, pathological myocardial remodeling, and activation of a heart failure transcriptional program. Partial reversal of these abnormalities following in vivo adenine base editing demonstrates that progeria cardiomyopathy is therapeutically modifiable. Future human trials of gene-editing therapies for HGPS should target both the arterial tree and the myocardium.
-
09 GSE241577 对Lamin相关扩张型心肌病小鼠模型进行mRNA测序,研究对象为成年小鼠心脏组织,分组基于Lmna基因型(F/F或F/+)与cGas基因型(null/null或+/+)组合,同时按tamoxifen处理时长分为1周、2周、11天三个时间点,各组样本按pool id(KIUC030、KIUC033、KIUC035、KIUC037、KICHMC007)区分,检测方式为RNA-Seq,主要比较不同基因型组合与处理时长下的心脏组织转录组差异。
设计对Lamin相关扩张型心肌病小鼠模型进行mRNA测序,研究对象为成年小鼠心脏组织,分组基于Lmna基因型(F/F或F/+)与cGas基因型(null/null或+/+)组合,同时按tamoxifen处理时长分为1周、2周、11天三个时间点,各组样本按pool id(KIUC030、KIUC033、KIUC035、KIUC037、KICHMC007)区分,检测方式为RNA-Seq,主要比较不同基因型组合与处理时长下的心脏组织转录组差异。
摘要Nuclear envelope (NE) ruptures are emerging observations in Lamin-related dilated cardiomyopathy, an adult-onset disease caused by loss-of-function mutations in Lamin A/C, a nuclear lamina component. Here, we test a prevailing hypothesis that NE ruptures trigger the pathological cGAS-STING cytosolic DNA-sensing pathway using a mouse model of Lamin cardiomyopathy. The reduction of Lamin A/C in cardiomyocytes of adult mice causes pervasive NE ruptures in cardiomyocytes, preceding inflammatory transcription, fibrosis, and fatal dilated cardiomyopathy. NE ruptures are followed by DNA damage accumulation without causing immediate cardiomyocyte death. However, cGAS-STING-dependent inflammatory signaling remains inactive. Deleting cGas or Sting does not rescue cardiomyopathy. The lack of cGAS-STING activation is likely due to the near absence of cGAS expression in adult cardiomyocytes at baseline. Instead, extracellular matrix (ECM) signaling is activated and predicted to initiate pro-inflammatory communication from Lamin-reduced cardiomyocytes to fibroblasts. Our work nominates ECM signaling, not cGAS-STING, as a potential inflammatory contributor in Lamin cardiomyopathy.
-
10 GSE304346 对LMNA基因突变导致的扩张型心肌病(LMNA-DCM)小鼠模型进行bulk RNA测序,研究对象为左心室游离壁组织,分组包括Lmna-cKO + DN Kash、Lmna-cKO - DN Kash、Lmna-cWT - DN Kash和Lmna-cWT + DN Kash,分别在11-dpi和25-dpi时间点采集样本,比较不同基因型与处理条件下的转录组变化。
设计对LMNA基因突变导致的扩张型心肌病(LMNA-DCM)小鼠模型进行bulk RNA测序,研究对象为左心室游离壁组织,分组包括Lmna-cKO + DN Kash、Lmna-cKO - DN Kash、Lmna-cWT - DN Kash和Lmna-cWT + DN Kash,分别在11-dpi和25-dpi时间点采集样本,比较不同基因型与处理条件下的转录组变化。
摘要Mutations in the LMNA gene, which encodes the nuclear envelope (NE) proteins lamins A and C, cause dilated cardiomyopathy (LMNA-DCM) and other diseases. The pathogenic mechanisms for LMNA-DCM remain poorly understood, limiting current treatment options and leading to high mortality amongst patients. We developed a mouse model with inducible, cardiomyocyte-specific Lmna deletion (cKO) and performed comprehensive bulk, single-nucleus, and spatial transcriptomic analyses across disease progression. Our analysis identified key disease-driving genes involved in cellular responses to DNA damage, cytosolic pattern recognition receptor signaling, and innate immunity that originated from two disease-specific cardiomyocyte subpopulations. Spatial mapping revealed aberrant interactions between these cardiomyocytes, fibroblasts, and immune cells, contributing to tissue-wide transcriptional changes in cKO hearts. Concurrent cardiomyocyte-specific disruption of the LINC complex, which transmits cytoskeletal forces to the nucleus, substantially reduced NE rupture in cKO cardiomyocytes, normalized expression of more than half of the dysregulated genes, and dramatically improved cardiac function and survival in cKO mice. These findings suggest that NE rupture in cKO cardiomyocytes triggers cytosolic DNA sensing pathways and maladaptive cell-cell communication with fibroblasts and immune cells, leading to fibrosis and inflammation driving LMNA-DCM pathogenesis.
-
11 GSE68857 将3个月龄的PKCε转基因小鼠与非转基因FVB/N小鼠分为四组:FVB/N小鼠接受非免疫IgG处理(n=10)或抗CTGF抗体FG-3149处理(n=12),PKCε小鼠同样接受IgG(n=10)或FG-3149(n=12)处理。所有小鼠在治疗3个月后采集左心室组织,通过Affymetrix 430A 2.0芯片检测基因表达,比较不同基因型与处理组间的转录差异。
设计将3个月龄的PKCε转基因小鼠与非转基因FVB/N小鼠分为四组:FVB/N小鼠接受非免疫IgG处理(n=10)或抗CTGF抗体FG-3149处理(n=12),PKCε小鼠同样接受IgG(n=10)或FG-3149(n=12)处理。所有小鼠在治疗3个月后采集左心室组织,通过Affymetrix 430A 2.0芯片检测基因表达,比较不同基因型与处理组间的转录差异。
摘要Cardiac structural changes associated with dilated cardiomyopathy (DCM) include cardiomyocyte hypertrophy and myocardial fibrosis. Connective Tissue Growth Factor (CTGF) has been associated with tissue remodeling and is highly expressed in failing hearts. To test if inhibition of CTGF would alter the course of cardiac remodeling and preserve cardiac function in the protein kinase Cε (PKCε) mouse model of DCM. Transgenic mice expressing constitutively active PKCε in cardiomyocytes develop cardiac dysfunction that was evident by 3 months of age, and that progressed to heart failure, cardiac fibrosis, and increased mortality. Beginning at 3 months of age, mice were treated with an antibody to CTGF (FG-3149) or non-immune IgG control antibody for an additional 3 months. CTGF inhibition significantly improved left ventricular (LV) systolic and diastolic function in PKCε mice, and slowed the progression of LV dilatation. Using gene arrays and quantitative PCR, the expression of many genes associated with tissue remodeling were elevated in PKCε mice, but significantly decreased by CTGF inhibition, however total collagen deposition was not attenuated. The observation of significantly improved LV function by CTGF inhibition in PKCε mice suggests that CTGF inhibition may benefit patients with DCM.
-
12 GSE261796 将携带异质性 CHCHD10 S55L 突变的小鼠与野生型小鼠进行比较,分别给予高脂饮食或对照饮食处理,采集心脏组织进行 RNA 测序,分析不同代谢条件下基因表达差异。
设计将携带异质性 CHCHD10 S55L 突变的小鼠与野生型小鼠进行比较,分别给予高脂饮食或对照饮食处理,采集心脏组织进行 RNA 测序,分析不同代谢条件下基因表达差异。
摘要Mutations in CHCHD10, a mitochondrial protein with undefined functions, are associated with autosomal dominant mitochondrial diseases. Chchd10 knock-in mice harboring a heterozygous S55L mutation (equivalent to human pathogenic S59L) develop a fatal mitochondrial cardiomyopathy caused by CHCHD10 aggregation and proteotoxic mitochondrial integrated stress response (mtISR). In mutant hearts, mtISR is accompanied by a metabolic rewiring characterized by increased reliance on glycolysis rather than fatty acid oxidation. To counteract this metabolic rewiring, heterozygous S55L mice were subjected to chronic high fat diet (HFD) to decrease insulin sensitivity and glucose uptake and enhance fatty acid utilization in the heart. HFD ameliorated the ventricular dysfunction of mutant hearts and significantly extended the survival of mutant female mice affected by severe pregnancy-induced cardiomyopathy. Gene expression profiles confirmed that HFD increased fatty acid utilization and ameliorated cardiomyopathy markers. Importantly, HFD also decreased accumulation of aggregated CHCHD10 in the S55L heart, suggesting activation of quality control mechanisms. Overall, our findings indicate that metabolic therapy can be effective in mitochondrial cardiomyopathies associated with proteotoxic stress.
-
13 GSE168610 研究对象为携带PLN-R14del突变的小鼠和野生型小鼠,材料为左心室组织。分组包括3周龄、5周龄、8周龄的PLN-R14del纯合突变小鼠、PLN-R14del杂合突变小鼠及野生型小鼠,同时包含缺血再灌注(I/R)、心肌梗死(MI)或假手术(sham)处理组。检测方式为RNA测序,主要比较不同基因型小鼠在不同年龄阶段的基因表达差异,以及与I/R、MI、sham处理组的表达差异。
设计研究对象为携带PLN-R14del突变的小鼠和野生型小鼠,材料为左心室组织。分组包括3周龄、5周龄、8周龄的PLN-R14del纯合突变小鼠、PLN-R14del杂合突变小鼠及野生型小鼠,同时包含缺血再灌注(I/R)、心肌梗死(MI)或假手术(sham)处理组。检测方式为RNA测序,主要比较不同基因型小鼠在不同年龄阶段的基因表达差异,以及与I/R、MI、sham处理组的表达差异。
摘要Background: The p.(Arg14del) pathogenic variant (R14del) of the phospholamban (PLN) gene is a prevalent cause of cardiomyopathy with heart failure. The exact underlying pathophysiology is unknown, and a suitable therapy is unavailable. We aim to identify molecular perturbations underlying this cardiomyopathy in a clinically relevant PLN-R14del mouse model. Methods: We investigated progression of cardiomyopathy in PLN-R14∆/∆ mice using echocardiography, electrocardiography and histological tissue analysis. RNA sequencing and mass spectrometry were performed on cardiac tissues at 3 weeks of age (before onset of disease), 5 weeks (mild cardiomyopathy), and 8 weeks (end-stage). Data were compared with cardiac expression levels of mice that underwent myocardial ischemia-reperfusion or myocardial infarction surgery, in an effort to identify alterations that are specific to PLN-R14del-related cardiomyopathy. Results: At 3 weeks of age, PLN-R14∆/∆ mice had normal cardiac function, but from the age of 4 weeks, we observed increased myocardial fibrosis and impaired global longitudinal strain. From 5 weeks onwards, ventricular dilatation, decreased contractility and diminished electrocardiogram voltages were observed. Strikingly, PLN protein aggregation was present prior to onset of functional deficits. Transcriptomics and proteomics revealed differential regulation of processes involved in remodeling, inflammation and metabolic dysfunction, in part similar to ischemic cardiomyopathy. Altered protein homeostasis pathways were identified exclusively in PLN-R14∆/∆ mice, even before disease onset, in concert with aggregate formation. Conclusions: We mapped the development of PLN-R14del-related cardiomyopathy, and identified alterations in proteostasis and PLN protein aggregation amongst the first manifestations of this disease, which could possibly be a novel target for therapy.
-
14 GSE9924 对C57BL/6品系雄性小鼠的心脏组织进行基因表达分析,分为非转基因对照组、人类CryAB野生型转基因组和人类R120G CryAB转基因组,分别在3个月和6个月时间点采集样本,每组4-7个重复,使用微阵列检测,比较不同品系和时间点的基因表达差异。
设计对C57BL/6品系雄性小鼠的心脏组织进行基因表达分析,分为非转基因对照组、人类CryAB野生型转基因组和人类R120G CryAB转基因组,分别在3个月和6个月时间点采集样本,每组4-7个重复,使用微阵列检测,比较不同品系和时间点的基因表达差异。
摘要Protein aggregation cardiomyopathy is a life-threatening manifestation of a multisystem disorder caused by the exchange mutation in the gene encoding the human small HSP ?B-crystallin (hR120GCryAB). Genetic studies in mice have established cardiac hR120GCryAB expression causes increased activity of glucose 6-phosphate dehydrogenase (G6PD) and 'reductive stress' (Rajasekeran et al., Cell. 2007;130(3):401-2). However, the initiating molecular events in the pathogenesis of this novel toxic gain-of-function mechanism remain poorly defined. In an integrated systems approach using gene expression profiling, we identified a 'biosignature,' whose features can be validated to predict the onset, rate of progression, and clinical outcome of R120GCryAB cardiomyopathy. Keywords: time-course, genetic modification, disease state analysis
-
15 GSE201042 研究对象为心肌细胞,采用四种基因型小鼠(Ptpmt1心肌细胞特异性敲除、Eif2a突变、Gcn2敲除、Hri敲除)进行基因表达分析,通过RNA-seq检测转录组变化,比较各基因型间的差异。
设计研究对象为心肌细胞,采用四种基因型小鼠(Ptpmt1心肌细胞特异性敲除、Eif2a突变、Gcn2敲除、Hri敲除)进行基因表达分析,通过RNA-seq检测转录组变化,比较各基因型间的差异。
摘要To study the mitochondrial stress response HRI-eIF2a-ATF4 signaling pathway in mitochondrial cardiomyopathy , we generated Ptpmt1 cardiomyocytes-specific Knockout mcie, Eif2a mutant mcie, Gcn2 Knockout mcie, and Hri Knockout mcie
-
16 GSE129962 对野生型和Myh6-Cre:DspW/F小鼠的心脏肌细胞进行总RNA测序,比较不同基因型在3个月和6个月年龄,以及是否进行3个月耐力跑步机运动处理后的转录特征差异。样本量为30,其中每个处理条件(如不同年龄和运动状态)的样本数为5。
设计对野生型和Myh6-Cre:DspW/F小鼠的心脏肌细胞进行总RNA测序,比较不同基因型在3个月和6个月年龄,以及是否进行3个月耐力跑步机运动处理后的转录特征差异。样本量为30,其中每个处理条件(如不同年龄和运动状态)的样本数为5。
摘要Mutations in desmosome genes cause arrhyythmogenic cardiomyopathy (ACM). Using desmoplakin haploinsufficient mouse model of ACM, we evaluated the effects of treadmill exercise on cardiac myocyte transcritional profile. Strand specific, ribosome depleted paired end RNA sequencing of cardiac myocytes from wild type and Myh6-Cre:DspW/F were generate using Illumina HiSeq 4000.
-
17 GSE25700 对2月龄C57BL/6小鼠左心室总RNA进行基因表达分析,研究大豆饮食与酪蛋白饮食对野生型及HCM基因型雄性与雌性小鼠心脏基因表达的影响。每组样本由两只小鼠的RNA混合池组成,共包含8种分组:雄性/雌性、野生型/HCM基因型、大豆/酪蛋白饮食,分别采集左心室组织进行分析,比较不同饮食、性别和基因型组合下的基因表达差异。
设计对2月龄C57BL/6小鼠左心室总RNA进行基因表达分析,研究大豆饮食与酪蛋白饮食对野生型及HCM基因型雄性与雌性小鼠心脏基因表达的影响。每组样本由两只小鼠的RNA混合池组成,共包含8种分组:雄性/雌性、野生型/HCM基因型、大豆/酪蛋白饮食,分别采集左心室组织进行分析,比较不同饮食、性别和基因型组合下的基因表达差异。
摘要The perception that soy food products and dietary supplements will have beneficial effects on heart health has led to a massive consumer market. However, we have previously noted that diet has a profound effect on disease progression in a genetic model of hypertrophic cardiomyopathy (HCM). In this model, a soy-based diet negatively impacts cardiac function in male mice. Given the frequent correlation between functional changes and transcriptional changes, we investigated the effect of diet (soy- vs. milk-based) on cardiac gene expression and how it relates to the additional factors of sex and disease. We found that gene expression in the heart is altered more by diet than by sex or an inherited disease. We also found that the healthy male heart may be sensitized to dietary perturbations of gene expression in that it displays a gene expression profile more similar to diseased hearts than to healthy female hearts. These observations may in part account for divergence in HCM phenotypes between males and females and between diets.
-
18 GSE335239 对cMyBP-C缺失的转基因小鼠与野生型小鼠心脏组织进行RNA测序,比较两组基因表达差异,探究炎症及分子变化在肥厚型心肌病向心力衰竭进展中的作用。
设计对cMyBP-C缺失的转基因小鼠与野生型小鼠心脏组织进行RNA测序,比较两组基因表达差异,探究炎症及分子变化在肥厚型心肌病向心力衰竭进展中的作用。
摘要RNA sequencing was performed to investigate the role of inflammation and molecular changes in cardiac pathology and heart failure. Inflammation and array of fetal gene reprogramming often associated with the hypertrophied mouse hearts. To determine its functional consequences, transcriptomic profiling was used to characterize gene expression changes in a murine model of hypertrophic transition to dilated cardiomyopathy associated with loss of cMyBP-C, providing insight into the pathological pathways involved in transition from hypertrophic to dilated cardiomyopathy.
-
19 GSE253224 对Pkp2条件性敲除小鼠模型进行RNA测序,比较野生型(WT)与Pkp2敲除(cKO)小鼠在不同处理条件下的基因表达差异。WT小鼠接受HBSS处理(n=8),cKO小鼠分为HBSS组(n=8)、TN-401低剂量组(3E13 vg/kg,n=6)和TN-401高剂量组(6E13 vg/kg,n=6)。所有样本均来自左心室和右心室组织,检测方式为RNA-Seq,分析各组间基因表达变化。
设计对Pkp2条件性敲除小鼠模型进行RNA测序,比较野生型(WT)与Pkp2敲除(cKO)小鼠在不同处理条件下的基因表达差异。WT小鼠接受HBSS处理(n=8),cKO小鼠分为HBSS组(n=8)、TN-401低剂量组(3E13 vg/kg,n=6)和TN-401高剂量组(6E13 vg/kg,n=6)。所有样本均来自左心室和右心室组织,检测方式为RNA-Seq,分析各组间基因表达变化。
摘要Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a familial cardiac disease associated with ventricular arrhythmias and an increased risk of sudden cardiac death. Currently, there are no approved treatments that address the underlying genetic cause of this disease, representing a significant unmet need. Mutations in Plakophilin-2 (PKP2), encoding a desmosomal protein, account for approximately 40% of ARVC cases and result in reduced gene expression. Methods: Our goal is to examine the feasibility and the efficacy of adeno-associated virus 9 (AAV9)-mediated restoration of PKP2 expression in a cardiac specific knock-out mouse model of Pkp2. Results: We show that a single dose of AAV9:PKP2 gene delivery prevents disease development before the onset of cardiomyopathy and attenuates disease progression after overt cardiomyopathy. Restoration of PKP2 expression leads to a significant extension of lifespan by restoring cellular structures of desmosomes and gap junctions, preventing or halting decline in left ventricular ejection fraction, preventing or reversing dilation of the right ventricle, ameliorating ventricular arrhythmia event frequency and severity, and preventing adverse fibrotic remodeling. RNA sequencing analyses show that restoration of PKP2 expression leads to highly coordinated and durable correction of PKP2-associated transcriptional networks beyond desmosomes, revealing a broad spectrum of biological perturbances behind ARVC disease etiology. Conclusions: We identify fundamental mechanisms of PKP2-associated ARVC beyond disruption of desmosome function. The observed PKP2 dose-function relationship indicates that cardiac-selective AAV9:PKP2 gene therapy may be a promising therapeutic approach to treat ARVC patients with PKP2 mutations.
-
20 GSE106201 对野生型 C57BL6 和 Mst-1 过表达小鼠(DCM 模型)的左心室组织进行 RNA-seq,比较遗传性 galectin-3 敲除(Gal-3 KO)与药理学抑制(改良柑橘果胶处理 4 个月)对 DCM 表型的影响。研究包含四组基因型:非 TG(nTG)、KO、Mst-1 过表达(Mst1-TG)及 Mst1-TG 与 Gal-3 KO 组合(Mst1Gal3),每组 5-8 个重复样本,总样本数 26。
设计对野生型 C57BL6 和 Mst-1 过表达小鼠(DCM 模型)的左心室组织进行 RNA-seq,比较遗传性 galectin-3 敲除(Gal-3 KO)与药理学抑制(改良柑橘果胶处理 4 个月)对 DCM 表型的影响。研究包含四组基因型:非 TG(nTG)、KO、Mst-1 过表达(Mst1-TG)及 Mst1-TG 与 Gal-3 KO 组合(Mst1Gal3),每组 5-8 个重复样本,总样本数 26。
摘要Background: Galectin-3 is upregulated in heart disease, and its inhibition has been reported to confer benefits on cardiac remodeling and dysfunction. It remains unknown whether galectin-3 plays a biological role in a setting of dilated cardiomyopathy (DCM). We determined galectin-3 expression in transgenic (TG) mice with cardiac-restricted overexpression of mammalian sterile 20-like kinase 1 (Mst1-TG), and studied the effects of pharmacological and genetic inhibition of galectin-3 on the DCM phenotype. Methods and results: The DCM phenotype of male Mst1-TG mice was assessed at 2, 3 and 6 months of age. Galectin-3 deletion in Mst1-TG mice was achieved by cross-breeding Mst1-TG with galectin-3 knockout (KO) mice to produce genotypes of non-TG (nTG), KO, Mst1-TG, and Mst1-TG mice with partial or complete deletion of the galectin-3 gene. Pharmacological inhibition of galectin-3 was tested by treating Mst1-TG mice with modified citrus pectin for 4 months. Changes in the DCM phenotype were assessed by serial echocardiography, ECG recording and biochemical assays. Mst1-TG mice exhibited upregulated levels of cardiac galectin-3 expression by 40~50-fold, atrial dilatation, reduced left ventricular (LV) ejection fraction, increased LV volume at systole and diastole, atrial conduction delay, severe cardiac fibrosis, and upregulated fibrosis-related genes. Galectin-3 gene deletion in Mst1-TG mice attenuates increased LV volume at systole and diastole, atrial conduction delay and cardiac fibrogenesis. Treatment with modified citrus pectin in Mst1-TG mice did not confer benefit on the DCM phenotype, possibly due to the very high expression of galectin-3. Conclusion: Galectin-3 expression is markedly increased in Mst1-TG hearts exhibiting DCM. Galectin-3 gene deletion effectively suppressed cardiac fibrotic signaling and LV dilatation, and was associated with better function. Thus, suppression of galectin-3 expression may represent a potential therapeutic approach in DCM. The development of new galectin-3 inhibitors are warranted.
-
21 GSE179656 使用BAG3缺陷的诱导多能干细胞衍生心肌细胞(iPSC-CMs)和BAG3心脏敲除小鼠模型开展研究,将野生型(WT)与BAG3敲除型小鼠分别设为对照组和实验组,实验组接受TYA-018(HDAC6选择性抑制剂)处理,采集心脏组织进行RNA测序,比较不同基因型与处理条件下的转录组差异。
设计使用BAG3缺陷的诱导多能干细胞衍生心肌细胞(iPSC-CMs)和BAG3心脏敲除小鼠模型开展研究,将野生型(WT)与BAG3敲除型小鼠分别设为对照组和实验组,实验组接受TYA-018(HDAC6选择性抑制剂)处理,采集心脏组织进行RNA测序,比较不同基因型与处理条件下的转录组差异。
摘要Dilated cardiomyopathy (DCM) is characterized by reduced cardiac output, as well as thinning and enlargement of left ventricular chambers. These characteristics eventually lead to heart failure. Current standards of care do not target the underlying molecular mechanisms associated with genetic forms of heart failure, driving a need to develop novel therapeutics for DCM. To identify candidate therapeutics, we developed an in vitro DCM model using induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) deficient in BCL2-associated athanogene 3 (BAG3). With these BAG3-deficient iPSC-CMs, we identified cardioprotective drugs with a phenotypic screen and deep learning. Using a library of 5500 bioactive compounds and siRNA validation, we identified that inhibiting histone deacetylase 6 (HDAC6) was cardioprotective at the sarcomere level. We translated this finding to a BAG3 cardiac-knockout (BAG3cKO) mouse model of DCM, showing that inhibiting HDAC6 with two isoform-selective inhibitors (tubastatin A and a novel inhibitor TYA-018) protected heart function. In BAG3cKO and BAG3 E455K mice, HDAC6 inhibitors improved left ventricular ejection fraction and reduced left ventricular diameter at diastole and systole. We also found that HDAC6 inhibitors protected the microtubule network from mechanical damage, increased autophagic flux, decreased apoptosis, and reduced inflammation in the heart. Our results demonstrate the power of combining iPSC-CMs with phenotypic screening and deep learning to accelerate target and drug discovery, and they support the development of novel therapies that address underlying mechanisms associated with heart disease.
-
22 GSE134121 对心脏特异性过表达 OGA 和 OGT 的转基因小鼠及野生型小鼠进行转录组分析,采集整个心脏组织进行 RNA-Seq 测序,比较转基因组与野生型组的心脏转录特征差异,重点分析病理 OGN 水平导致的代谢紊乱变化。
设计对心脏特异性过表达 OGA 和 OGT 的转基因小鼠及野生型小鼠进行转录组分析,采集整个心脏组织进行 RNA-Seq 测序,比较转基因组与野生型组的心脏转录特征差异,重点分析病理 OGN 水平导致的代谢紊乱变化。
摘要Heart failure is a leading cause of death worldwide, and failing heart muscle is marked by increased O-GlcNAcylation (OGN). It is unknown if excessive OGN contributes to cardiomyopathy and heart failure. OGN modifies serines and threonines, total OGN levels follow cellular nutrient and metabolic flux in addition to net activity of O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). We developed new transgenic mouse models with myocardial delimited over-expression of OGA and OGT, and found that OGT transgenic mice developed severe cardiomyopathy and premature death. In contrast, OGA transgenic hearts had normal function, but were resistant to pathological stress. Interbreeding OGA transgenic mice rescued cardiomyopathy and premature death in OGT transgenic mice. RNA Seq and functional studies highlighted disrupted metabolism in hearts from OGT transgenic mice that was rescued by OGA transgenic interbreeding. Here we show excessive OGN causes cardiomyopathy, identify gene programs responsive to pathological OGN, and suggest attenuation of OGN may be an effective therapy for heart failure.
-
23 GSE16909 对雄性小鼠的左心室组织进行基因表达分析,比较Control(Cont或WT)与cardiac-specific EP4 KO(Tg或KO)小鼠的基因表达差异,样本量为24(Control n=11,Tg n=13)。
设计对雄性小鼠的左心室组织进行基因表达分析,比较Control(Cont或WT)与cardiac-specific EP4 KO(Tg或KO)小鼠的基因表达差异,样本量为24(Control n=11,Tg n=13)。
摘要Analysis of the effects of aging on the development of dilated cardiomyopathy by characterizing both changes in ejection fraction (EF) and gene expression profile in 3 groups of male mice: Control (Cont or WT, n=11) and transgenic (Tg or KO) mice with either high EF (KO-H or Tg-H, n=7) or low EF (KO-L or Tg-L, n=6). We previously produced a line of transgenic mice (Tg) on a mixed genetic background where cardiac-specific overexpression of Cre recombinase reduced expression of the EP4 receptor gene. There were no obvious phenotypes in 10-12-week-old male Tg mice. To determine if a cardiac phenotype developed in aged mice, we assessed cardiac structure and function by echocardiography, histology and gene expression in 23-33-week-old male Tg and littermates (Cont). After echocardiography, hearts were removed to assess hypertrophy (MCSA), fibrosis (ICF) and macrophage infiltration by histological methods and for extraction of total RNA and protein. Cont mice had a normal EF of 80±0.6% (n=70), whereas Tg mice had a lower EF (60±2.7%, n=55, p<0.001) coupled with left ventricular dilatation. The distribution of EFs in the Tg mice was large, ranging from normal to below 30%. MCSA and infiltrating macrophages were not different between groups, but ICF increased by 35% in Tg mice. Cre protein levels in heart lysates did not correlate with either age or EF. In contrast to male Tg mice, female Tg mice had no cardiac dysfunction assessed by echocardiography from 12 to 28 weeks of age. To understand gene expression differences between Cont and Tg mice, whole genome gene expression profiling (Illumina BeadChips) on hearts of 30-32 week old male mice was done. Data indicated that 595 genes were overexpressed in the Tg hearts, 156 of which changed more than 2-fold, including genes involved in remodeling, inflammation, and oxidative stress. 512 genes were downregulated in the Cont hearts, 79 of which changed more than 2-fold, including genes involved with calcium handling, K+ channels, and fatty acid transport and metabolism. In conclusion, Cre overexpression and EP4 knock down in cardiac myocytes in aged male but not female Tg mice are in part associated with increased fibrosis, reduced EF and dilated cardiomyopathy; however, Cre protein itself does not seem to be responsible for the cardiomyopathy. The absence of cardiac dysfunction in female mice suggests a sexual dimorphism in the phenotype. Creation of the cardiac-myocyte specific EP4 KO mouse and littermate controls was described in JY Qian et al, Hypertension 2008: 51(pt 2):560-566.
-
24 GSE262123 使用 FKbp1a floxed (FL) 小鼠构建两种 FKBP12 缺陷条件模型,分别通过 α-肌球蛋白重链启动子 (αMHC) 和肌肉肌酸激酶启动子 (MCK) 驱动 Cre+ 重组酶表达,差异体现在发育阶段 (E9 vs E13) 和 Cre+ 表达水平。采集全心组织进行 RNA 测序,比较 FKBP12 缺陷模型 (αMHC-Cre+ 和 MCK-Cre+) 与 FL 小鼠、仅 αMHC Cre+ 半合子小鼠的基因表达差异。
设计使用 FKbp1a floxed (FL) 小鼠构建两种 FKBP12 缺陷条件模型,分别通过 α-肌球蛋白重链启动子 (αMHC) 和肌肉肌酸激酶启动子 (MCK) 驱动 Cre+ 重组酶表达,差异体现在发育阶段 (E9 vs E13) 和 Cre+ 表达水平。采集全心组织进行 RNA 测序,比较 FKBP12 缺陷模型 (αMHC-Cre+ 和 MCK-Cre+) 与 FL 小鼠、仅 αMHC Cre+ 半合子小鼠的基因表达差异。
摘要To define the role of the immunophilin FKBP12 in cardiac function, two conditional models of FKBP12 deficiency were created using Fkbp1a floxed (FL) mice expressing Cre+ recombinase under the control of different promoters (α-myosin heavy chain, αMHC, and muscle creatine kinase, MCK) that differ in both developmental stage of expression (E9 versus E 13) and Cre+ expression levels. In adult mice FKBP12 was reduced by 96% and 86% in αMHC-Cre+- and MCK-Cre+-FKBP12 deficient mice, respectively, compared to FL mice. FL mice and mice hemizygous for the αMHC Cre+ recombinase only (to assess potential cytotoxic effects of the Cre+ recombinase) were used as controls. Of these four strains of mice, only the αMHC-Cre+-FKBP12 deficient mice developed an early-onset dilated cardiomyopathy (DCM) and displayed both increased cardiomyocyte sarcoplasmic reticulum Ca2+ leak and large elevations (assessed with RNAseq and western blots) in Ankyrin repeat domain 1 protein (ANKRD1), a negative regulator of cardiac gene expression in response to stress. These data suggest that an FKBP12 deficiency that begins during cardiac development and reduces FKBP12 below a critical level causes RyR2 mediated Ca2+ leak and ANKRD1 elevation, leading to cardiac structural remodeling and the development of DCM. This Ca2+ leak/ANKRD1 pathway may represent a common and targetable mechanism for DCM.
-
25 GSE349270 对携带 Rbm20 S639G 突变的转基因小鼠左心室组织进行 RNA 测序,比较 Rosa26+/+、Myh6-Cre、Rosa26Rbm20-S639G/+ 与 Rosa26Rbm20-S639G/+;Myh6-Cre 四种基因型小鼠的转录组差异,每组 6 只 1 月龄雄性小鼠,检测 polyA RNA 表达特征。
设计对携带 Rbm20 S639G 突变的转基因小鼠左心室组织进行 RNA 测序,比较 Rosa26+/+、Myh6-Cre、Rosa26Rbm20-S639G/+ 与 Rosa26Rbm20-S639G/+;Myh6-Cre 四种基因型小鼠的转录组差异,每组 6 只 1 月龄雄性小鼠,检测 polyA RNA 表达特征。
摘要Pathogenic genetic variants in the RBM20 gene, encoding the splicing factor RNA binding motif protein 20 (RBM20), are causative in a severe form of dilated cardiomyopathy (DCM) known as RBM20 cardiomyopathy.Certain variants in RBM20 disrupt a nuclear localization signal (NLS) in the protein, impairing nuclear import and leading to its accumulation in cytoplasmic granules.We recently showed that non-targeted knockdown of RBM20 improves cardiac function in mice heterozygous for an NLS-disrupting Rbm20 variant secondary to alleviation of cytoplasmic RBM20 granule burden. Notably, the improvement in cardiac function occurred despite similar or worsened mis-splicing of RBM20 target genes.These findings strongly support a role for cytoplasmic RBM20 granules in disease severity; yet it is not clear whether these molecular assemblies can drive the development of severe DCM. The findings of the present study directly demonstrate that cytoplasmic RBM20 granules cause severe DCM in mice with minimal contributions from target gene mis-splicing.
-
26 GSE42892 对携带 α-tropomyosin (Tm180) 突变的转基因小鼠、phospholamban (PLB) 敲除小鼠、Tm180/PLB 敲除杂交小鼠及非转基因对照小鼠的左心室组织进行微阵列分析,比较不同基因型在 4 个月和 12 个月年龄阶段的基因表达差异。研究对象为 12 月龄和 4 月龄小鼠的心脏组织,材料包括 Tm180 转基因、PLB 敲除、Tm180/PLB 敲除杂交及非转基因对照四类基因型,检测方式为微阵列表达分析,主要比较各基因型在不同年龄的基因表达变化。
设计对携带 α-tropomyosin (Tm180) 突变的转基因小鼠、phospholamban (PLB) 敲除小鼠、Tm180/PLB 敲除杂交小鼠及非转基因对照小鼠的左心室组织进行微阵列分析,比较不同基因型在 4 个月和 12 个月年龄阶段的基因表达差异。研究对象为 12 月龄和 4 月龄小鼠的心脏组织,材料包括 Tm180 转基因、PLB 敲除、Tm180/PLB 敲除杂交及非转基因对照四类基因型,检测方式为微阵列表达分析,主要比较各基因型在不同年龄的基因表达变化。
摘要Familial hypertrophic cardiomyopathy (FHC) is a disease characterized by ventricular hypertrophy, fibrosis, and aberrant systolic and/or diastolic function. Our laboratories have previously developed 2 mouse models that affect cardiac performance. One transgenic mouse model encodes an FHC-associated mutation in α-tropomyosin (Tm180) that displays severe cardiac hypertrophy with fibrosis and impaired physiological performance. The other model was a gene knockout of phospholamban (PLB), a regulator of calcium uptake in the sarcoplasmic reticulum of cardiomyocytes; the hearts of these mice exhibit hypercontractility with no pathological abnormalities. Previous work in our laboratories show that the hearts of mice that were genetically crossed between the Tm180 and PLB KO mice rescues the hypertrophic phenotype and improves their cardiac morphology and function. We used microarrays to detail the global program of gene expression underlying cardiac remodeling and rescue of the hypertrophic cardiomyopathic phenotype and identified distinct classes of regulated genes during this process.
-
27 GSE15848 对6个月龄的转基因 frataxin 缺陷小鼠(KIKO)与野生型小鼠(WT)心脏、骨骼肌和肝脏组织进行微阵列表达分析,比较两组间各组织的基因表达差异。采用Trizol法提取总RNA,使用BeadStudio平台进行量化并执行quantile标准化处理,检测对象包含心脏(KIKO E3/E6/E7/E4及对应control C3/C4/C8/C6)、骨骼肌(KIKO E3/E6/E7/E4及对应control C3/C4/C6)和肝脏(KIKO E3/E6/E7及对应control C3/C4/C8)的RNA表达谱。
设计对6个月龄的转基因 frataxin 缺陷小鼠(KIKO)与野生型小鼠(WT)心脏、骨骼肌和肝脏组织进行微阵列表达分析,比较两组间各组织的基因表达差异。采用Trizol法提取总RNA,使用BeadStudio平台进行量化并执行quantile标准化处理,检测对象包含心脏(KIKO E3/E6/E7/E4及对应control C3/C4/C8/C6)、骨骼肌(KIKO E3/E6/E7/E4及对应control C3/C4/C6)和肝脏(KIKO E3/E6/E7及对应control C3/C4/C8)的RNA表达谱。
摘要Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARγ pathway as a therapeutic target in Friedreich's ataxia Friedreich's ataxia (FRDA), the most common inherited ataxia, is characterized by focal neurodegeneration, diabetes mellitus, and life-threatening cardiomyopathy. Frataxin, which is significantly reduced in patients with this recessive disorder, is a mitochondrial iron-binding protein, but how its deficiency leads to neurodegeneration and metabolic derangements is not known. We performed microarray analysis of heart and skeletal muscle in a mouse model of frataxin deficiency, and found molecular evidence of increased lipogenesis in skeletal muscle, and alteration of fiber-type composition in heart, consistent with insulin resistance and cardiomyopathy, respectively. Since the peroxisome proliferator-activated receptor gamma (PPARγ) pathway is known to regulate both processes, we hypothesized that dysregulation of this pathway could play a key role in frataxin deficiency. We confirmed this by showing a coordinate dysregulation of the PPARγ coactivator Pgc1a and transcription factor Srebp1 in cellular and animal models of frataxin deficiency, and in cells from FRDA patients, who have marked insulin resistance. Finally, we show that genetic modulation of the PPARγ pathway affects frataxin levels in vitro, supporting PPARγ as a novel therapeutic target in FRDA.
-
28 GSE221675 将 TAZ knockout (KO/Y) 与同窝野生型 (WT/Y) 小鼠在 C57BL6J、CAST/EiJ 和 A/J 遗传背景下进行比较,使用心室组织的总 RNA 进行 RNA 测序,年龄为 2 个月。
设计将 TAZ knockout (KO/Y) 与同窝野生型 (WT/Y) 小鼠在 C57BL6J、CAST/EiJ 和 A/J 遗传背景下进行比较,使用心室组织的总 RNA 进行 RNA 测序,年龄为 2 个月。
摘要TAZ knockout (KO/Y) and littermate control (WT/Y) mice were generated by crossing TAZ(KO/X) females in the C57BL6J background to male mice from C57BL6J, CAST/EiJ or A/J backgrounds. F1 mutant males in C57 and CAST-F1 backgrounds had cardiomyopathy and low heart function, whereas A/J F1 mutant males had normal heart function.
-
29 GSE315790 对携带tropomyosin E180G突变的HCM小鼠及野生型小鼠左心室组织进行RNA-Seq分析,比较其在控制饮食(CD)与含sotagliflozin(SOTA)饮食处理下的基因表达差异。实验将7-8周龄雄性小鼠随机分配至SOTA饮食组(30 mg/kg chow)或CD对照组,持续8周。治疗期间每周测量体重,第4周和第8周通过超声心动图评估心脏结构与功能,第8周处死小鼠以获取心室组织进行转录组测序。样本按处理分组,每组包含不同基因型(E180G或WT),具体分组为:E180G-CD、E180G-SOTA、WT-CD、WT-SOTA。检测方式为总RNA提取后进行高通量测序,数据对齐至小鼠mm10基因组。
设计对携带tropomyosin E180G突变的HCM小鼠及野生型小鼠左心室组织进行RNA-Seq分析,比较其在控制饮食(CD)与含sotagliflozin(SOTA)饮食处理下的基因表达差异。实验将7-8周龄雄性小鼠随机分配至SOTA饮食组(30 mg/kg chow)或CD对照组,持续8周。治疗期间每周测量体重,第4周和第8周通过超声心动图评估心脏结构与功能,第8周处死小鼠以获取心室组织进行转录组测序。样本按处理分组,每组包含不同基因型(E180G或WT),具体分组为:E180G-CD、E180G-SOTA、WT-CD、WT-SOTA。检测方式为总RNA提取后进行高通量测序,数据对齐至小鼠mm10基因组。
摘要Background. Hypertrophic cardiomyopathy (HCM) is associated with mitochondrial dysfunction and oxidative stress. Our goal was to determine the effects of the dual SGLT1 and SGLT2 inhibitor sotagliflozin (SOTA) on myocardial remodeling, diastolic function, mitochondrial gene expression and oxidative stress in mice with HCM due to the tropomyosin E180G mutation (E180G). Methods. Male E180G and non-carrier (NC) mice 7-8 weeks old were randomized to SOTA formulated in the chow (30 mg/kg chow) or control diet (CD) for 8 weeks. Cardiac structure and function were assessed by echocardiography at baseline, and after 4 and 8 weeks of treatment. At 8 weeks mice were sacrificed to assess myocardial histology, RNA expression, oxidative stress and oxidative sulfonylation of sarcoplasmic reticulum calcium ATPase (SERCA). Results. At baseline E180G mice had myocardial hypertrophy, interstitial fibrosis, diastolic dysfunction and atrial enlargement - all of which worsened over the next 8 weeks. In E180G mice treatment with SOTA for 8 weeks prevented further LV hypertrophy and atrial enlargement, decreased interstitial fibrosis and normalized diastolic function. Mitochondrial gene sets were downregulated, and oxidative stress was increased and associated with oxidative sulfonylation of SERCA at C674. SOTA treatment upregulated mitochondrial gene sets and prevented the increases in oxidative stress and SERCA oxidation. Upregulated fibrosis gene sets in E180G hearts were not affected by SOTA. Conclusion. In E180G HCM mice downregulation of mitochondrial gene sets is associated with increased oxidative stress and oxidative modification of SERCA. In E180G hearts, SOTA corrected the HCM phenotype, normalized diastolic function, upregulated mitochondrial gene sets, and decreased oxidative stress and SERCA oxidation. Upregulation of mitochondrial gene sets leading to improved mitochondrial function may improve energetics and decrease oxidative stress. Oxidative stress leads to oxidative modification of SERCA and stimulation of fibrosis pathways which may play a significant role in HCM, and thus provide an opportunity for therapeutic intervention with agents that improve mitochondrial function and/or decrease oxidative stress.
-
30 GSE247576 对Taz基因系统性减少的小鼠心脏和骨骼肌组织与同龄野生型对照组进行比较,采用Doxycycline处理至20周龄,采集总RNA进行RNA测序,分析不同基因型在心脏和骨骼肌中的转录组差异。按总单位数与组数估计,每组5个样本。
设计对Taz基因系统性减少的小鼠心脏和骨骼肌组织与同龄野生型对照组进行比较,采用Doxycycline处理至20周龄,采集总RNA进行RNA测序,分析不同基因型在心脏和骨骼肌中的转录组差异。按总单位数与组数估计,每组5个样本。
摘要Barth Syndrome (BTHS) is an inherited cardiomyopathy caused by defects in the mitochondrial transacylase TAFAZZIN (Taz), required for the synthesis of the phospholipid cardiolipin. BTHS is characterized by heart failure, increased propensity for arrhythmias and a blunted inotropic reserve. Defects in Ca2+-induced Krebs cycle activation contribute to these functional defects, but despite oxidation of pyridine nucleotides, no oxidative stress developed in the heart. Here, we investigated how retrograde signaling pathways orchestrate metabolic rewiring to compensate for mitochondrial defects. In mice with an inducible knockdown (KD) of TAFAZZIN, mitochondrial uptake and oxidation of fatty acids was strongly decreased, while glucose uptake was increased. Unbiased transcriptomic analyses revealed that the activation of the eIF2/ATF4 axis of the integrated stress response upregulates one-carbon metabolism, which diverts glycolytic intermediates towards the biosynthesis of serine and fuels the biosynthesis of glutathione. In addition, strong upregulation of the glutamate/cystine antiporter xCT increases cardiac cystine import required for glutathione synthesis. Increased glutamate uptake facilitates anaplerotic replenishment of the Krebs cycle, sustaining energy production and antioxidative pathways. These data indicate that ATF4-driven rewiring of metabolism compensates for defects in mitochondrial uptake of fatty acids to sustain energy production and antioxidation.
-
31 GSE54681 在转基因小鼠模型中,于心脏损伤后不同时间点采集左心室心肌组织,通过微阵列分析比较非心力衰竭对照组、早期心力衰竭(2和3天后)、高峰心力衰竭(10天)及恢复期(28天)的基因表达差异。研究对象为雄性C57Bl6/J小鼠,年龄12-20周,采用转基因Cre系统(MerCreMer, MCM, 005650)诱导短暂性心肌病,通过腹腔注射tamoxifen自由碱(5天,40mg/kg/day)引发病理变化,后续在正常饮食下观察恢复过程。检测方式为总RNA提取后进行微阵列表达分析,主要比较各时间点基因型与病理状态下的转录组差异。
设计在转基因小鼠模型中,于心脏损伤后不同时间点采集左心室心肌组织,通过微阵列分析比较非心力衰竭对照组、早期心力衰竭(2和3天后)、高峰心力衰竭(10天)及恢复期(28天)的基因表达差异。研究对象为雄性C57Bl6/J小鼠,年龄12-20周,采用转基因Cre系统(MerCreMer, MCM, 005650)诱导短暂性心肌病,通过腹腔注射tamoxifen自由碱(5天,40mg/kg/day)引发病理变化,后续在正常饮食下观察恢复过程。检测方式为总RNA提取后进行微阵列表达分析,主要比较各时间点基因型与病理状态下的转录组差异。
摘要Altered myocardial gene expression from heart failure (HF) has mostly been identified by single-point analysis of end-stage disease. This may miss earlier changes in gene expression that are transient and/or directionally opposite to those observed later. By sampling left ventricular myocardial tissue at different time points in a mouse model of cardiomyopathy, we examined differentially expressed transcripts between non-failing controls, early-HF (2 and 3 days after cardiac insult), peak-HF (10 days) and after recovery from HF (28 days). As a results, we found that gene expression followed varying patterns: Downregulation of metabolic pathways occurred early and was sustained into late stage-HF. In contrast, most signaling pathways undergo a complex biphasic pattern: Calcium signaling, p53, apoptosis and MAP-kinase pathways displayed a bi-directional response, declining early but rising late, while NF-κB-related transcription displayed the opposite pattern. The HF-induced transcriptomic changes were reversed after recovery at 28 days. We conclude that the myocardial transcriptome in evolving HF displays distinct and dynamic transcript clusters. Therapies targeting different phases of HF should consider these dynamic features when identifying high-value targets.
-
32 GSE116200 将16个月大的Bag3-P209L转基因小鼠与同龄Bag3-WT小鼠的心肌细胞和成纤维细胞进行RNA测序,比较两种基因型的转录组差异。
设计将16个月大的Bag3-P209L转基因小鼠与同龄Bag3-WT小鼠的心肌细胞和成纤维细胞进行RNA测序,比较两种基因型的转录组差异。
摘要Cardiac-specific Bag3-P209L transgenic (Tg+) mice develop dilated cardiomyopathy by 12 months of age. The goals of this project are to utilize RNA-sequencing to compare both cardiomyocyte and cardiac fibroblast transcriptomes between aged Bag3-P209L Tg+ and Bag3-WT mice to identify cardiomyocyte and fibroblast specific gene sets that contribute to the functional and morphological changes previously identified in Bag3-P209L Tg+ hearts.
-
33 GSE133693 将LMNA纯合敲除小鼠与野生型小鼠的心肌组织分别在1周、2周、1月三个时间点采集,使用RNeasy Fibrous Tissue Mini Kit提取总RNA并经Illumina TruSeq RNA Sample Prep Kit构建测序文库,通过RNA-Seq检测基因表达差异,比较不同基因型在三个时间点的转录组变化。
设计将LMNA纯合敲除小鼠与野生型小鼠的心肌组织分别在1周、2周、1月三个时间点采集,使用RNeasy Fibrous Tissue Mini Kit提取总RNA并经Illumina TruSeq RNA Sample Prep Kit构建测序文库,通过RNA-Seq检测基因表达差异,比较不同基因型在三个时间点的转录组变化。
摘要Gene expression profiling in homozygous LMNA-/- mouse model with cardiomyopathy phenotype unraveled novel LMNA-mediated alterations of signaling pathways leading to dilated cardiomyopathy
-
34 GSE164353 将小鼠左心室组织分为野生型(WT)和Ythdc1敲除(KO)组,每组按总样本数18与组数估计为9个,进行RNA-Seq检测,比较两组mRNA表达差异。
设计将小鼠左心室组织分为野生型(WT)和Ythdc1敲除(KO)组,每组按总样本数18与组数估计为9个,进行RNA-Seq检测,比较两组mRNA表达差异。
摘要N6-methyladenosine (m6A) is the most common internal modification in eukaryotic messenger RNAs (mRNAs) and plays essential roles in mammals. The function of this chemical modification is deciphered by m6A-specific binding proteins of the YTH family. Recent studies indicated that m6A methyltransferase METTL3 ('writer') and demethylase FTO ('eraser') play critical roles in cardiovascular diseases. However, function of m6A 'reader' proteins in the heart is still largely unknown. Here, we report that cardiac-specific ablation of Ythdc1 in postnatal heart exhibits progressive dilated cardiomyopathy, heart failure and dramatically increases the incidence of postnatal lethality. Mechanically, the transcript of Titin-the major DCM and heart failure related gene-is decorated by m6A modification and directly recognized by YTHDC1, deficiency of Ythdc1 in heart results in abnormal splicing of TTN and disarray of sarcomeric structures in the cardiomyocytes subsequently. Collectively, we demonstrated that YTHDC1-dependent TTN splicing is crucial for the postnatal heart development and cardiac function, which probably provides a potential target for treating DCM through tuning m6A modification of TTN mRNA.
-
35 GSE225008 对MLPKO小鼠与同龄野生型小鼠的左心室中隔组织进行RNA测序,采集三周、六周和十周龄样本(每组3只),比较不同年龄阶段基因型对基因表达的影响。
设计对MLPKO小鼠与同龄野生型小鼠的左心室中隔组织进行RNA测序,采集三周、六周和十周龄样本(每组3只),比较不同年龄阶段基因型对基因表达的影响。
摘要To investigate molecular profiles of progressive heart failure, we studied mice that lack expression of the muscle LIM protein (MLPKO). These mice showed dramatic HF progression between three and six weeks of age. We then performed gene expression profile analysis using data obtained from RNA-seq of mid wall left ventricular heart tissue from MLPKO mice and wild-type (WT) controls at three, six, and ten weeks of age (n=3 per group).
-
36 GSE240745 针对LMNA扩张型心肌病小鼠模型的心脏组织,设置WT对照组、Lmna shRNA处理组、Lmna shRNA+Lamin C组及Lmna shRNA+Lamin A组,采用RNA测序检测基因表达,比较心脏功能、纤维化、炎症及DNA损伤等指标。其中,Lamin C或Sun1 shRNA处理组与对照组相比,生存期延长,而Lamin A补充未改善生存期。
设计针对LMNA扩张型心肌病小鼠模型的心脏组织,设置WT对照组、Lmna shRNA处理组、Lmna shRNA+Lamin C组及Lmna shRNA+Lamin A组,采用RNA测序检测基因表达,比较心脏功能、纤维化、炎症及DNA损伤等指标。其中,Lamin C或Sun1 shRNA处理组与对照组相比,生存期延长,而Lamin A补充未改善生存期。
摘要Dilated cardiomyopathy (DCM) is a severe, non-ischemic heart disease, which ultimately results in heart failure (HF). Pathological genetic variants in LMNA cause DCM, which currently lacks specific treatment. Perturbing candidates related to dysregulated pathways have shown to ameliorate LMNA DCM, but their long-term efficacy as potential therapeutic targets is unknown. Here, we evaluated 14 potential candidates including Lmna gene products, key signaling pathways, calcium handling, proliferation regulators and Lamin interacting proteins, in a cardiac-specific Lmna DCM model. The candidates with improved cardiac function were further assessed through survival analysis. After comparing cardiac function, marker gene expression, Tgfβ signaling pathway activation, fibrosis, inflammation, proliferation, and DNA damage, we uncovered that restored cardiac function significantly correlated with suppression of HF/fibrosis marker expression and cardiac fibrosis in Lmna DCM. Interestingly, Lamin C or Sun1 shRNA administration achieved consistent, prolonged survival which highly correlated with reduced heart inflammation and DNA damage. In addition to Sun1 shRNA, perturbing the interaction between the nucleoskeleton and cytoskeleton via the KASH domain of Nesprin1 also effectively suppressed Lmna DCM. In contrast, Lamin A supplementation did not rescue long term survival and may impart a detrimental cardiotoxicity risk. Furthermore, transcriptome profiling was used to compare the differences between Lamin A and Lamin C treatment. Mechanistically, we identified that this lapse was attributed to a dose-dependent toxicity of Lamin A, which was independent of its maturation. This study highlights the potential for advancing Lamin C and Sun1 as therapeutic targets for the treatment of LMNA DCM.
-
37 GSE268984 将心脏特异性过表达Gαq的非糖尿病小鼠与野生型小鼠分为四组,分别接受ERTU饮食或对照饮食处理,每组样本数按总单位数18与组数4估计,采集左心室组织进行RNA测序,比较基因型与处理的交互作用对线粒体基因表达和功能的影响。
设计将心脏特异性过表达Gαq的非糖尿病小鼠与野生型小鼠分为四组,分别接受ERTU饮食或对照饮食处理,每组样本数按总单位数18与组数4估计,采集左心室组织进行RNA测序,比较基因型与处理的交互作用对线粒体基因表达和功能的影响。
摘要Background. Mitochondrial dysfunction with decreased ATP production and increased release of reactive oxygen species (ROS) is a hallmark of the failing heart. Although SGLT2 inhibitors have been shown to improve myocardial metabolism in the failing heart, independent of diabetes, the mechanism of this effect is not clear. Objectives. Our goal was to test the effect of the SGLT2 inhibitor ertugliflozin on mitochondrial gene expression and function in myocardium and isolated mitochondria from non-diabetic mice with dilated cardiomyopathy due to cardiac-specific over-expression of Gαq. Methods. Gαq and wild-type (WT) littermates 4 weeks of age were treated for 16 weeks with or without the SGLT2 inhibitor ertugliflozin (ERTU) formulated in the chow (0.5 mg/g chow). Results. From weeks 4 to 20, Gαq mice developed progressive cardiac hypertrophy, dilation, contractile dysfunction, myocyte apoptosis and interstitial fibrosis – all of which were prevented by ERTU treatment. Isolated cardiac mitochondria from Gαq mice had decreased maximal ATP production and increased ROS release - both of which were normalized by ERTU. In isolated beating hearts from Gαq mice, contractile reserve and high energy phosphates measured simultaneously by 31P NMR spectroscopy were decreased - and both were improved by ERTU. In Gαq mice, marked suppression of myocardial gene programs for oxidative phosphorylation and fatty acid metabolism was reversed by ERTU. Conclusions. The SGLT2 inhibitor ERTU corrected the expression of myocardial gene programs for oxidative phosphorylation and fatty acid metabolism, thereby leading to increased production of ATP, decreased release of mitochondrial ROS, and amelioration of the consequences of mitochondrial dysfunction on myocardial structure and function.
-
38 GSE292553 对转基因小鼠心脏组织进行RNA测序,比较野生型(WT)、CHD7 T720A杂合(Chd7T720A/+)和CHD7 T720A纯合(Chd7T720A/T720A)基因型在雄性和雌性中的转录组差异。研究对象为C57BL/6品系小鼠,样本按基因型和性别分组,每组包含3个生物重复,共18个GSM记录。
设计对转基因小鼠心脏组织进行RNA测序,比较野生型(WT)、CHD7 T720A杂合(Chd7T720A/+)和CHD7 T720A纯合(Chd7T720A/T720A)基因型在雄性和雌性中的转录组差异。研究对象为C57BL/6品系小鼠,样本按基因型和性别分组,每组包含3个生物重复,共18个GSM记录。
摘要Loss-of-function of the chromatin remodeler CHD7 causes CHARGE syndrome, characterized by variable penetrance and diverse abnormalities. However, establishing genotype-phenotype correlations has been challenging, as most CHD7 inactivating mutations are null alleles. Through CHD7 missense variant analysis at potential phosphorylation sites, we identified T730 (T720 in mice) as a critical residue associated with pathogenesis. Using a CHD7 T730 missense mutation (Chd7T720A) and a frameshift null allele (Chd7fs) in a mouse model, we found that Chd7fs/fs mice were non-viable, while Chd7fs/+ mice exhibited haploinsufficiency-related circling behavior. Notably, Chd7fs/T720A mice died before postnatal day 2, indicating the Chd7T720A allele is hypomorphic. Micro-CT analysis at E18.5 revealed heterozygous mice primarily exhibited hypertrophic cardiomyopathy (HCM), while homozygous mice developed both HCM and dilated cardiomyopathy (DCM). RNA-seq analysis of neonatal Chd7T720A/T720A hearts revealed a disrupted transcriptome, which in males and females was characterized by downregulation of mitochondrial energy metabolism genes and enrichment of ETS family transcription factor targets. We further identified GSK3β, GSK3α, HIPK1, and DYRK2 as candidate kinases for this site, suggesting a regulatory role in CHD7. This missense mutation causing developmental heart abnormalities establishes the first genotype-phenotype correlation for CHD7, and offers new insights into CHARGE syndrome pathogenesis.
-
39 GSE308777 对携带LMNA基因突变的成年小鼠心脏组织进行bulk RNA测序,比较野生型、R249Q纯合突变型和L35P杂合突变型样本在不同处理条件下的转录组差异。WT样本未接受处理,R249Q突变样本接受AAV9: control处理,L35P突变样本接受AAV9: ABE+sgRNA5处理,同时包含AAV9: ABE+sgRNA3处理的R249Q样本。检测采用RNA-Seq技术,样本来源为心脏组织,主要比较突变型与野生型在基因编辑处理前后的转录特征变化。
设计对携带LMNA基因突变的成年小鼠心脏组织进行bulk RNA测序,比较野生型、R249Q纯合突变型和L35P杂合突变型样本在不同处理条件下的转录组差异。WT样本未接受处理,R249Q突变样本接受AAV9: control处理,L35P突变样本接受AAV9: ABE+sgRNA5处理,同时包含AAV9: ABE+sgRNA3处理的R249Q样本。检测采用RNA-Seq技术,样本来源为心脏组织,主要比较突变型与野生型在基因编辑处理前后的转录特征变化。
摘要Mutations in the lamin A (LMNA) gene, which encodes the lamin A and C proteins, cause severe human diseases collectively known as laminopathies. These conditions are often devastating and lack effective therapies. In this study, we developed precise base editing (BE) strategies targeting the human LMNA gene variants L35P and R249Q, which cause Congenital Muscular Dystrophy (CMD) and Dilated Cardiomyopathy with Conduction Defects (DCM-CD), respectively. Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) carrying the R249Q mutation displayed nuclear aberrations, DNA damage, and abnormal Ca2+ transients. Similarly, L35P iPSC-CMs exhibited abnormal contraction, DNA damage, and reduced lamin A/C protein expression. We also generated novel “humanized” mouse models carrying these pathogenic human mutations. R249Q homozygous mice exhibited cardiac conduction abnormalities, cardiac arrhythmias, and premature death. Mice with the homozygous L35P mutation displayed severe muscle-wasting and reduced lifespan, while heterozygous L35P mice displayed dilated cardiomyopathy (DCM). We developed an adenine base editing (ABE) approach for correcting the R249Q mutation and a cytosine base editing (CBE) strategy for the L35P variant. Precise correction of these mutations in iPSC-CMs successfully rescued all of the in vitro abnormalities. Furthermore, delivery of the BE components using adeno-associated virus (AAV) prevented the pathological phenotypes and extended longevity of mice carrying the LMNA L35P and the R249Q mutations. These results demonstrate the efficacy of ABE and CBE in correcting pathogenic LMNA mutations that cause cardiac disease, highlighting BE as a promising therapeutic approach for human laminopathies.
-
40 GSE318858 对TM54 (Myh6-Tpm1*E54K)小鼠与野生型小鼠心脏组织进行RNA-seq分析,两组小鼠均接受AAV9sc.shControl或AAV9sc.shCDC14A处理,按3-6只/队列分组,比较不同基因型与处理条件下的基因表达差异。
设计对TM54 (Myh6-Tpm1*E54K)小鼠与野生型小鼠心脏组织进行RNA-seq分析,两组小鼠均接受AAV9sc.shControl或AAV9sc.shCDC14A处理,按3-6只/队列分组,比较不同基因型与处理条件下的基因表达差异。
摘要RNA-seq analysis was performed to study the effect of cardiomyocyte-specific CDC14a RNA interference on gene expression in the TM54 (Myh6-Tpm1*E54K) mouse dilated cardiomyopathy model.
-
41 GSE125603 对86周龄野生型(WT)和CAP2-/-小鼠心脏组织进行RNA-seq分析,实验A包含3个WT重复和3个CAP2-/-重复;实验B针对13周龄Loxp小鼠(5个重复)和L/L,Myh6-cre+小鼠(4个重复),采用Illumina GAIIx平台测序,其中KO_m_1623样本因原始测序失败后重新测序被纳入。检测对象为总RNA,比较CAP2-/-与WT基因型在心脏组织中的转录特征差异。
设计对86周龄野生型(WT)和CAP2-/-小鼠心脏组织进行RNA-seq分析,实验A包含3个WT重复和3个CAP2-/-重复;实验B针对13周龄Loxp小鼠(5个重复)和L/L,Myh6-cre+小鼠(4个重复),采用Illumina GAIIx平台测序,其中KO_m_1623样本因原始测序失败后重新测序被纳入。检测对象为总RNA,比较CAP2-/-与WT基因型在心脏组织中的转录特征差异。
摘要About one third of dilated cardiomyopathy (DCM) cases are caused by mutations in sarcomere or cytoskeletal proteins. Yet treating the cytoskeleton directly is not possible because drugs that bind to actin are not well tolerated. Mutations in the actin binding protein CAP2 can cause DCM and knockout mice, either whole body (CAP2 KO) or cardiomyocyte specific knockouts (CAP2 CKO), develop DCM with cardiac conduction disease. RNA-seq analysis of CAP2 KO hearts and isolated cardiomyocytes revealed over-activation of fetal genes including serum response factor (SRF) regulated genes such as Myl9 and Acta2 prior to the emergence of cardiac disease. To test if we could treat CAP2 KO mice, we synthesized and tested the SRF inhibitor CCG-1423-8u. CCG-1423-8u reduced expression of the SRF targets Myl9 and Acta2, as well as the biomarker of heart failure, NPPA. The median survival of CAP2 CKO mice was 98 days, while CCG-1423-8u treated CKO mice survived for 116 days and also maintain normal cardiac function longer. These results suggest that some forms of sudden cardiac death and cardiac conduction disease are under cytoskeletal stress and that inhibiting signaling through SRF may benefit DCM by reducing cytoskeletal stress.
-
42 GSE144098 对携带cTnC-A8V突变的Homozygous小鼠与野生型小鼠的左心室组织进行RNA测序,比较两组在雄性和雌性中的转录组差异。采用Illumina HiSeq 2500平台,8个生物重复。
设计对携带cTnC-A8V突变的Homozygous小鼠与野生型小鼠的左心室组织进行RNA测序,比较两组在雄性和雌性中的转录组差异。采用Illumina HiSeq 2500平台,8个生物重复。
摘要Heart disease remains the number one killer of women in the US. Nonetheless, studies in women and female animal models continue to be underrepresented in cardiac research. Hypertrophic cardiomyopathy (HCM), the most commonly inherited cardiac disorder, has been tied to sarcomeric protein variants. Among the susceptible genes, TNNC1—encoding cardiac troponin C (cTnC)—has contributed to a substantial HCM phenotype in mice. In this study we sought to characterize the sexual dimorphism observed within cardiac physiology and transcriptomics of adult male and female mice bearing the HCM-associated cTnC-A8V point mutation. The HCM mice showed a significant decrease in stroke volume, left ventricular diameter, volume, and relative wall thickness. Importantly, isovolumetric contraction time was significantly higher for female HCM mice. RNA sequencing revealed several altered canonical pathways within the HCM mice vs WT groups including an increase in EIF2 signaling, ILK signaling, actin nucleation by ARP-WASP complex, regulation of actin-based motility by Rho, VDR/RXR activation, and glutathione redox reactions pathways. In contrast, Valine Degradation, TCA Cycle II, Methionine Degradation, and Inositol Phosphate Compound pathways were notably down regulated in HCM mice. HCM male vs. female mice followed similar trends of the canonical pathways altered between the HCM and WT. Interestingly, seven of the genes that were differentially expressed in both the WT and HCM male vs female comparisons changed directions in fold change between the sexes. These data suggest a sexually-dimorphic HCM phenotype and identify several key pathways and genes that could be critical to sex differences seen in disease manifestation.
-
43 GSE153124 研究对象为心脏组织,材料来自C57BL/6小鼠,分组为野生型(Dsg2+/+)和Dsg2-/-基因型,分别在2周和10周龄时采集样本进行RNA测序,比较不同基因型在不同年龄的转录组差异。
设计研究对象为心脏组织,材料来自C57BL/6小鼠,分组为野生型(Dsg2+/+)和Dsg2-/-基因型,分别在2周和10周龄时采集样本进行RNA测序,比较不同基因型在不同年龄的转录组差异。
摘要We studied how loss of the desmosome associated protein, desmoglein-2 (Dsg2), in the heart leads to Arrhythmogenic Cardiomyopathy with particular interest in the early stages of disease progression. Mice expressing the cardiac αMHC-Cre promoter were crossed with Dsg2 floxed mice in which exon 4-5 of the Dsg2 gene was flanked by loxP sites, resulting in Cre-mediated excision of Dsg2 in cardiac myocytes. Wild type Dsg2+/+ (Cre-, Dsg2flx/flx) and knockout Dsg2-/- (Cre+, Dsg2flx/flx) mice were generated. RNA-seq was performed on heart tissue obtained from wild-type and Dsg2-/- mice at 2-weeks and 10-weeks of age.
-
44 GSE218672 对新生(P1)及 2 月龄 Rbpms 心脏特异性敲除小鼠与对照小鼠的心脏室壁组织进行 RNA 测序,比较不同年龄组间基因表达及可变剪接差异。研究对象为心脏室壁组织,材料包括 Rbpms fl/fl 野生型及 Myh6-Cre, Rbpms fl/fl 敲除型小鼠,分组依据年龄(P1 和 8 周)及基因型(野生型与敲除型),检测方式为配对末端 RNA 测序,主要比较不同年龄组间 Rbpms 敲除与野生型小鼠的转录组差异。
设计对新生(P1)及 2 月龄 Rbpms 心脏特异性敲除小鼠与对照小鼠的心脏室壁组织进行 RNA 测序,比较不同年龄组间基因表达及可变剪接差异。研究对象为心脏室壁组织,材料包括 Rbpms fl/fl 野生型及 Myh6-Cre, Rbpms fl/fl 敲除型小鼠,分组依据年龄(P1 和 8 周)及基因型(野生型与敲除型),检测方式为配对末端 RNA 测序,主要比较不同年龄组间 Rbpms 敲除与野生型小鼠的转录组差异。
摘要Background: Modulation of mRNA splicing acts as an important layer of gene regulation, in addition to transcriptional regulation and epigenetic modifications. RNA binding proteins (RBPs) play essential roles in mediating RNA splicing and are key regulators of heart development and function. Our previous studies demonstrated that RBPMS (RNA-binding protein with multiple splicing) regulates cardiac development through modulating mRNA splicing during embryogenesis. Here we explored the postnatal function of RBPMS in the heart. Methods: We ablated Rbpms in the heart by generating a cardiac-specific knockout mouse line (Myh6-Cre, Rbpmsfl/fl), and evaluated its cardiac functions by histology, echocardiography, and gene expression. Paired-end RNA sequencing and RT-PCR were performed to identify and validate splicing targets of RBPMS in adult mouse hearts. Proximity-dependent Biotin Identification (BioID) assay and mass spectrometry analysis were performed to identify RBPMS binding partners. We also measured contractility and calcium fluxes in isolated mouse cardiomyocytes, and contractile forces of cardiac papillary muscle. Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) were also used as a model to explore the influence of RBPMS on contractility of human cardiomyocytes. Results: he absence of Rbpms in the heart led to dilated cardiomyopathy (DCM) and heart failure, causing early death in mice. Mice with cardiac-specific knockout of Rbpms showed myocardium noncompaction with reduced cardiomyocyte number at the neonatal stage and developed DCM with pervasive myocardial fibrosis in adulthood. We found that RBPMS mediates a largely distinct RNA splicing profile in adult mouse hearts compared to neonatal hearts, indicating a stage-specific modulation of alternative RNA splicing by RBPMS. In adult hearts, RBPMS mainly influenced alternative splicing of genes associated with sarcomere structures and cardiomyocyte contraction, such as Ttn, Pdlim5 and Nexn, to generate new protein isoforms. In neonatal hearts, RBPMS influenced the splicing of cytoskeletal genes. RBMPS was associated with spliceosome factors and other RNA binding proteins that play important roles in the heart, such as RBM20 and GATA4. Importantly, we found that the absence of Rbpms caused severe cardiomyocyte contractile defects and reduced calcium sensitivity in both mouse and hiPSC-CMs. Our results demonstrated that Rbpms is crucial for postnatal cardiac function and cardiomyocyte contractility by regulating RNA alternative splicing. Conclusions: Loss of Rbpms in the heart causes reduced cardiomyocyte number and impaired cardiomyocyte contraction, leading to DCM and heart failure.
-
45 GSE273192 对P56小鼠心脏组织进行基因表达分析,比较Ckmm-cre+/+; Tfamf/+; Dele1+/-、Ckmm-cre+/+; Tfamf/+; Dele1-/-、Ckmm-cretg/+; Tfamf/f; Dele1-/-和Ckmm-cretg/+; Tfamf/f; Dele+/-四个基因型的差异。样本按生物重复分组,每组4只小鼠,使用Clariom S Assay检测总RNA表达,筛选FDR≤0.05且fold-change≥2的基因进行分析。
设计对P56小鼠心脏组织进行基因表达分析,比较Ckmm-cre+/+; Tfamf/+; Dele1+/-、Ckmm-cre+/+; Tfamf/+; Dele1-/-、Ckmm-cretg/+; Tfamf/f; Dele1-/-和Ckmm-cretg/+; Tfamf/f; Dele+/-四个基因型的差异。样本按生物重复分组,每组4只小鼠,使用Clariom S Assay检测总RNA表达,筛选FDR≤0.05且fold-change≥2的基因进行分析。
摘要Mitochondrial dysfunction causes devastating disorders, including mitochondrial myopathy. Here, we identified that diverse mitochondrial myopathy models elicit a protective mitochondrial integrated stress response (mt-ISR), mediated by OMA1-DELE1 signaling. The response was similar following disruptions in mtDNA maintenance, from knockout of Tfam, and mitochondrial protein unfolding, from disease-causing mutations in CHCHD10 (G58R and S59L). The preponderance of the response was directed at upregulating pathways for aminoacyl-tRNA biosynthesis, the intermediates for protein synthesis, and was similar in heart and skeletal muscle but more limited in brown adipose challenged with cold stress. Strikingly, models with early DELE1 mt-ISR activation failed to grow and survive to adulthood in the absence of Dele1, accounting for some but not all of OMA1’s protection. Notably, the DELE1 mt-ISR did not slow net protein synthesis in stressed striated muscle, but instead prevented loss of translation-associated proteostasis in muscle fibers. Together our findings identify that the DELE1 mt-ISR mediates a stereotyped response to diverse forms of mitochondrial stress and is particularly critical for maintaining growth and survival in early-onset mitochondrial myopathy. This experiment used the "Clariom S Assay, mouse" from Affymetrix/Applied Biosystems to analyze the effect of Dele1 KO in Ckmm-cre Tfam (Tfam mKO) mouse model of mitochondrial myopathy/cardiomyopathy.
-
46 GSE276289 将野生型小鼠与心脏特异性 Gαq 过表达小鼠(扩张型心肌病模型)按基因型分组,分别喂食对照饮食或含 0.5 mg/g ertugliflozin 的饮食,于 4 周和 20 周时间点处死,采集左心室组织进行 RNA 测序,比较不同基因型在不同时间点的基因表达差异及 ERTU 处理组与相应对照组的差异。
设计将野生型小鼠与心脏特异性 Gαq 过表达小鼠(扩张型心肌病模型)按基因型分组,分别喂食对照饮食或含 0.5 mg/g ertugliflozin 的饮食,于 4 周和 20 周时间点处死,采集左心室组织进行 RNA 测序,比较不同基因型在不同时间点的基因表达差异及 ERTU 处理组与相应对照组的差异。
摘要Background. Mitochondrial dysfunction with decreased ATP production and increased release of reactive oxygen species (ROS) is a hallmark of the failing heart. Although SGLT2 inhibitors have been shown to improve myocardial metabolism in the failing heart, independent of diabetes, the mechanism of this effect is not clear. Objectives. Our goal was to test the effect of the SGLT2 inhibitor ertugliflozin on mitochondrial gene expression and function in myocardium and isolated mitochondria from non-diabetic mice with dilated cardiomyopathy due to cardiac-specific over-expression of Gαq. Methods. Gαq and wild-type (WT) littermates 4 weeks of age were treated for 16 weeks with or without the SGLT2 inhibitor ertugliflozin (ERTU) formulated in the chow (0.5 mg/g chow). Results. From weeks 4 to 20, Gαq mice developed progressive cardiac hypertrophy, dilation, contractile dysfunction, myocyte apoptosis and interstitial fibrosis – all of which were prevented by ERTU treatment. Isolated cardiac mitochondria from Gαq mice had decreased maximal ATP production and increased ROS release - both of which were normalized by ERTU. In isolated beating hearts from Gαq mice, contractile reserve and high energy phosphates measured simultaneously by 31P NMR spectroscopy were decreased - and both were improved by ERTU. In Gαq mice, marked suppression of myocardial gene programs for oxidative phosphorylation and fatty acid metabolism was reversed by ERTU. Conclusions. The SGLT2 inhibitor ERTU corrected the expression of myocardial gene programs for oxidative phosphorylation and fatty acid metabolism, thereby leading to increased production of ATP, decreased release of mitochondrial ROS, and amelioration of the consequences of mitochondrial dysfunction on myocardial structure and function.
-
47 GSE326721 对携带 MYBPC3 基因 R502W 错义突变和野生型 (WT) 小鼠心脏组织进行 bulk RNA-Seq 测序,比较不同基因型在 3 周和 18 周龄时的基因表达差异,评估突变对心脏结构与功能的影响及 mavacamten 处理的效应。
设计对携带 MYBPC3 基因 R502W 错义突变和野生型 (WT) 小鼠心脏组织进行 bulk RNA-Seq 测序,比较不同基因型在 3 周和 18 周龄时的基因表达差异,评估突变对心脏结构与功能的影响及 mavacamten 处理的效应。
摘要Myosin inhibitor mavacamten is the first targeted treatment available for hypertrophic cardiomyopathy (HCM), a disease caused by hundreds of genetic variants that affect mainly sarcomeric myosin and its negative regulator cardiac myosin-binding protein C (cMyBP-C, encoded by MYBPC3). Here, we have examined whether the reported limited efficacy of mavacamten in a fraction of HCM patients can result from dissimilar HCM pathomechanisms triggered by different genetic variants, a scenario particularly relevant for MYBPC3-associated HCM. To this aim, we have generated knock-in mice including missense pathogenic variant cMyBP-C p.R502W, which, different from patients who carry truncations in the protein, develop progressive pathogenic myocardial remodeling in the absence of alterations of cMyBP-C levels and localization. Mechanistically, mutation R502W reduces the binding affinity of cMyBP-C for myosin, increases Ca2+ sensitivity and promotes the ON structural state of myosin heads without inducing a shift towards more active myosin conformations as observed when cMyBP-C levels are reduced. Despite these differences, we demonstrate that mavacamten blunts myocardial remodeling both in R502W and cMyBP-C-deficient, knock-out hearts, correlating with its ability to normalize the levels of ON myosins in R502W sarcomeres. These beneficial effects are accompanied by improved tolerance to exercise in R502W animals. In human engineered heart tissues carrying R502W, we show that mavacamten opposes hypercontractility induced by the mutation. Hence, in combination our results indicate that myosin inhibition is effective to treat HCM caused by both truncating and missense variants in MYBPC3 regardless of the primary pathomechanisms they elicit.
-
48 GSE86074 对条件性 p38MAPKα 敲除小鼠与对照小鼠的心脏组织进行基因表达分析,比较两组在基线状态及 48 小时 Angiotensin II 治疗后的差异。研究对象为 3 月龄雄性 C57BL/6 小鼠,心脏尖端组织作为被测材料,分组包括:未治疗对照组(Control Basal)、未治疗 KO 组(KO Basal)、AngII 治疗对照组(Control Ang)和 AngII 治疗 KO 组(KO Ang),每组 4 个样本。检测方式为基于微阵列的表达谱分析,采用 GPL10787 平台,所有样本进行分位数归一化处理。
设计对条件性 p38MAPKα 敲除小鼠与对照小鼠的心脏组织进行基因表达分析,比较两组在基线状态及 48 小时 Angiotensin II 治疗后的差异。研究对象为 3 月龄雄性 C57BL/6 小鼠,心脏尖端组织作为被测材料,分组包括:未治疗对照组(Control Basal)、未治疗 KO 组(KO Basal)、AngII 治疗对照组(Control Ang)和 AngII 治疗 KO 组(KO Ang),每组 4 个样本。检测方式为基于微阵列的表达谱分析,采用 GPL10787 平台,所有样本进行分位数归一化处理。
摘要p38MAPKα KO mice develop in response to Angiotensin II treatment a dilative cardiomyopathy. Gene expression profile of KO hearts was compared to equally treated control heart under baseline conditions and after 48 hours of Angiotensin II treatment via osmotic mini pumps.
-
49 GSE109790 将雄性与雌性 C57BL/6 小鼠按性别分组,分别接受每周递增剂量的 methamphetamine hydrochloride(初始 5 mg/kg,最终 40 mg/kg)或 PBS 处理,持续 5 个月。处理组与 PBS 对照组均按每周 2 mg 增量递增,心脏组织在实验结束时采集。采用微阵列技术检测心脏组织基因表达,比较性别差异及 methamphetamine 处理对心脏的影响。
设计将雄性与雌性 C57BL/6 小鼠按性别分组,分别接受每周递增剂量的 methamphetamine hydrochloride(初始 5 mg/kg,最终 40 mg/kg)或 PBS 处理,持续 5 个月。处理组与 PBS 对照组均按每周 2 mg 增量递增,心脏组织在实验结束时采集。采用微阵列技术检测心脏组织基因表达,比较性别差异及 methamphetamine 处理对心脏的影响。
摘要In this study, we have created a mouse model of methamphetamine cardiomyopathy that reproduces the chronic, progressive dosing commonly encountered in addicted subjects. We gradually increased the quantity of methamphetamine given to C57Bl/6 mice from 5 to 40 mg/kg over five months. At the fifth month, heart weight was increased, echocardiograms showed a dilated cardiomyopathy and survival was lower in males, with less effect in females. Interestingly, these findings correspond to previous observations in human patients, suggesting greater male susceptibility to the effects of methamphetamine on the heart.Transcriptional analysis showed changes in genes dysregulated in previous methamphetamine neurological studies as well as many that likely play a role in cardiac response to this toxic stress. We expect that a deeper understanding of the molecular biology of methamphetamine exposure in the heart will provide insights into the mechanism of cardiomyopathy in addicts and potential routes to more effective treatment.
-
50 GSE140418 将C3H/HeJ、C57BL/6J和B6C3F1/J雄性小鼠按品系分组,每组10只,年龄9-10周,采集心脏尖端组织进行基因表达分析。其中,每个品系的5只作为对照样本,其余用于其他分析。比较各品系在基因表达上的差异,特别是C3H/HeJ与B6C3F1/J、C57BL/6J的比较,以及B6C3F1/J的中间表型。
设计将C3H/HeJ、C57BL/6J和B6C3F1/J雄性小鼠按品系分组,每组10只,年龄9-10周,采集心脏尖端组织进行基因表达分析。其中,每个品系的5只作为对照样本,其余用于其他分析。比较各品系在基因表达上的差异,特别是C3H/HeJ与B6C3F1/J、C57BL/6J的比较,以及B6C3F1/J的中间表型。
摘要Human cardiomyopathies often lead to heart failure, a major cause of morbidity and mortality in industrialized nations. Described here is a phenotypic characterization of cardiac function and genome-wide expression from C3H/HeJ, C57BL/6J, and B6C3F1/J male mice. Histopathologic analysis identified a low-grade background cardiomyopathy (murine progressive cardiomyopathy) in eight of nine male C3H/HeJ mice (age nine to ten weeks), but not in male C57BL/6J and in only of ten male B6C3F1/J mice. The C3H/HeJ mouse had an increased heart rate and a shorter RR interval compared to the B6C3F1/J and C57BL/6J mice. Cardiac genomic studies indicated the B6C3F1/J mice exhibited an intermediate gene expression phenotype relative to the 2 parental strains. Disease-centric enrichment analysis indicated a number of cardiomyopathy-associated genes were induced in B6C3F1/J and C3H/HeJ mice, including Myh7, My14, and Lmna and also indicated differential expression of genes associated with metabolic (e.g., Pdk2) and hypoxic stress (e.g. Hif1a). A novel coexpression and integrated pathway network analysis indicated Prkaa2, Pdk2, Rhoj, and Sgcb are likely to play a central role in the pathophysiology of murine progressive cardiomyopathy in C3H/HeJ mice. Our studies indicate that genetically determined baseline differences in cardiac phenotype have the potential to influence the results of cardiotoxicity studies.
-
51 GSE180216 对携带 RBM20 S637A 和 S639G 突变的小鼠心脏组织进行 RNA 测序,比较野生型(WT)、杂合型(+/-)和纯合型(-/-)基因型在心脏重塑过程中的转录组差异。样本取自 2 月龄小鼠左心室,按总单位数与组数估计分组,检测方式为 RNA-Seq,分析涉及不同基因型间的比较。
设计对携带 RBM20 S637A 和 S639G 突变的小鼠心脏组织进行 RNA 测序,比较野生型(WT)、杂合型(+/-)和纯合型(-/-)基因型在心脏重塑过程中的转录组差异。样本取自 2 月龄小鼠左心室,按总单位数与组数估计分组,检测方式为 RNA-Seq,分析涉及不同基因型间的比较。
摘要Genetic studies show that mutations in a gene named as RNA binding motif 20 (RBM20) are associated with dilated cardiomyopathy (DCM). We selected two mutations (S637A and S639G) located in arginine/serine-rich (RS) domain of RNA binding motif 20 (RBM20) and generated two knock-in mouse models (Rbm20S637A and Rbm20S639G) respectively. The heterozygous (HT) and homozygous (HM) in both mouse lines displayed DCM phenotype with enlarged left ventricular (LV) chamber, thinner ventricular walls and reduced ejection fraction. We also observed higher mortality rate in both HM mice, ~50% in Rbm20S639G and ~34% in Rbm20S637A at an early age (<100days). Differentially expressed and spliced genes from RNA-seq data were involved in arrhythmia, cardiomyopathy, and sudden death based on Human Phenotype Ontology enrichment analysis (FDR≤0.05) in both mouse lines. Immunofluorescent analysis in tissues and single cardiomyocytes respectively showed both mutations promote RBM20 nucleocytoplasmic trafficking and protein condensates, suggesting they are gain-of-function mutations, leading to high mortality rate at younger age. Together, we reported a new mechanism by which cardiac genetic mutations causes protein trafficking and RNA-protein aggregation in cardiac remodelling.
-
52 GSE272375 将野生型小鼠左心室组织分为假手术组、腺嘌呤饮食诱导组和改良肾切除诱导组,通过RNA测序分析其转录组变化。腺嘌呤饮食诱导组接受5周0.25%腺嘌呤饮食(前2周为正常饮食)后处死,改良肾切除诱导组进行左肾 subtotal nephrectomy,1周后移除右肾,5周后处死。假手术组仅接受手术但不切除肾脏,所有样本均采集左心室组织进行RNA-Seq检测,比较两种诱导方式下尿毒症心肌病模型的转录组差异。
设计将野生型小鼠左心室组织分为假手术组、腺嘌呤饮食诱导组和改良肾切除诱导组,通过RNA测序分析其转录组变化。腺嘌呤饮食诱导组接受5周0.25%腺嘌呤饮食(前2周为正常饮食)后处死,改良肾切除诱导组进行左肾 subtotal nephrectomy,1周后移除右肾,5周后处死。假手术组仅接受手术但不切除肾脏,所有样本均采集左心室组织进行RNA-Seq检测,比较两种诱导方式下尿毒症心肌病模型的转录组差异。
摘要Adenine and nephrectomy can be used to establish models of uremic cardiomyopathy in rodents. Although these two approaches cause similar phenotypes of heart, adenine may directly act on cardiomyocytes and lead to different molecular changes from nephrectomy-induced uremic cardiomyopathy. Transcriptome analysis on left ventricles showed 789 upregulated and 345 downregulated genes in mice with nephrectomy-induced uremic cardiomyopathy compared to control mice, while 432 upregulated and 155 downregulated genes in mice with adenine diet-induced uremic cardiomyopathy compared to control mice. Functional analysis revealed that these DEGs were involved in pathways related to immune inflammation, metabolic responses, and synaptic transmission. Further analysis demonstrated that nephrectomy-induced uremic cardiomyopathy has enhanced cell cycle process/extracellular matrix remodeling and suppressed fatty acid metabolism, whereas adenine diet-induced uremic cardiomyopathy only exhibits increased inflammatory response/extracellular matrix remodeling. Compared with nephrectomy-induced uremic cardiomyopathy, adenine diet-induced uremic cardiomyopathy showed improved oxidative phosphorylation, aerobic electron transport chain, and tricarboxylic acid cycle, and suppressed cell cycle-related process, indicating that adenine and its derivates may affect the process of chronic kidney induced cardiac changes.
-
53 GSE273187 对P140年龄的CHCHD10 S59L突变小鼠与野生型小鼠心脏组织,分别设置Dele1基因敲除与正常状态,采集总RNA进行表达分析,比较不同基因型组合下的基因表达差异。
设计对P140年龄的CHCHD10 S59L突变小鼠与野生型小鼠心脏组织,分别设置Dele1基因敲除与正常状态,采集总RNA进行表达分析,比较不同基因型组合下的基因表达差异。
摘要Mitochondrial dysfunction causes devastating disorders, including mitochondrial myopathy. Here, we identified that diverse mitochondrial myopathy models elicit a protective mitochondrial integrated stress response (mt-ISR), mediated by OMA1-DELE1 signaling. The response was similar following disruptions in mtDNA maintenance, from knockout of Tfam, and mitochondrial protein unfolding, from disease-causing mutations in CHCHD10 (G58R and S59L). The preponderance of the response was directed at upregulating pathways for aminoacyl-tRNA biosynthesis, the intermediates for protein synthesis, and was similar in heart and skeletal muscle but more limited in brown adipose challenged with cold stress. Strikingly, models with early DELE1 mt-ISR activation failed to grow and survive to adulthood in the absence of Dele1, accounting for some but not all of OMA1’s protection. Notably, the DELE1 mt-ISR did not slow net protein synthesis in stressed striated muscle, but instead prevented loss of translation-associated proteostasis in muscle fibers. Together our findings identify that the DELE1 mt-ISR mediates a stereotyped response to diverse forms of mitochondrial stress and is particularly critical for maintaining growth and survival in early-onset mitochondrial myopathy. This experiment used the "Clariom S Assay, mouse" from Affymetrix/Applied Biosystems to analyze the effect of Dele1 KO in CHCHD10 S59L mouse model of mitochondrial myopathy/cardiomyopathy.
-
54 GSE309726 对野生型小鼠、Myh6-Cre:LmnaF/F(LMNA-KO)小鼠及Myh6-Cre:LmnaF/F:Kdm5aF/F(LMNA-5A-KO)小鼠的心肌细胞进行RNA-seq和CUT&RUN检测,比较三组间基因表达及H3K4me3修饰差异。每组包含5个独立样本,采集心肌组织后分离心肌细胞进行转录组分析,同时通过CUT&RUN检测全基因组范围内H3K4me3水平变化。
设计对野生型小鼠、Myh6-Cre:LmnaF/F(LMNA-KO)小鼠及Myh6-Cre:LmnaF/F:Kdm5aF/F(LMNA-5A-KO)小鼠的心肌细胞进行RNA-seq和CUT&RUN检测,比较三组间基因表达及H3K4me3修饰差异。每组包含5个独立样本,采集心肌组织后分离心肌细胞进行转录组分析,同时通过CUT&RUN检测全基因组范围内H3K4me3水平变化。
摘要Mutations in the LMNA gene, cause of dilated cardiomyopathy (LMNA-DCM); a progressive cardiac disorder currently lacking targeted therapeutic interventions. While the genetic basis is established, the epigenetic mechanisms driving LMNA-DCM pathogenesis remain poorly understood. In this study, we identify the histone demethylase KDM5A as an epigenetic regulator in the pathogenesis of LMNA-DCM. Using a cardiomyocyte-specific Lmna knockout mouse model (Myh6-Cre:LmnaF/F), we observed upregulation of KDM5A, which coincided with the downregulation of genes involved in myocardial contractility, mitochondrial bioenergetics, and oxidative phosphorylation (OXPHOS). We show that cardiomyocyte-specific deletion of Kdm5a in the LMNA-DCM background (Myh6-Cre:LmnaF/F:Kdm5aF/F) led to improved cardiac function, extended survival, and marked reductions in fibrosis and apoptosis. Transcriptomic analysis of cardiomyocytes from wild-type, Myh6-Cre:LmnaF/F, and Myh6-Cre:LmnaF/F:Kdm5aF/F mice revealed restoration of expression in over 1,400 genes, including pathways regulating fatty acid metabolism, myogenesis, and OXPHOS in the Myh6-Cre:LmnaF/F:Kdm5aF/F. Corresponding genome-wide profiling using CUT&RUN across the three groups showed reduced promoter-associated H3K4me3 in Myh6-Cre:LmnaF/F hearts, which was partially restored by Kdm5a deletion. Notably, H3K4me3 levels were reinstated at loci encoding cardiac transcription factors and metabolic regulators, in Myh6-Cre:LmnaF/F:Kdm5aF/F CM. These epigenetic and transcriptional changes were accompanied by decreased cardiomyocyte death and fibrosis. Overall, our findings position KDM5A as an epigenetic mediator of gene dysregulation in LMNA-DCM and provide mechanistic insights in the pathogenesis of the disease.
-
55 GSE350015 将雄性与雌性 C57BL/6N 野生型小鼠分为生理盐水组与多柔比星(Dox)处理组,Dox 按 5 mg/kg 腹腔注射每周一次持续五周(累积剂量 25 mg/kg)。七周后通过超声心动图评估心脏功能,随后采集左心室心肌组织进行 bulk RNA 测序,比较不同性别及处理组间的转录组差异。
设计将雄性与雌性 C57BL/6N 野生型小鼠分为生理盐水组与多柔比星(Dox)处理组,Dox 按 5 mg/kg 腹腔注射每周一次持续五周(累积剂量 25 mg/kg)。七周后通过超声心动图评估心脏功能,随后采集左心室心肌组织进行 bulk RNA 测序,比较不同性别及处理组间的转录组差异。
摘要Anthracyclines such as doxorubicin (Dox) are effective chemotherapies, but their use is limited by cardiotoxicity. Several Dox treatment regimens have been reported in mice, from acute high-dose models to chronic low-dose models. Some regimens cause fulminant cardiomyocyte apoptosis and heart failure within days, failing to accurately recapitulate the human toxicity phenotype which is typically delayed in onset. Our goal was to identify a Dox dosing regimen in mice that causes the most consistent delayed cardiomyopathy, as seen in patients, with minimal systemic toxicity. We administered four different Dox dosing regimens to C57BL/6N female and male mice, based on published protocols and our laboratory's prior studies. Cardiac function was assessed after seven weeks by echocardiography, prior to sacrifice. Hearts and blood were isolated for molecular analyses. A protocol consisting of Dox 5 mg/kg IP once a week for five weeks (cumulative dose of 25 mg/kg) demonstrated the most consistent difference in fractional shortening between mice treated with saline compared to those treated with Dox, as assessed by conscious echocardiography. This protocol resulted in the least amount of loss in body weight and the most prolonged survival after Dox treatment. A dosing regimen of Dox 5 mg/kg IP once a week for five weeks resulted in a reproducible cardiomyopathy phenotype with the least evidence of systemic toxicity. The use of consistent and reproducible mouse models can facilitate investigation of the molecular mechanisms of Dox cardiotoxicity, as well as the development of more effective cardioprotective strategies for translation to patients.
-
56 GSE6397 对Lmna H222P杂合小鼠和对照小鼠的心脏组织进行基因表达分析,使用微阵列平台,数据处理采用GC-RMA方法,样本量为15,按总样本数与组数估计分组数量,比较两组间的基因表达差异。
设计对Lmna H222P杂合小鼠和对照小鼠的心脏组织进行基因表达分析,使用微阵列平台,数据处理采用GC-RMA方法,样本量为15,按总样本数与组数估计分组数量,比较两组间的基因表达差异。
摘要The present research is devoted to the identification of gene(s) severely affected by LMNA mutations, leading to striated muscle laminopathies and more specifically the cardiomyopathy. For this purpose, we developped a large-scale gene expression approach on heart and skeletal tissues from Lmna H222P heterozygous Knock-In mouse model. Keywords: disease state modification
-
57 GSE242819 对线粒体心肌病小鼠模型(FS6KD)心脏组织进行单核RNA测序,分析不同基因型(Atf3 WT、Atf3 knockout)及AAV介导的Atf3敲低处理组的转录特征变化,比较其动态表达模式与细胞状态转变。
设计对线粒体心肌病小鼠模型(FS6KD)心脏组织进行单核RNA测序,分析不同基因型(Atf3 WT、Atf3 knockout)及AAV介导的Atf3敲低处理组的转录特征变化,比较其动态表达模式与细胞状态转变。
摘要Oxidative phosphorylation defects results in mitochondrial diseases, with cardiac involvement markedly impacting prognosis. However, the mechanisms underlying the transition from compensation to dysfunction in response to metabolic deficiency remain unclear, impeding the development of effective treatments. Here, we employed single-nucleus RNA sequencing (snRNA-seq) on hearts from mitochondrial cardiomyopathy (MCM) mice with cardiac-specific Ndufs6 knockdown of (FS6KD). Pseudotime trajectory analysis of cardiomyocytes from early stage of female FS6KD hearts revealed dynamic cellular state transitioning from compensation to severe compromise, coincided with transient upregulation of a critical transcription factor, activating transcription factor 3 (Atf3). Genetic ablation or adeno-associated virus-mediated Atf3 knockdown in FS6KD mice effectively delayed cardiomyopathy progression in a female-specific manner. Notably, human MCM snRNA-seq revealed a similar transition, including the dynamic expression of ATF3. In conclusion, our findings highlight a fate-determining role of Atf3 in female MCM progression, providing a promising therapeutic candidate for the currently intractable disease.
-
58 GSE6398 对Lmna H222P纯合子小鼠与对照组小鼠的整个心脏组织进行基因表达分析,比较两组间差异表达基因。研究采用微阵列平台,检测总RNA,设定两组比较,差异基因筛选标准为FDR阈值0.05及至少两倍表达差异。
设计对Lmna H222P纯合子小鼠与对照组小鼠的整个心脏组织进行基因表达分析,比较两组间差异表达基因。研究采用微阵列平台,检测总RNA,设定两组比较,差异基因筛选标准为FDR阈值0.05及至少两倍表达差异。
摘要The present research is devoted to the identification of gene(s) severely affected by LMNA mutations, leading to striated muscle laminopathies and more specifically the cardiomyopathy. For this purpose, we developped a large-scale gene expression approach on heart and skeletal tissues from Lmna H222P heterozygous Knock-In mouse model. Keywords: disease state modification
-
59 GSE6399 对Emd敲除小鼠与对照小鼠心脏组织进行基因表达比较,采用微阵列分析技术检测总RNA,识别差异表达基因并分析其与心肌病的关联。
设计对Emd敲除小鼠与对照小鼠心脏组织进行基因表达比较,采用微阵列分析技术检测总RNA,识别差异表达基因并分析其与心肌病的关联。
摘要The present research is devoted to the identification of gene(s) severely affected by EMD mutations, leading to striated muscle laminopathies and more specifically the cardiomyopathy. For this purpose, we developped a large-scale gene expression approach on heart and skeletal tissues from Emd KO mouse model. Keywords: disease state modification
-
60 GSE147834 对C57BL/6小鼠心脏组织进行RNA-seq测序,按出生后第8周和第12周年龄分组,同时根据doxorubicin注射0周、1周、2周、3周、4周及SR-A1-/-基因型与wild type对照分组。5个混池样本用于RNA提取和测序,每个混池包含不同处理时间点的样本,比较各组心脏组织基因表达差异。
设计对C57BL/6小鼠心脏组织进行RNA-seq测序,按出生后第8周和第12周年龄分组,同时根据doxorubicin注射0周、1周、2周、3周、4周及SR-A1-/-基因型与wild type对照分组。5个混池样本用于RNA提取和测序,每个混池包含不同处理时间点的样本,比较各组心脏组织基因表达差异。
摘要Rationale: Doxorubicin-induced cardiomyopathy (DiCM) is a significant cause of heart failure and mortality in cancer patients, in which macrophage-orchestrated inflammation serves as an essential pathogenic mechanism. However, the specific roles of tissue-resident and monocyte-derived macrophages in DiCM remain poorly understood. Objective: Uncovering the origins, phenotypes, and functions of proliferative cardiac resident macrophages and mechanistic insights into the self-maintenance of cardiac macrophage during DiCM progression. Methods and Results: Mice were administrated with doxorubicin to induce cardiomyopathy. Dynamic changes of resident and monocyte-derived macrophages were examined by lineage tracing, parabiosis, and bone marrow transplantation. We found that the monocyte-derived macrophages primarily exhibited a pro-inflammatory phenotype that dominated the whole DiCM pathological process and impaired cardiac function. In contrast, cardiac resident macrophages were vulnerable to doxorubicin insult. The survived resident macrophages exhibited enhanced proliferation and conferred a reparative role. Global or myeloid specifically ablation of class A1 scavenger receptor (SR-A1) inhibited proliferation of cardiac resident reparative macrophages and therefore exacerbated cardiomyopathy in DiCM mice. Importantly, the detrimental effect of macrophage SR-A1 deficiency was confirmed by transplantation of GFP+ wild type bone marrow. At the mechanistic level, we show that c-Myc, a key transcriptional factor for the SR-A1-P38-SIRT1 pathway, mediated the effect of SR-A1 in reparative macrophage proliferation in DiCM. Conclusions: The SR-A1-c-Myc axis may represent a promising target to treat DiCM through augmentation of cardiac resident reparative macrophage proliferation.
-
61 GSE305362 对野生型小鼠与DSG2突变型小鼠的右心室组织进行RNA测序,比较两组间基因表达差异以研究PPAR-γ信号通路在ARVC发病机制中的作用。
设计对野生型小鼠与DSG2突变型小鼠的右心室组织进行RNA测序,比较两组间基因表达差异以研究PPAR-γ信号通路在ARVC发病机制中的作用。
摘要Background:Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disorder characterized by fibrofatty myocardial replacement and ventricular arrhythmias. While desmosomal gene mutations, including DSG2, are well-established causes, the mechanisms by which specific missense mutations contribute to disease progression remain poorly understood. Methods:We generated a physiologically relevant Dsg2F536C knock-in (KI) mouse model using CRISPR/Cas9 to mimic the human DSG2p.Phe531Cys mutation. Comprehensive phenotyping included histopathology, immunostaining, transcriptomic profiling, in vitro cardiomyocyte and fibroblast assays, in vivo image and ECG analysis, and ex vivo optical mapping. Therapeutic potential was assessed using the PPAR-γ antagonist GW9662. Results:Dsg2F536C/F536C mice developed progressive cardiac hypertrophy, interstitial fibrosis, lipid accumulation, and inducible ventricular arrhythmias following isoproterenol infusion and programmed electrical stimulation. These changes resulted in severe cardiac dysfunction and were associated with reduced survival. Mechanistically, the mutation led to decreased DSG2 expression and nuclear accumulation of β-catenin and PPAR-γ, promoting triacylglycerol biosynthesis, oxidative stress, cardiomyocyte death, and calcium-handling abnormalities. We also identified activation of epicardial epithelial-to-mesenchymal transition (EMT) and paracrine fibroblast activation via IL-6 and PDGF-BB as key contributors to fibrotic remodeling. Optical mapping revealed prolonged and heterogeneous action potential duration and demonstrated both reentrant and focal ectopic mechanisms of ventricular tachycardia. Treatment with GW9662 attenuated lipid accumulation, fibrosis, ROS production, and arrhythmogenic susceptibility. Conclusions:This study establishesdsg2F536C KI mice as a robust genotype-specific ARVC model and uncovers a mechanistic link between desmosomal dysfunction, metabolic remodeling, epicardial EMT, and arrhythmia. Pharmacological inhibition of PPAR-γ mitigated structural and electrophysiological abnormalities, identifying it as a promising therapeutic target. These findings support a precision medicine framework for the treatment of desmosome-related cardiomyopathies.
-
62 GSE326720 对24周龄野生型(WT)和R502W突变型小鼠的心脏组织进行Bulk RNA-seq分析,分为WT对照组(n=5)、R502W对照组(n=4)及R502W mavacamten治疗组(2.5 mg/kg/day,n=4)。比较基因型与治疗条件下的基因表达差异。
设计对24周龄野生型(WT)和R502W突变型小鼠的心脏组织进行Bulk RNA-seq分析,分为WT对照组(n=5)、R502W对照组(n=4)及R502W mavacamten治疗组(2.5 mg/kg/day,n=4)。比较基因型与治疗条件下的基因表达差异。
摘要Myosin inhibitor mavacamten is the first targeted treatment available for hypertrophic cardiomyopathy (HCM), a disease caused by hundreds of genetic variants that affect mainly sarcomeric myosin and its negative regulator cardiac myosin-binding protein C (cMyBP-C, encoded by MYBPC3). Here, we have examined whether the reported limited efficacy of mavacamten in a fraction of HCM patients can result from dissimilar HCM pathomechanisms triggered by different genetic variants, a scenario particularly relevant for MYBPC3-associated HCM. To this aim, we have generated knock-in mice including missense pathogenic variant cMyBP-C p.R502W, which, different from patients who carry truncations in the protein, develop progressive pathogenic myocardial remodeling in the absence of alterations of cMyBP-C levels and localization. Mechanistically, mutation R502W reduces the binding affinity of cMyBP-C for myosin, increases Ca2+ sensitivity and promotes the ON structural state of myosin heads without inducing a shift towards more active myosin conformations as observed when cMyBP-C levels are reduced. Despite these differences, we demonstrate that mavacamten blunts myocardial remodeling both in R502W and cMyBP-C-deficient, knock-out hearts, correlating with its ability to normalize the levels of ON myosins in R502W sarcomeres. These beneficial effects are accompanied by improved tolerance to exercise in R502W animals. In human engineered heart tissues carrying R502W, we show that mavacamten opposes hypercontractility induced by the mutation. Hence, in combination our results indicate that myosin inhibition is effective to treat HCM caused by both truncating and missense variants in MYBPC3 regardless of the primary pathomechanisms they elicit.
-
63 GSE113251 将 Nkx2-5 条件性删除小鼠的左心室组织按胚胎期(E10.5 和 E11.5)与胎儿期(E13.5 和 E14.5)不同时间点进行 tamoxifen 注射处理,对照组未注射,采集 6 月龄小鼠左心室总 RNA 进行微阵列分析,比较不同处理时间点与对照组的基因表达差异。
设计将 Nkx2-5 条件性删除小鼠的左心室组织按胚胎期(E10.5 和 E11.5)与胎儿期(E13.5 和 E14.5)不同时间点进行 tamoxifen 注射处理,对照组未注射,采集 6 月龄小鼠左心室总 RNA 进行微阵列分析,比较不同处理时间点与对照组的基因表达差异。
摘要Left ventricular non-compaction (LVNC) is a rare cardiomyopathy associated with a hypertrabeculated phenotype and a large spectrum of symptoms. The developmental origins and mechanistic basis of varying severity of this pathology are unknown. To investigate these issues, we inactivated the cardiac transcription factor Nkx2-5 in trabecular myocardium at different stages of trabecular morphogenesis. Conditional deletion of Nkx2-5 at embryonic stages, during trabecular formation, provokes a severe hypertrabeculated phenotype associated with subendocardial fibrosis and Purkinje fiber hypoplasia. A milder phenotype was observed after Nkx2-5 deletion at fetal stages, during trabecular compaction. A longitudinal study of cardiac function in adult Nkx2-5 conditional mutant mice demonstrates that excessive trabeculation is associated with complex ventricular conduction defects, progressively leading to strain defects, and, in 50% of mutant mice, to heart failure. Progressive impaired cardiac function correlates with conduction and strain defects independently of the degree of hypertrabeculation. Transcriptomic analysis of molecular pathways reflects myocardial remodeling with a larger number of differentially expressed genes in the severe versus mild phenotype and identifies Six1 as a marker upregulated in hypertrabeculated hearts. Our results provide insights into the etiology of LVNC and link its pathogenicity with compromised trabecular development including compaction defects and ventricular conduction system hypoplasia.
-
64 GSE118945 对aMHC-+/+;Jarid2 f/f对照组和aMHC-C/+;Jarid2 f/f突变体组小鼠的心脏组织,在出生后第10天(P10)和7个月龄(7M)两个时间点各采集3个样本,进行RNA测序,比较不同基因型在各时间点的基因表达差异。
设计对aMHC-+/+;Jarid2 f/f对照组和aMHC-C/+;Jarid2 f/f突变体组小鼠的心脏组织,在出生后第10天(P10)和7个月龄(7M)两个时间点各采集3个样本,进行RNA测序,比较不同基因型在各时间点的基因表达差异。
摘要Analysis of heart from myocardil specific deletion of Jarid2 by crossing Jarid2 floxed mice with aMHC-Cre mice (Jarid2-aMHC). Jarid2-aMHC mice regult in dilated cardomyopathy and reveal premature death. To identify differentially expressed genes in Jarid2-aMHC hearts, we performed RNA-seq analysis on mutant hearts and control heart at postnatal day 10 (P10) and 7 months of ages (7M).
-
65 GSE142125 对2周龄野生型(WT)和Myocyte-Specific Lamin A/C Null小鼠(Myh6-cre:LmnaF/F)的心脏成肌细胞进行RNA-Seq,比较两种基因型的基因表达差异。样本量为12个GSM,包含6个Control组和6个KO组样本。检测方式为使用total RNA进行RNA-Seq,库选cDNA,库源为转录组。
设计对2周龄野生型(WT)和Myocyte-Specific Lamin A/C Null小鼠(Myh6-cre:LmnaF/F)的心脏成肌细胞进行RNA-Seq,比较两种基因型的基因表达差异。样本量为12个GSM,包含6个Control组和6个KO组样本。检测方式为使用total RNA进行RNA-Seq,库选cDNA,库源为转录组。
摘要Deletion of Lmna, encoding nuclear membrane protein LMNA, specifically in mouse cardiac myocytes activates BRD4 and leads to heart failure, arrhythmias, myocardial fibrosis, apoptosis, and premature death, which were partially rescued upon inhibition of BRD4.
-
66 GSE155377 将糖尿病性心肌病模型小鼠分为负对照组、糖尿病组及糖尿病+高剂量AngIV治疗组,每组4只。采集心肌组织进行基因表达检测,比较各组间差异。负对照组每日注射载体5天,糖尿病组通过连续5天腹腔注射链脲佐菌素诱导糖尿病并选择空腹血糖≥16.7mM的小鼠,糖尿病+高剂量AngIV组在糖尿病模型建立后从第8周持续至第24周高剂量AngIV输注。
设计将糖尿病性心肌病模型小鼠分为负对照组、糖尿病组及糖尿病+高剂量AngIV治疗组,每组4只。采集心肌组织进行基因表达检测,比较各组间差异。负对照组每日注射载体5天,糖尿病组通过连续5天腹腔注射链脲佐菌素诱导糖尿病并选择空腹血糖≥16.7mM的小鼠,糖尿病+高剂量AngIV组在糖尿病模型建立后从第8周持续至第24周高剂量AngIV输注。
摘要Activation of the systemic and myocardial rennin-angiotensin-aldosterone system (RAAS) by hyperglycemia plays a critical role in the development of diabetic cardiomyopathy. To test the hypothesis that AngIV protects against diabetic cardiomyopathy via stimulation of AT4R and inhibition of overactive autophagy, diabetic mice were treated with low-, medium- and high-dose AngIV, AT4R antagonist divalinal, forkhead box protein O1 (FoxO1) inhibitor AS1842856 (AS) or their combinations. In vitro, cardiomyocytes were treated with different concentrations of glucose, low-, medium- and high-dose AngIV, divalinal, FoxO1-overexpression plasmid (FoxO1-OE), AS or their combinations. The results showed that AngIV treatment dose-dependently attenuated left ventricular dysfunction, remodeling, fibrosis, and myocyte apoptosis in diabetic mice. Besides, autophagy and FoxO1 protein expression enhanced by diabetes were dose-dependently suppressed by AngIV treatment. However, these cardioprotective effects of AngIV were completely abolished by divalinal administration. Bioinformatic analyses revealed that the differentially expressed genes were enriched in autophagy, apoptosis, and FoxO signaling pathways among control, diabetes, and diabetes+high-dose AngIV groups. Similar to AngIV, AS treatment ameliorated diabetic cardiomyopathy in mice. In vitro, AngIV inhibited collagen expression, apoptosis, overactive autophagy flux, and FoxO1 nuclear translocation induced by high glucose in cardiomyocytes. However, these protective effects of AngIV were completely blocked by the use of divalinal or FoxO1-OE, and these detrimental effects were reversed by the additional administration of AS. In summary, AngIV treatment dose-dependently attenuated left ventricular dysfunction and remodeling in a mouse model of diabetic cardiomyopathy, and the mechanism involved stimulation of AT4R, suppression of FoxO1 nuclear translocation and inhibition of FoxO1-mediated overactive autophagy.
-
67 GSE157331 将糖尿病性心肌病模型小鼠与未处理对照小鼠的心肌组织进行表达谱分析,比较不同处理组间的基因表达差异。糖尿病性心肌病模型通过连续5天腹腔注射链脲佐菌素诱导,选择空腹血糖≥16.7mM的小鼠;对照组每日腹腔注射载体5天。实验设置三个处理组:糖尿病模型组(DM)、糖尿病模型+高剂量Ang IV治疗组(糖尿病模型小鼠接受高剂量Ang IV治疗至24周)、未处理对照组(NC)。检测采用Affymetrix平台进行表达谱分析,未提及混池方式。
设计将糖尿病性心肌病模型小鼠与未处理对照小鼠的心肌组织进行表达谱分析,比较不同处理组间的基因表达差异。糖尿病性心肌病模型通过连续5天腹腔注射链脲佐菌素诱导,选择空腹血糖≥16.7mM的小鼠;对照组每日腹腔注射载体5天。实验设置三个处理组:糖尿病模型组(DM)、糖尿病模型+高剂量Ang IV治疗组(糖尿病模型小鼠接受高剂量Ang IV治疗至24周)、未处理对照组(NC)。检测采用Affymetrix平台进行表达谱分析,未提及混池方式。
摘要It is well known that rennin-angiotensin-aldosterone system (RAAS) plays a critical role in the development of diabetic cardiomyopathy. The present study was aimed to clarify the role of a novel member of RAAS, angiotensin IV (Ang IV) and its downstream mediator forkhead box protein O1 (FoxO1), in the pathogenesis of diabetic cardiomyopathy. In vivo, diabetic mice were treated with low-, medium- and high-dose Ang IV, AT4R antagonist divalinal, FoxO1 inhibitor AS1842856 (AS), or their combinations. In vitro, cardiomyocytes and cardiofibroblasts were treated with different concentrations of glucose, low-, medium- and high-dose Ang IV, divalinal, FoxO1-overexpression plasmid (FoxO1-OE), AS or their combinations. The results showed that Ang IV treatment dose-dependently attenuated left ventricular dysfunction, fibrosis, and myocyte apoptosis in diabetic mice. Besides, enhanced autophagy and FoxO1 protein expression by diabetes were dose-dependently suppressed by Ang IV treatment. However, these cardioprotective effects of Ang IV were completely abolished by divalinal administration. Bioinformatics analysis revealed that the differentially expressed genes were enriched in autophagy, apoptosis, and FoxO signaling pathways among control, diabetes, and diabetes+high-dose Ang IV groups. Similar to Ang IV, AS treatment ameliorated diabetic cardiomyopathy in mice. In vitro, high glucose stimulation increased collagen expression, apoptosis, overactive autophagy flux and FoxO1 nuclear translocation in cardiomyocytes, and upregulated collagen and FoxO1 expression in cardiofibroblasts, which were substantially attenuated by Ang IV treatment. However, these protective effects of Ang IV were completely blocked by the use of divalinal or FoxO1-OE, and these detrimental effects were reversed by the additional administration of AS. In summary, Ang IV treatment dose-dependently attenuated left ventricular dysfunction and remodeling in a mouse model of diabetic cardiomyopathy, and the mechanisms involved stimulation of AT4R and suppression of FoxO1-mediated fibrosis, apoptosis, and overactive autophagy.
-
68 GSE15843 对Friedreich's ataxia小鼠模型的KIKO基因型与野生型(Control)小鼠心肌及骨骼肌组织进行微阵列分析,比较两组在目标组织中的基因表达差异。样本按基因型(KIKO vs Control)和组织(心肌、骨骼肌)分层,每个分组包含3个独立重复,采用Trizol法提取总RNA,经Feature Extraction Software处理后进行log2转换和lowess归一化。
设计对Friedreich's ataxia小鼠模型的KIKO基因型与野生型(Control)小鼠心肌及骨骼肌组织进行微阵列分析,比较两组在目标组织中的基因表达差异。样本按基因型(KIKO vs Control)和组织(心肌、骨骼肌)分层,每个分组包含3个独立重复,采用Trizol法提取总RNA,经Feature Extraction Software处理后进行log2转换和lowess归一化。
摘要Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARγ pathway as a therapeutic target in Friedreich's ataxia Friedreich's ataxia (FRDA), the most common inherited ataxia, is characterized by focal neurodegeneration, diabetes mellitus, and life-threatening cardiomyopathy. Frataxin, which is significantly reduced in patients with this recessive disorder, is a mitochondrial iron-binding protein, but how its deficiency leads to neurodegeneration and metabolic derangements is not known. We performed microarray analysis of heart and skeletal muscle in a mouse model of frataxin deficiency, and found molecular evidence of increased lipogenesis in skeletal muscle, and alteration of fiber-type composition in heart, consistent with insulin resistance and cardiomyopathy, respectively. Since the peroxisome proliferator-activated receptor gamma (PPARγ) pathway is known to regulate both processes, we hypothesized that dysregulation of this pathway could play a key role in frataxin deficiency. We confirmed this by showing a coordinate dysregulation of the PPARγ coactivator Pgc1a and transcription factor Srebp1 in cellular and animal models of frataxin deficiency, and in cells from FRDA patients, who have marked insulin resistance. Finally, we show that genetic modulation of the PPARγ pathway affects frataxin levels in vitro, supporting PPARγ as a novel therapeutic target in FRDA.
-
69 GSE194218 对携带人类 c.T38>G LEMD2 突变的小鼠心脏组织进行 RNA 测序,比较突变型与野生型基因表达差异。研究包含成年(2 个月)及 P1(产后第一天)小鼠心脏样本,涉及 Lemd2 WT、Lemd2 KI/KI(c.T38>G)和 Lemd2 cKO(心脏特异性敲除)三种基因型。检测对象为小鼠心脏组织,采用 RNA-Seq 技术分析 polyA RNA,通过 DESeq2 识别差异表达基因,主要比较突变型与野生型在不同年龄阶段的基因表达差异。
设计对携带人类 c.T38>G LEMD2 突变的小鼠心脏组织进行 RNA 测序,比较突变型与野生型基因表达差异。研究包含成年(2 个月)及 P1(产后第一天)小鼠心脏样本,涉及 Lemd2 WT、Lemd2 KI/KI(c.T38>G)和 Lemd2 cKO(心脏特异性敲除)三种基因型。检测对象为小鼠心脏组织,采用 RNA-Seq 技术分析 polyA RNA,通过 DESeq2 识别差异表达基因,主要比较突变型与野生型在不同年龄阶段的基因表达差异。
摘要Mutations in nuclear envelope proteins (NEPs) cause devastating genetic diseases, known as envelopathies, which primarily affect the heart and skeletal muscle. A mutation in the NEP LEMD2 causes severe cardiomyopathy in humans. However, the roles of LEMD2 in the heart and the pathological mechanisms responsible for its association with cardiac disease are unknown. To explore the mechanistic basis of this pathology, we generated mice carrying the human c.T38>G LEMD2 mutation. These mice phenocopied the human disease and developed severe dilated cardiomyopathy with extensive cardiac fibrosis leading to premature death. At the cellular level, LEMD2 mutant cardiomyocytes exhibited disorganization of the transcriptionally silent heterochromatin associated with the nuclear envelope. Moreover, mice with cardiac-specific deletion of LEMD2 also died shortly after birth due to heart abnormalities. LEMD2 mutant mice displayed aberrant cardiac gene expression and extensive DNA damage. The development of cardiac disease in both mouse models is linked to p53 activation. Together, our results reveal the essentiality of the nuclear envelope protein LEMD2 for genome stability and normal cardiac function.
-
70 GSE204849 对9个月龄野生型(WT)和Lemd2 p.L13R敲入(KI)小鼠心脏进行RNA-Seq测序,比较两基因型小鼠心脏的基因表达差异。
设计对9个月龄野生型(WT)和Lemd2 p.L13R敲入(KI)小鼠心脏进行RNA-Seq测序,比较两基因型小鼠心脏的基因表达差异。
摘要To determine transcriptional changes caused by the Lemd2 mutation and to gain insights into the mechanisms responsible for the phenotype of arrhythmic cardiomyopathy we performed RNA-sequencing in 9 months old mouse hearts
-
71 GSE210611 对糖尿病小鼠模型心脏组织进行基因和 miRNA 表达谱分析,比较健康对照组、MAO 抑制剂 Pargyline 处理组、糖尿病模型组及糖尿病合并 Pargyline 处理组的转录组差异。心脏样本来自每组 3 只雄性 C57BL6/J 小鼠,使用 total RNA 进行微阵列表达分析,检测对象为心脏组织中的 mRNA 和 lncRNA。
设计对糖尿病小鼠模型心脏组织进行基因和 miRNA 表达谱分析,比较健康对照组、MAO 抑制剂 Pargyline 处理组、糖尿病模型组及糖尿病合并 Pargyline 处理组的转录组差异。心脏样本来自每组 3 只雄性 C57BL6/J 小鼠,使用 total RNA 进行微阵列表达分析,检测对象为心脏组织中的 mRNA 和 lncRNA。
摘要Diabetes leads to cardiomyopathy and heart failure, the leading cause of death for diabetic patients. Monoamine oxidase (MAO)-dependent reactive oxygen species (ROS) formation contributes to the development of diabetic cardiomyopathy by inducing mitochondrial and cardiomyocyte dysfunction. Yet, it is unclear whether, in addition to the direct effects exerted by MAO-dependent ROS on mitochondria, MAO activity is able to post-transcriptionally regulate cardiomyocyte function and survival in diabetes. To this aim, we performed gene and miRNA expression profiling in cardiac tissue from a mouse model of type 1 diabetes (T1D) with or without pharmacological MAO inhibition. We found that MAO-dependent ROS generation in T1D hearts leads to profound transcriptomic changes, affecting autophagy and pro-survival pathways activation. MAO activity in T1D hearts affected expression levels of miR-133a-3p, -193a-3p, and -27a-3p that target insulin-like growth factor receptor 1 (Igf1r), growth factor receptor bound protein 10 and inositol polyphosphate 4 phosphatase type 1A, respectively, all components of the Igf1r/PI3K/Akt signaling pathway. Indeed, Akt activation was significantly downregulated in T1D hearts, whereas MAO inhibition restored the activation of this pro-survival pathway. The present study provides an important link between MAO activity, transcriptomic changes, and activation of pro-survival signaling and autophagy in diabetic cardiomyopathy.
-
73 GSE211955 对成年小鼠心肌细胞和新生大鼠心肌细胞进行RNA-Seq分析,比较Jmjd4敲除小鼠心脏组织与对照组的基因表达差异,以及si-Jmjd4处理与si-NC对照的差异。研究对象包括Jmjd4 knockout (MCM+ Jmjd4f/f (myh6 cre))小鼠和新生大鼠心肌细胞,分别采用tamoxifen处理(Day 14后)和siRNA处理(48h),检测方式为RNA-Seq,主要比较基因型差异及si-Jmjd4与si-NC处理组间的转录组变化。
设计对成年小鼠心肌细胞和新生大鼠心肌细胞进行RNA-Seq分析,比较Jmjd4敲除小鼠心脏组织与对照组的基因表达差异,以及si-Jmjd4处理与si-NC对照的差异。研究对象包括Jmjd4 knockout (MCM+ Jmjd4f/f (myh6 cre))小鼠和新生大鼠心肌细胞,分别采用tamoxifen处理(Day 14后)和siRNA处理(48h),检测方式为RNA-Seq,主要比较基因型差异及si-Jmjd4与si-NC处理组间的转录组变化。
摘要RNA-Seq results of adult mouse cardiomyocytes with Jmjd4 knockout and neonatal rat cardiomyocytes with Jmjd4 knockdown. To investigate the role of Jmjd4 in dilated cardiomyopathy, we performed gene expression profiling with RNA-Seq results from heart samples of MCM+ Jmjd4f/f and control Jmjd4f/f mice, as well as neonatal rat ventricuar cardiomyocytes (NRVCs) treated with si-Jmjd4 and si-NC control.
-
74 GSE24088 将慢性恰加斯心肌病小鼠的心脏与正常对照小鼠的心脏以及接受骨髓细胞移植治疗的小鼠心脏进行比较,通过微阵列分析检测基因表达变化。慢性恰加斯心肌病小鼠在感染 T. cruzi 后接受骨髓细胞移植或生理盐水处理,2 个月后取心脏组织进行 RNA 提取和微阵列分析,比较不同组别间的基因表达差异。
设计将慢性恰加斯心肌病小鼠的心脏与正常对照小鼠的心脏以及接受骨髓细胞移植治疗的小鼠心脏进行比较,通过微阵列分析检测基因表达变化。慢性恰加斯心肌病小鼠在感染 T. cruzi 后接受骨髓细胞移植或生理盐水处理,2 个月后取心脏组织进行 RNA 提取和微阵列分析,比较不同组别间的基因表达差异。
摘要Chronic chagasic cardiomyopathy is one of the leading causes of heart failure in Latin American countries, being associated with intense inflammatory response and fibrosis. We have previously shown that bone marrow mononuclear cell (BMC) transplantation improves inflammation, fibrosis and ventricular diameter in hearts of mice with chronic Chagas’ disease. Here we investigated alterations of gene expression in the hearts of chronic chagasic mice submitted or not to BMC therapy. C57Bl/6 mice chronically infected with T. cruzi (6 months) were transplanted with BMC or saline i.v. and sacrificed 2 months later. RNA was extracted from the hearts of normal controls, chagasic and BMC transplanted mice and microarray analysis was performed using MO30k oligonucleotide arrays. Out of the 9390 unigenes quantified in all samples, 1702 had their expression altered in chronic chagasic hearts compared to those of normal mice. Major categories of significantly upregulated genes were related to inflammation, fibrosis and immune responses, while genes involved in mitochondrion function were downregulated. When BMC-treated chagasic hearts were compared to infected mice, 1631 (96%) of the alterations detected in infected hearts were not found, although an additional 109 genes were altered by treatment, indicating a remarkable 84% transcriptomic recovery. Immunofluorescence and morphometric analyses confirmed the effects of BMC therapy in the pattern of inflammatory-immune response and expression of adhesion molecules. Our results demonstrate important immunomodulatory effects of BMC therapy in chagasic cardiomyopathy and indicate potentially relevant factors involved in the pathogenesis of the disease that may provide new therapeutic targets.
-
75 GSE241176 对 Smad3 敲除与 Smad3 野生型小鼠的心脏成纤维细胞进行 RNA 测序,比较糖尿病模型(db/db)与正常小鼠(lean)之间的转录组差异。每组取 3 个样本,共 12 个样本。
设计对 Smad3 敲除与 Smad3 野生型小鼠的心脏成纤维细胞进行 RNA 测序,比较糖尿病模型(db/db)与正常小鼠(lean)之间的转录组差异。每组取 3 个样本,共 12 个样本。
摘要Our study provides the first direct evidence supporting a fibroblast-mediated mechanism of dysfunction and adverse remodeling in the diabetic heart, highlighting the importance of interstitial cells in the pathogenesis of diabetic cardiomyopathy. Diabetes-associated activation of the TGF-b/Smad3 cascade may promote dysfunction not only by accentuating ECM deposition and crosslinking, but also by modulating cardiomyocyte phenotype and function. Thus, the TGF-b system may be a promising therapeutic target in patients with diabetes-associated heart failure.
-
76 GSE309626 对LCHADD基因型小鼠与野生型小鼠的心室组织进行RNA测序,按性别分组比较基因表达差异。采集12个独立样本的总RNA,采用cDNA文库策略,使用Illumina Bcl2Fastq软件处理,检测心脏心室组织的转录组特征。
设计对LCHADD基因型小鼠与野生型小鼠的心室组织进行RNA测序,按性别分组比较基因表达差异。采集12个独立样本的总RNA,采用cDNA文库策略,使用Illumina Bcl2Fastq软件处理,检测心脏心室组织的转录组特征。
摘要Patients with LCHADD, a mitochondrial fatty acid oxidation (FAO) disorder, frequently present with cardiomyopathy and can suffer life-threatening arrhythmias and heart failure. While these remain the leading causes of death, the pathophysiology remains unknown. We used an LCHADD mouse model to examine the mechanisms of impaired cardiac function. Methods: We previously determined that LCHADD mice (Hadha c.1528G>C homozygotes) recapitulate human disease and develop cardiomyopathy. We performed electrophysiological tests on LCHADD and WT mice, followed by cardiac tissue and molecular expression analysis. Results: LCHADD mice showed significantly increased frequency of atrial premature beats, premature ventricular contractions, atrial flutter, and atrial and ventricular fibrillation after b-agonist stimulation compared to WT mice. Long QRS and long QT intervals were also observed. LCHADD heart sections demonstrated increased cardiomyocyte cross-sectional area, increased lipid and collagen deposition, and decreased glycogen deposits. There was global sympathetic denervation in LCHADD hearts compared to WT. Differentially expressed gene analysis showed increased expression of glycolytic and glutathione synthesis enzymes, decreased gene expression of TCA cycle enzymes, Ca++ signaling, and cardiac muscle contraction proteins. Conclusions: LCHADD cardiomyopathy has a hypertrophic phenotype with diffuse fibrosis, accumulation of lipids, and lower glycogen storage in the absence of obesity. LCHADD cardiomyocyte metabolism suggests a shift from FAO toward glycolysis with chronic oxidative stress. Energy deficiency and lipotoxicity likely influence Ca++ signaling and cardiac contraction. Long QRS and QT intervals with global sympathetic denervation may predispose the heart to repolarization abnormalities susceptible to arrhythmias and increased risk of sudden cardiac arrest and death.
-
77 GSE40677 对三周龄雌性小鼠的心脏组织进行微阵列分析,比较MHC-CELFdelta-10和MHC-CELFdelta-574转基因线与野生型之间的基因表达差异。研究对象为FVB/N品系小鼠,被测材料为总RNA,分组包括三个MHC-CELFdelta-10转基因、三个MHC-CELFdelta-574转基因及六个野生型对照,检测方式为微阵列分析,主要比较转基因高表达、低表达组与野生型组的基因表达差异。
设计对三周龄雌性小鼠的心脏组织进行微阵列分析,比较MHC-CELFdelta-10和MHC-CELFdelta-574转基因线与野生型之间的基因表达差异。研究对象为FVB/N品系小鼠,被测材料为总RNA,分组包括三个MHC-CELFdelta-10转基因、三个MHC-CELFdelta-574转基因及六个野生型对照,检测方式为微阵列分析,主要比较转基因高表达、低表达组与野生型组的基因表达差异。
摘要Members of the CUG-BP, Elav-like family (CELF) regulate alternative splicing in the heart. In MHC-CELFdelta transgenic mice, CELF splicing activity is inhibited postnatally in heart muscle via expression of a nuclear dominant negative CELF protein under an a-myosin heavy chain promoter. MHC-CELFdelta mice develop dilated cardiomyopathy characterized by alternative splicing defects, enlarged hearts, and severe contractile dysfunction. In this study, gene expression profiles in the hearts of wild type, high- and low-expressing lines of MHC-CELFdelta mice were compared using microarrays. Gene ontology and pathway analyses identified contraction and calcium signaling as the most affected processes. Network analysis revealed that the serum response factor (SRF) network is highly affected. Downstream targets of SRF were up-regulated in MHC-CELFdelta mice compared to the wild type, suggesting an increase in SRF activity. Although SRF levels remained unchanged, known inhibitors of SRF activity were down-regulated. These results suggest a role for CELF-mediated alternative splicing in the regulation of contractile gene expression, achieved in part through modulating the activity of SRF, a key cardiac transcription factor.
-
78 GSE54838 对转基因小鼠心脏组织进行基因表达分析,包含野生型对照组、IDH2 R140Q突变组和IDH2 R172K突变组,每组4个样本。通过微阵列技术检测基因表达水平,比较突变组与对照组的转录组差异。
设计对转基因小鼠心脏组织进行基因表达分析,包含野生型对照组、IDH2 R140Q突变组和IDH2 R172K突变组,每组4个样本。通过微阵列技术检测基因表达水平,比较突变组与对照组的转录组差异。
摘要Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) have been discovered in several cancer types and cause the neurometabolic syndrome D2-Hydroxyglutaric aciduria (D2HGA). The mutant enzymes exhibit neomorphic activity resulting in production of D2- hydroxyglutaric acid (D-2HG). To study the pathophysiological consequences of the accumulation of D2-HG, we generated transgenic mice with conditionally activated IDH2R140Q and IDH2R172K alleles. Global induction of mutant IDH2 expression in adults resulted in dilated cardiomyopathy, white matter abnormalities throughout the central nervous system (CNS), and muscular dystrophy. Embryonic activation of mutant IDH2 resulted in more pronounced phenotypes, including runting, hydrocephalus, and shortened life span—recapitulating the abnormalities observed in D2HGA patients. The diseased hearts exhibited mitochondrial damage and glycogen accumulation with a concordant upregulation of genes involved in glycogen biosynthesis. Notably, mild cardiac hypertrophy was also observed in nude mice implanted with IDH2R140Q expressing xenografts, suggesting that 2HG may potentially act in a paracrine fashion. Finally, we show that silencing of IDH2R140Q in mice with an inducible transgene restores heart function by lowering 2HG levels. Together, these findings indicate that inhibitors of mutant IDH2 may be beneficial in the treatment of D2HGA and suggest that 2HG produced by IDH mutant tumors has the potential to provoke a paraneoplastic condition.
-
79 GSE59672 将野生型和CHIP敲除C57BL/6J小鼠心脏组织分别进行DOX处理(单次15mg/kg剂量)和未处理,采集样本进行微阵列分析,比较处理组与对照组及两种基因型间的基因表达差异。
设计将野生型和CHIP敲除C57BL/6J小鼠心脏组织分别进行DOX处理(单次15mg/kg剂量)和未处理,采集样本进行微阵列分析,比较处理组与对照组及两种基因型间的基因表达差异。
摘要The clinical application of doxorubicin as a broad-spectrum anti-tumor antibiotic is limited greatly by its cardiotoxicity. Various mechanisms have been studied, but little is known about whether genes or pathways relevant with energy metabolism contributes to doxorubicin-induced cardiomyopathy or not. We used microarrays to detail the global expression profiling of acute cardiomyopathy induced by doxorubicin in wild type or CHIP knockout C57BL/6J mice and discovered distinct classes of changed genes during this process.
-
80 GSE252044 对糖尿病性心肌病小鼠模型心脏组织进行基因表达谱分析,比较不同处理组的转录组差异。将6周龄小鼠分为chow饮食组和高脂饮食组,喂养18周后注射低剂量STZ,随后部分小鼠接受AAV表达control或METTL3的过表达处理,持续8周。采集全心脏组织进行RNA测序,分析各处理组间的基因表达差异。
设计对糖尿病性心肌病小鼠模型心脏组织进行基因表达谱分析,比较不同处理组的转录组差异。将6周龄小鼠分为chow饮食组和高脂饮食组,喂养18周后注射低剂量STZ,随后部分小鼠接受AAV表达control或METTL3的过表达处理,持续8周。采集全心脏组织进行RNA测序,分析各处理组间的基因表达差异。
摘要To investigate the role of METTL3 in diabetic cardiomyopathy, 6-week-old mice were fed either a chow diet or high-fat diet (HFD) for 18 weeks followed by low doses of STZ injections, some of the mice were then injected with AAV expressing control or METTL3 in cardiomyocytes for 8 weeks. We then performed gene expression profiling analysis using data obtained from RNA-seq.
-
81 GSE161931 对自发性糖尿病心肌病(Db/db)小鼠与健康对照(BKS)小鼠的心脏组织进行RNA测序,比较两组间基因表达差异。所有小鼠均为雄性,16周龄,处死前饲养于标准条件,不限制食物和水,保持12小时光照/12小时黑暗周期。每组按总单位数与组数估计为5个样本,使用Trizol试剂提取总RNA,每样本输入量为1 µg。
设计对自发性糖尿病心肌病(Db/db)小鼠与健康对照(BKS)小鼠的心脏组织进行RNA测序,比较两组间基因表达差异。所有小鼠均为雄性,16周龄,处死前饲养于标准条件,不限制食物和水,保持12小时光照/12小时黑暗周期。每组按总单位数与组数估计为5个样本,使用Trizol试剂提取总RNA,每样本输入量为1 µg。
摘要To explore the key genes involved in spontaneous diabetic cardiomyopathy, db/db and BKS mice were used to examine the differently expressed genes in the related progresses. Briely, the heart transcriptome of db/db and BKS mice was correlated with the heart function, cardiomyocyte ultrastructure and histopathology characters.
-
82 GSE29648 对2个月龄的HCM和野生型C57BL/6雄性及雌性小鼠左心室组织进行基因表达分析,所有小鼠均喂养补充植物雌激素(genistein和daidzein)的酪蛋白饮食。每个样本取自2-3只动物等量RNA混池,采用Affymetrix Mouse Genome 430 2.0微阵列检测,比较不同性别和基因型间的转录组差异。
设计对2个月龄的HCM和野生型C57BL/6雄性及雌性小鼠左心室组织进行基因表达分析,所有小鼠均喂养补充植物雌激素(genistein和daidzein)的酪蛋白饮食。每个样本取自2-3只动物等量RNA混池,采用Affymetrix Mouse Genome 430 2.0微阵列检测,比较不同性别和基因型间的转录组差异。
摘要A soy diet worsens the progression of an inherited form of hypertrophic cardiomyopathy (HCM) in male mice when compared to casein-fed mice. Females are largely resistant to this diet effect and better preserve cardiac function. We hypothesized that the abundant phytoestrogens found in soy are mainly responsible for this diet-dependent phenotype. Indeed, feeding male mice a phytoestrogen-supplemented casein-based diet can recapitulate the negative outcome seen when male mice are fed a standard soy-based diet. To gain mechanistic insights into disease pathogenesis, we used Affymetrix microarrays to profile gene expression in left ventricular tissue from 2 month old HCM male and female mice as well as wild-type littermate controls. These mice were fed a phytoestrogen (genistein + daidzein)-supplemented casein-based diet. We identified a number of molecular pathways that could explain both the male and female phenotypes.
-
83 GSE317118 将C57BL/6雄性小鼠随机分为正常对照组、ART处理对照组、LPS诱导SICM模型组和LPS+ART治疗组,每组5只,采集心脏组织进行RNA测序,比较LPS模型组与LPS+ART治疗组的基因表达差异。
设计将C57BL/6雄性小鼠随机分为正常对照组、ART处理对照组、LPS诱导SICM模型组和LPS+ART治疗组,每组5只,采集心脏组织进行RNA测序,比较LPS模型组与LPS+ART治疗组的基因表达差异。
摘要Sepsis-induced cardiomyopathy (SICM) is a life-threatening complication of sepsis characterized by acute and reversible myocardial dysfunction, for which effective targeted therapies remain limited. Artesunate (ART), a well-established first-line antimalarial agent, has attracted increasing attention for its anti-inflammatory, antioxidant, and cytoprotective properties. However, its role in SICM has not been fully elucidated. In this study, a murine SICM model was established using lipopolysaccharide to evaluate the effects of ART on animal mortality, cardiac function, histopathology, and biomarkers of myocardial injury.
-
84 GSE43798 对3个月龄的PGC-1a-/-bf/f/MerCre小鼠心脏双心室组织进行微阵列分析,比较Tamoxifen注射组与车辆油注射组的基因表达差异。样本来自2个月龄时接受连续两天50mg/kg/day Tamoxifen注射或同等体积车辆油处理的小鼠,采集时间分别为注射后1个月。研究对象为小鼠心脏双心室组织,被测材料为total RNA,检测方式为Expression profiling by array,主要比较不同处理条件下基因表达谱的差异。
设计对3个月龄的PGC-1a-/-bf/f/MerCre小鼠心脏双心室组织进行微阵列分析,比较Tamoxifen注射组与车辆油注射组的基因表达差异。样本来自2个月龄时接受连续两天50mg/kg/day Tamoxifen注射或同等体积车辆油处理的小鼠,采集时间分别为注射后1个月。研究对象为小鼠心脏双心室组织,被测材料为total RNA,检测方式为Expression profiling by array,主要比较不同处理条件下基因表达谱的差异。
摘要The following abstract from the submitted manuscript describes the major findings of this work. The metabolic development of high energy-utilizing organs such as the heart involves mitochondrial proliferation at birth followed by a maturation process during the postnatal period. Conditional gene targeting was used in mice to explore the role of the PPARgamma coactivator 1 (PGC-1) coactivators during postnatal development and in adult heart. Marked mitochondrial derangements were observed in hearts of PGC-1a/b-deficient mice during the postnatal period, including fragmentation and elongation associated with the development of a lethal cardiomyopathy. The expression of multiple genes involved in mitochondrial fusion and fission was downregulated in hearts of PGC-1a/b-deficient mice. PGC-la was shown to activate transcription of the mitofusin 1 (Mfn1) gene by coactivating the estrogen-related receptor a (ERRa) upon a highly conserved element. Surprisingly, PGC-1a/b deficiency did not alter cardiac function or general mitochondrial density and myocyte distribution in adult heart. However, transcriptional profiling and mitochondrial function studies demonstrated that the PGC-1 coactivators are required for full respiratory capacity and high level expression of nuclear- and mitochondrial-encoded genes involved in mitochondrial energy transduction and oxidative phosphorylation pathways in adult heart. These results unveil distinct developmental stage-specific transcriptional programs involved in the maturation and maintenance of mitochondria.
-
85 GSE4678 对2.5月龄非转基因对照组(NTG)、FHC alpha-TM175和alpha-TM180转基因小鼠的心室组织总RNA进行微阵列分析,比较三组间基因表达差异。每个基因型组包含两个或多个非混池(NP)个体RNA提取物及一个由20个个体心提取物混池(P)而成的样本,共开展10次杂交实验。
设计对2.5月龄非转基因对照组(NTG)、FHC alpha-TM175和alpha-TM180转基因小鼠的心室组织总RNA进行微阵列分析,比较三组间基因表达差异。每个基因型组包含两个或多个非混池(NP)个体RNA提取物及一个由20个个体心提取物混池(P)而成的样本,共开展10次杂交实验。
摘要Familial hypertrophic cardiomyopathy (FHC) is a disease characterized by ventricular hypertrophy, fibrosis, and aberrant systolic and/or diastolic function. We previously developed two transgenic mouse models that carry FHC associated mutations in alpha-tropomyosin (TM): FHC alpha-TM175 mice show patchy areas of mild ventricular disorganization and limited hypertrophy; whereas FHC alpha-TM180 mice exhibit severe hypertrophy and fibrosis and die within 6 months. To obtain a better understanding of the molecular mechanisms associated with the early onset of cardiac hypertrophy, we conducted a detailed comparative analysis of gene expression in 2.5-month-old control and FHC alpha-TM175 and alpha-TM180 ventricular tissue. Results show that 754 genes (from a total of 22,600) were differentially expressed between the NTG and the FHC hearts. There are 178 differentially regulated genes between NTG and the FHC alpha-TM175 hearts, 388 genes are differentially expressed between NTG and FHC alpha-TM180 hearts, and 266 genes are differentially expressed between FHC alpha-TM175 and FHC alpha-TM180 hearts. Genes that exhibit the largest increase in expression belong to the "secreted/extracellular matrix" category, and those with the most significant decrease in expression are associated with "metabolic enzymes." Keywords: Cardiac hypertrophy, Tropomyosin, Mutation, Transgenic mouse, Microarray
-
86 GSE73677 对野生型(WT)和心脏条件性EED敲除(CKO)小鼠的心肌细胞进行H3K27me3和H3K27ac组蛋白修饰的ChIP-seq及微阵列分析,比较两组间基因表达差异。
设计对野生型(WT)和心脏条件性EED敲除(CKO)小鼠的心肌细胞进行H3K27me3和H3K27ac组蛋白修饰的ChIP-seq及微阵列分析,比较两组间基因表达差异。
摘要Through H3K27me3 and H3K27ac ChIP-seq and microarray data in wile-tpye (WT) and EED-knockout (CKO) mouse cardiomyocytes, we unexpectedly uncovered a novel mechanism of PRC2-mediated gene repression. EED inactivation in the postnatal heart (EEDCKO) caused progressive, lethal dilated cardiomyopathy, with upregulation of components of the slow-twitch muscle gene program. Surprisingly, upregulation of these genes was not associated with their loss of H3K27me3, but rather with their gain of H3K27 acetylation (H3K27ac), an activating histone mark4,5. Moreover, re-expression of EED in juvenile hearts rescued heart function and normalized H3K27ac, but not H3K27me3.
-
87 GSE97027 对21日龄心脏特异性Cdk8过表达转基因小鼠与野生型小鼠的心室组织进行RNA测序,每组取5个样本,比较两组间基因表达差异。
-
88 GSE98439 对MC4R-/-和WT C57BL6/J小鼠的左心室后壁组织进行RNA-seq,比较两组基因表达差异。小鼠在24°C环境下饲养30周,按总样本数10和组数2估计每组5个样本。
设计对MC4R-/-和WT C57BL6/J小鼠的左心室后壁组织进行RNA-seq,比较两组基因表达差异。小鼠在24°C环境下饲养30周,按总样本数10和组数2估计每组5个样本。
摘要Deletion of the melanocortin-4 receptor in mice causes dilated cardiomyopathy that is independent of obesity.
-
89 GSE120625 将野生型和 delta-sarcoglycan (dSG) 敲除小鼠的左心室总 RNA 采集后进行 RNA 测序,比较基因型(野生型 vs dSG 敲除)与治疗(载体 vs ifetroban)的交互作用对心肌病的转录组影响。按总单位数 9 与 4 组估计各组样本量。
设计将野生型和 delta-sarcoglycan (dSG) 敲除小鼠的左心室总 RNA 采集后进行 RNA 测序,比较基因型(野生型 vs dSG 敲除)与治疗(载体 vs ifetroban)的交互作用对心肌病的转录组影响。按总单位数 9 与 4 组估计各组样本量。
摘要Expression analysis of left ventricle taken from wildtype or delta-sarcoglycan knockout mice, a model of muscular dystrophy. Mice were treated from weaning with vehicle or the thromboxane-prostanoid (TP) receptor antagonist ifetroban. Results provide insight into effects of TP receptor antagonism on cardiomyopathy of muscular dystrophy.
-
90 GSE154096 将野生型小鼠与cTnT-DK210突变小鼠心脏组织分别进行AAV9-Luciferase或AAV9-ABRA处理,采集3月龄心肌样本进行RNA测序,比较不同基因型与处理组间的转录组差异。
设计将野生型小鼠与cTnT-DK210突变小鼠心脏组织分别进行AAV9-Luciferase或AAV9-ABRA处理,采集3月龄心肌样本进行RNA测序,比较不同基因型与处理组间的转录组差异。
摘要The cTnT-DK210 DCM mice showed ABRA protein deficiency, sarcomeric disruption, and compromised heart contractility. Heart-specific expression of ABRA in cTnT-DK210 mice restored sarcomeric structures, reversed the disease progress, and rescued the DCM phenotypes. ABRA deficiency and compromised downstream serum response factor-regulated muscle gene expression play a key role in familial DCM caused by the cTnT-DK210 mutation. ABRA is a good therapeutic gene for cTnT-DK210-induced DCM and could be translated to other cTnT mutations-induced familial DCM.
-
91 GSE220177 对8–12周龄C57BL/6小鼠心脏组织进行RNA测序,将健康小鼠设为正常组,DOX处理小鼠设为模型组,TPTN处理小鼠设为治疗组,按总样本数9与3组估计,每组3个样本,比较三组间基因表达差异。
设计对8–12周龄C57BL/6小鼠心脏组织进行RNA测序,将健康小鼠设为正常组,DOX处理小鼠设为模型组,TPTN处理小鼠设为治疗组,按总样本数9与3组估计,每组3个样本,比较三组间基因表达差异。
摘要To investigate the intrinsic mechanism of TPTN in treating DOX-induced dilated cardiomyopathy, we established DOX-induced dilated cardiomyopathy model mice and TPTN treated mice, using healthy mice as the normal control. We then performed gene expression profiling analysis of the RNA-seq data obtained from the heart tissues of these three groups of mice.
-
92 GSE220517 对携带异质性HCM致病突变myosin R403Q的129SvEv/S4 F1小鼠进行单剂量和双剂量基因编辑治疗,采集左心室尖端组织进行RNA测序,比较治疗组与未处理对照组的转录反应差异。
设计对携带异质性HCM致病突变myosin R403Q的129SvEv/S4 F1小鼠进行单剂量和双剂量基因编辑治疗,采集左心室尖端组织进行RNA测序,比较治疗组与未处理对照组的转录反应差异。
摘要Dominant pathogenic variants encoding amino acid substitutions in cardiac myosin heavy chain cause hypertrophic cardiomyopathy (HCM), a currently incurable disorder that increases risk for stroke, heart failure, and sudden cardiac death. We assessed the efficacy of two different genetic therapies, an adenine base editor (ABE8e) and a potent Cas9 nuclease delivered by AAV9, to prevent disease in mice carrying the heterozygous HCM pathogenic variant myosin R403Q. One dose of dual AAV9 vectors, each carrying one half of RNA-guided ABE8e, corrected the pathogenic variant in ≥70% of ventricular cardiomyocytes and maintained durable, normal cardiac structure and function. An additional dose provided more global editing especially in the atria but also increased bystander editing. AAV9 delivery of RNA-guided Cas9 nuclease effectively inactivated the pathogenic allele, albeit with dose-dependent toxicities, necessitating a narrow therapeutic window to maintain health. These preclinical studies demonstrate considerable potential for single-dose genetic therapies to correct or silence pathogenic variants and prevent the development of HCM.
-
93 GSE292651 将携带 Q374fs-Rbm20 变体的 KI 小鼠与野生型小鼠按基因型分组(Wildtype n=3, Heterozygote n=3, Homozygote n=3),采集心脏组织进行 RNA 测序,分析不同基因型组间基因剪接模式及表达差异,比较其对心肌结构基因和钙调控基因的影响。
设计将携带 Q374fs-Rbm20 变体的 KI 小鼠与野生型小鼠按基因型分组(Wildtype n=3, Heterozygote n=3, Homozygote n=3),采集心脏组织进行 RNA 测序,分析不同基因型组间基因剪接模式及表达差异,比较其对心肌结构基因和钙调控基因的影响。
摘要RBM20 is one of the genes predisposing to dilated cardiomyopathy (DCM). Variants in the RS domain and the RNA-recognition motif have been well studied, but the pathogenicity of variants outside the hotspot remains unknown. A human patient with the Q373fs-RBM20 variant without a typical DCM phenotype was identified in sudden death cohorts. In the mouse experiments, RNA seq analysis revealed that Q374fs-Rbm20 mice showed some different splicing patterns in such as Ttn, Ldb3, Camk2d,Obscn, and Ryr2. The expressions of Casq1, Mybpc2, and Myot were also upregulated in Q374fs-Rbm20 mice. The pathway analysis indicated the involvement of some of the 1770 differentially expressed genes in Cytoplasmic ribosomal proteins Calcium regulation in cardiac cells and Striated muscle contraction. Cardiac dysfunction such as cardiac dilation and extended duration of QRS and QTc were observed by ultrasound echocardiography and Electro-cardiogram. The Q373fs-RBM20 (Q374fs-Rbm20) variant changes gene splicing and affects gene expression of sarcomere structural genes and Ca handling genes and presented cardiac dysfunction, suggesting that Q373fs-RBM20 human patient may cause arrhythmogenic sudden death.
-
94 GSE317489 对肥胖心肌病模型小鼠心脏组织进行 bulk RNA 测序,比较正常饮食加空载体(ND+AAV-CON)、高脂饮食加空载体(HFD+AAV-CON)和高脂饮食加 BCKDK 过表达(HFD+AAV-BCKDK)三组的基因表达差异,每组包含 3 个生物重复。
设计对肥胖心肌病模型小鼠心脏组织进行 bulk RNA 测序,比较正常饮食加空载体(ND+AAV-CON)、高脂饮食加空载体(HFD+AAV-CON)和高脂饮食加 BCKDK 过表达(HFD+AAV-BCKDK)三组的基因表达差异,每组包含 3 个生物重复。
摘要Obesity cardiomyopathy (OCM), characterized by diastolic dysfunction, often progresses to obese heart failure with preserved ejection fraction and remains a major clinical challenge. Accumulating evidence indicates that impaired branched-chain amino acid (BCAA) catabolism is present in OCM, and systemic enhancement of BCAA catabolism through global inhibition of branched-chain ketoacid dehydrogenase kinase (BCKDK), a key negative regulator of BCAA oxidation, alleviates cardiac dysfunction. However, whether cardiac-restricted manipulation of BCAA catabolism is sufficient to confer therapeutic benefits remains unknown. Here, we generated an inducible cardiomyocyte-specific BCKDK knockout mouse model to enhance cardiac BCAA catabolism. Unexpectedly, this model fails to improve and instead exacerbates cardiac dysfunction and ventricular remodelling in OCM. Notably, cardiac BCKDK expression is reduced in both OCM mice and obese patients. Cardiomyocyte-specific BCKDK overexpression robustly improves cardiac function and pathological remodelling in OCM, accompanied by further lowering myocardial BCAA levels. Bulk-RNA sequencing and untargeted metabolomics reveal that the cardiomyocyte-specific BCKDK overexpression restore mitochondrial respiratory function and suppress MAPK-driven inflammatory response. Overall, these findings uncover an unanticipated BCAA-independent role of BCKDK in maintaining cardiomyocyte mitochondrial function and restraining inflammatory signalling, positioning BCKDK as a promising therapeutic target for OCM.
-
95 GSE335971 对转基因小鼠心室组织进行bulk RNA测序,比较野生型对照组(PBS + Oil)、Flnc条件性敲除组(PBS + TAM)及AAV治疗组(AAV + TAM)的转录组差异。每组包含3个生物重复,分别在5周龄接受retro-orbital注射处理,6周龄起通过腹腔注射tamoxifen诱导Flnc敲除,15周龄采集心室组织用于测序。
设计对转基因小鼠心室组织进行bulk RNA测序,比较野生型对照组(PBS + Oil)、Flnc条件性敲除组(PBS + TAM)及AAV治疗组(AAV + TAM)的转录组差异。每组包含3个生物重复,分别在5周龄接受retro-orbital注射处理,6周龄起通过腹腔注射tamoxifen诱导Flnc敲除,15周龄采集心室组织用于测序。
摘要Loss-of-function variants in filamin-C (FLNC) are a major genetic cause of dilated cardiomyopathy (DCM) and arrhythmogenic cardiomyopathy (ACM). These variants are associated with progressive ventricular dysfunction, malignant ventricular arrhythmias, heart failure, and an increased risk of sudden cardiac death. Although current clinical therapies can alleviate symptoms and reduce arrhythmic burden, they do not directly restore FLNC expression or address the underlying molecular defect. To investigate the transcriptional consequences of FLNC deficiency and the molecular effects of FLNC restoration, we performed bulk RNA sequencing on ventricular tissues from control mice, cardiomyocyte-specific inducible Flnc knockout (iCKO) mice, and iCKO mice treated with a 3-intein adeno-associated virus (AAV) system designed to reconstitute full-length FLNC expression. Comparative transcriptomic analyses identified gene expression changes associated with Flnc deficiency and their modulation following AAV-mediated FLNC replacement. This dataset provides a resource for studying the molecular mechanisms underlying FLNC-related cardiomyopathy and evaluating gene replacement strategies for inherited cardiac diseases.
-
96 GSE123916 对2周龄野生型小鼠和表达突变型LMNAD300N蛋白的小鼠心脏组织进行RNA测序,比较两组间基因表达差异。研究通过doxycycline-inducible系统在心脏成纤维细胞中分别表达野生型LMNA和携带致病性p.Asp300Asn变异的突变型LMNAD300N,采集心脏组织样本进行高通量测序,分析突变型LMNAD300N引发的心肌病表型相关转录特征变化。
设计对2周龄野生型小鼠和表达突变型LMNAD300N蛋白的小鼠心脏组织进行RNA测序,比较两组间基因表达差异。研究通过doxycycline-inducible系统在心脏成纤维细胞中分别表达野生型LMNA和携带致病性p.Asp300Asn变异的突变型LMNAD300N,采集心脏组织样本进行高通量测序,分析突变型LMNAD300N引发的心肌病表型相关转录特征变化。
摘要To gain insights into the molecular pathogenesis of DCM caused by LMNA mutation, a doxycycline-inducible (Dox-Off) gene expression system was used to express either a wild type (WT) or a mutant LMNA containing the pathogenic variant p.Asp300Asn (LMNAD300N) in cardiac myocytes. The LMNAD300N is associated with DCM in patients with atypical progeroid/Werner syndrome and non-syndromic cardiac progeria. Expression of the mutant LMNAD300N protein in cardiac myocytes led to severe fibrosis, apoptosis, cardiac dysfunction, and premature death. RNA-seq was performed (prior to onset of cardiac dysfunction) to identify gene signatures and transcriptional regulators responsible for this phenotype. Mechanistic studies identified activation of E2F/TP53/DDR, as a major mechanism responsible for the pathogenesis of DCM caused by the LMNAD300N mutation.
-
97 GSE133052 对野生型和TNNT2ΔK210/ΔK210小鼠的左心室组织进行基因表达分析,分别在出生后0天和1周时取样,每个时间点的每个基因型取2个样本混池,比较两组在不同时间点的基因表达差异。
设计对野生型和TNNT2ΔK210/ΔK210小鼠的左心室组织进行基因表达分析,分别在出生后0天和1周时取样,每个时间点的每个基因型取2个样本混池,比较两组在不同时间点的基因表达差异。
摘要Cardiac phenotypes of homozygous ΔK210 knock-in (TNNT2ΔK210/ΔK210) mice including comprehensive gene expression profiles were investigated to establish an animal model of neonatal DCM and to identify early progression factors of pediatric DCM.
-
99 GSE209657 将db/db小鼠心脏组织分为vehicle组和DIZE组,分别给予对照液或ACE2激活剂(diaminazene aceturate)处理8周,采用超声心动图检测心脏功能,组织学与免疫组化分析心脏结构及纤维化变化,qRT-PCR与Western blotting检测基因及蛋白表达水平,RNA测序探究DIZE对糖尿病心肌病的潜在机制及治疗靶点。
设计将db/db小鼠心脏组织分为vehicle组和DIZE组,分别给予对照液或ACE2激活剂(diaminazene aceturate)处理8周,采用超声心动图检测心脏功能,组织学与免疫组化分析心脏结构及纤维化变化,qRT-PCR与Western blotting检测基因及蛋白表达水平,RNA测序探究DIZE对糖尿病心肌病的潜在机制及治疗靶点。
摘要Angiotensin-converting enzyme 2 (ACE2) is the main key for reducing angiotensin II (Ang II) in renin-angiotensin-aldosterone system (RAAS) inducing diabetic cardiomyopathy (DCM). ACE2 modulates cardioprotective activity not only by reducing deleterious Ang II signaling but also generating the protective peptide Ang-(1-7). Recently, several studies have reported that depletion of ACE2 worsens DCM, whereas ACE2 activation attenuates Ang II-induced cardiac dysfunction. In the present study, we aimed to evaluate the hypothesis that the enhancement of ACE2, using a US Food and Drug Administration (FDA)-approved ACE2 activator (diaminazene aceturate, DIZE), would have cardioprotective roles in a murine DCM. DIZE was administered intraperitoneally to male db/db mice (8 weeks old) for 8 weeks. Transthoracic echocardiography was used to assess cardiac mass and function in mice. Cardiac structure and fibrotic changes were examined using histology and immunohistochemistry. Gene and protein expression levels were examined using qRT-PCR and western blotting, respectively. Additionally, RNA sequencing was performed to investigate the underlying mechanisms of the effects of DIZE and identify novel potential therapeutic targets for DCM. DIZE prevented the diabetes mellitus-mediated structural and functional deterioration of mouse heart. Our findings suggest that the pharmacological activation of ACE2 could be a novel treatment strategy for DCM.
-
100 GSE213707 对3周龄C57BL6小鼠左心室组织进行脂质组学、转录组学及免疫印迹分析,比较Hippo通路激活诱导的实验性扩张型心肌病(DCM)模型与对照组的脂质谱变化。研究包含Mst1-TG(Mst1基因过表达)、WT(野生型)、Gal3-KO(Galectin-3基因敲除)及TG/KO(Mst1过表达联合Gal3敲除)四组基因型,其中DCM组为Mst1-TG及TG/KO,对照组为WT及Gal3-KO。检测覆盖脂质类别(如鞘脂类、甘油三酯、磷脂等)及特定基因表达,分析不同基因型在DCM早期阶段的脂质代谢差异。
设计对3周龄C57BL6小鼠左心室组织进行脂质组学、转录组学及免疫印迹分析,比较Hippo通路激活诱导的实验性扩张型心肌病(DCM)模型与对照组的脂质谱变化。研究包含Mst1-TG(Mst1基因过表达)、WT(野生型)、Gal3-KO(Galectin-3基因敲除)及TG/KO(Mst1过表达联合Gal3敲除)四组基因型,其中DCM组为Mst1-TG及TG/KO,对照组为WT及Gal3-KO。检测覆盖脂质类别(如鞘脂类、甘油三酯、磷脂等)及特定基因表达,分析不同基因型在DCM早期阶段的脂质代谢差异。
摘要Dilated cardiomyopathy (DCM) and heart failure are associated with mitochondrial dysfunction and dysregulated lipid metabolism. Recent studies have implicated a pivotal role of Hippo pathway activation in the development of DCM with profound metabolic remodelling. However, alterations in the cardiac lipid profile and responsible molecular mechanisms, including upregulated galectin-3, remain unclear in the setting of DCM. Mice with DCM induced by Hippo pathway activation (Mst1 gene overexpression alone or with galectin-3 gene deletion) were studied by lipidomic profiling, transcriptomic profiling and immunoblotting for mRNA and protein expression. Profound alterations in cardiac lipid classes were observed, notably elevated sphingolipids, reduced triacylglycerol (TG) and ether lipids, alterations in phospholipid species, elevated lysophosphatidylcholine, and a profound reduction in mitochondria-specific cardiolipin and coenzyme Q10. Relative to adult mice with advanced DCM, reduced TG content was evident but sphingolipid accumulation was absent in young mice at early phase of DCM. Mechanistically, the lipidomic profile in DCM heart was in consistent with dysregulated expression of specific gene sets for biosynthesis of ceramides or TG, TG storage/hydrolysis, mitochondrial lipid metabolism, peroxisome biogenesis, and suppressed PPAR-alpha signaling. Furthermore, galectin-3 gene deletion resulted in changes in some lipid classes and numerous lipid species in settings of healthy and DCM. Multiple alterations in cardiac lipids were identified by lipidomics in a mouse model of DCM due to activation of the Hippo pathway. By employing transcriptome and galectin-3 gene deletion, we revealed underlying mechanisms for lipid abnormalities involving upregulated galectin-3, downregulated expression of specific gene sets of lipid metabolism, and attenuated PPAR-alpha signaling.
-
101 GSE23598 将6-8周龄雄性MT+/+与MT-/-小鼠随机分为DOX处理组和盐水对照组,每组设2个生物重复。处理后第4天处死动物,提取心脏组织total RNA进行微阵列分析,比较基因型间处理组与对照组的基因表达差异。
设计将6-8周龄雄性MT+/+与MT-/-小鼠随机分为DOX处理组和盐水对照组,每组设2个生物重复。处理后第4天处死动物,提取心脏组织total RNA进行微阵列分析,比较基因型间处理组与对照组的基因表达差异。
摘要The present study was designed using MT knockout mice in concert with genomic approaches to explore the possible molecular and cellular mechanisms involved in the protective effects of MT against DOX cardiotoxicity. MT-Ⅰ/Ⅱ null (MT-/-) mice and corresponding wild-type mice (MT+/+) were administrated with a single dose of DOX (15 mg/kg, i.p.) or an equal volume of saline. Animals were sacrificed on the 4th day after DOX administration and samples were collected for further analyses. Global gene expression profiles of cardiac mRNA from two genotype mice revealed that 381 characteristically MT-responsive genes were identified between MT+/+ mice and MT-/- mice in response to DOX, including fos, ucp3, car3, atf3, map3k6, etc.. Functional analysis implied MAPK signaling pathway, p53 signaling pathway, Jak-STAT signaling pathway, PPAR signaling pathway, Wnt signaling pathway, etc. might be involved to mediate the protection of DOX cardiomyopathy by MT. Results from the present study not only validated the previously reported possible mechanisms of MT protection against DOX toxicity, but also provided new clues into the molecular mechanisms involved in this process.
-
102 GSE274500 对24周龄雄性C57BLKS/J品系db/m和db/db小鼠的心脏组织进行RNA-seq分析,比较两组间心脏mRNA谱型差异。
设计对24周龄雄性C57BLKS/J品系db/m和db/db小鼠的心脏组织进行RNA-seq分析,比较两组间心脏mRNA谱型差异。
摘要Diabetic cardiomyopathy (DbCM) is an important clinical syndrome of diabetes and cause great burden to the people's life and health. Understanding its intrinsic epigenetic and metabolic alterations is critical to develop drugs for the treatment of DbCM. Multiple omics technology provides a feasible way for parsing the epigenetic characteristics and metabolic signatures associated with DbCM. The heart isolated from Male db/db mice and db/m mice were used for the analysis of high-throughput sequencing. Non-targeted metabolomics and amino acid-targeted metabolomics analyses were performed to detect the metabolites in plasma and heart tissues. Additionally, RNA-seq, proteomics, and ATAC-seq were employed to elucidate the underlying transcriptional-metabolic regulatory network mechanism in DbCM.
-
103 GSE281873 将BALB/C和TRIM21敲除小鼠心脏组织分别在Day0和Day21进行RNA测序,比较野生型与TRIM21敲除型小鼠在实验性自身免疫性心肌炎(EAM)处理前后的基因表达差异。TRIM21敲除小鼠在Day21接受EAM处理,野生型小鼠同样在Day21接受EAM处理,对照组小鼠在Day0和Day21分别接受CFA/PBS处理,所有样本采用Illumina平台进行高通量测序。
设计将BALB/C和TRIM21敲除小鼠心脏组织分别在Day0和Day21进行RNA测序,比较野生型与TRIM21敲除型小鼠在实验性自身免疫性心肌炎(EAM)处理前后的基因表达差异。TRIM21敲除小鼠在Day21接受EAM处理,野生型小鼠同样在Day21接受EAM处理,对照组小鼠在Day0和Day21分别接受CFA/PBS处理,所有样本采用Illumina平台进行高通量测序。
摘要Myocarditis is a major health concern worldwide, often progressing to dilated cardiomyopathy (DCM) and sudden death, particularly in young individuals. However, the mechanisms driving the transition from acute myocarditis to inflammatory DCM (DCMi) remain unclear. Autoimmune responses, especially those involving interleukin (IL)-17A signaling, have been implicated, though the specific cellular targets and upstream regulators in the cardiac environment are not well understood. Here, we identify TRIM21, an E3 ubiquitin ligase, as a key regulator in this process. Using the experimental autoimmune myocarditis (EAM) model, we show that TRIM21 expression is significantly upregulated in cardiac fibroblasts (CFs) during DCMi and upon IL-17A stimulation. Surprisingly, TRIM21 deficiency attenuated EAM progression, reducing inflammatory neutrophils and Ly6Chigh monocytes/macrophages infiltration. Bone marrow chimeric and IL-17A neutralization experiments confirmed TRIM21's role in CFs, where it promotes IL-17A signaling by facilitating TRAF3 degradation via K27-linked polyubiquitination. These findings identify TRIM21 as a new target in CFs and uncover a regulatory mechanism for IL-17A signaling, suggesting that therapies targeting TRIM21 may need to be adapted to different microenvironments.
-
104 GSE31208 将4周龄和10周龄的雌性frataxin基因型敲除(KO)小鼠与野生型(WT)小鼠的心脏组织分别提取总RNA,采用Affymetrix Mouse Genome 430 2.0 Array进行基因芯片分析,比较KO与WT小鼠在不同年龄阶段的心脏基因表达差异。
设计将4周龄和10周龄的雌性frataxin基因型敲除(KO)小鼠与野生型(WT)小鼠的心脏组织分别提取总RNA,采用Affymetrix Mouse Genome 430 2.0 Array进行基因芯片分析,比较KO与WT小鼠在不同年龄阶段的心脏基因表达差异。
摘要Frataxin deficiency in human is the cause of Friedreich's ataxia (FA), a lethal neuro- and cardio-degenerative disease. Knock-out (KO) mice of this mouse model of FA exhibit classical cardiomyopathy of the patients. The onset of FA phenotypes in the KO mice is approximately 6-7 weeks of age. This genearray analysis was conducted to examine the changes in gene expression in the heart of KO mice relative to their wild-type (WT) littermates at 4- and 10-weeks of age. At 10-weeks of age, the KO mice begin to die from severe cardiomyopathy.
-
105 GSE31251 将6周龄C57BL/6 WT与MCH3-KO小鼠(各4只雄性)心脏组织进行RNA提取,采用Affymetrix Mouse Gene 1.0ST微阵列分析基因表达,比较两组间差异。
设计将6周龄C57BL/6 WT与MCH3-KO小鼠(各4只雄性)心脏组织进行RNA提取,采用Affymetrix Mouse Gene 1.0ST微阵列分析基因表达,比较两组间差异。
摘要Gene expression changes in the heart of MCH3-KO mouse (HDAC3 f/f, Muscle Creatine Kinase-Cre) versus control WT mouse (HDAC3 f/f). Histone deacetylases (HDACs) play important roles in cardiac development and function. We show here that mice deficient of HDAC3 in heart and skeletabl muscle are relatively normal on normal chow, but develop hypertrophic cardiomyopathy and heart failure that leads to death on high-fat diet. This microarray experiment is to explore the underlying molecular mechanism.
-
106 GSE71912 将 WT 和 Mib1flox; TnT-Cre 小鼠的心室组织分别按每组 16 只混池,分成四个重复,进行 RNA 测序,比较两组基因表达差异。
设计将 WT 和 Mib1flox; TnT-Cre 小鼠的心室组织分别按每组 16 只混池,分成四个重复,进行 RNA 测序,比较两组基因表达差异。
摘要Left ventricular noncompaction (LVNC) Causes prominent ventricular trabeculations and reduces cardiac systolic function. The clinical presentation of LVNC ranges from asymptomatic to heart failure. We show that germline mutations in human MIB1 (mindbomb homolog 1), which encodes an E3 ubiquitin ligase that promotes endocytosis of the NOTCH ligands DELTA and JAGGED, cause LVNC in autosomal-dominant pedigrees, with affected individuals showing reduced NOTCH1 activity and reduced expression of target genes. Functional studies in cells and zebrafish embryos and in silico modeling indicate that MIB1 functions as a dimer, which is disrupted by the human mutations. Targeted inactivation of Mib1 in mouse myocardium causes LVNC, a phenotype mimicked by inactivation of myocardial Jagged1 or endocardial Notch1. Myocardial Mib1 mutants show reduced ventricular Notch1 activity, expansion of compact myocardium to proliferative, immature trabeculae and abnormal expression of cardiac development and disease genes. These results implicate NOTCH signaling in LVNC and indicate that MIB1 mutations arrest chamber myocardium development, preventing trabecular maturation and compaction.
-
107 GSE112319 将C57BL6J小鼠左心室组织分为LacZ对照组与Ttn-KO基因型组,通过胰岛素注射器在出生后第10天向胸腔注射Control shRNA或Ttn shRNA病毒,3周后采集样本进行RNA-Seq测序,比较两组间基因表达差异及心脏功能相关指标变化。
设计将C57BL6J小鼠左心室组织分为LacZ对照组与Ttn-KO基因型组,通过胰岛素注射器在出生后第10天向胸腔注射Control shRNA或Ttn shRNA病毒,3周后采集样本进行RNA-Seq测序,比较两组间基因表达差异及心脏功能相关指标变化。
摘要Dilated cardiomyopathy (DCM), defined by left ventricular (LV) enlargement associated with impaired cardiac performance, is a major cause of heart failure (HF). This results in a dilated, thin-walled left ventricle that fails to supply sufficient blood to the body. Truncating variants in TTN (TTNtv), coding for the largest structural protein in the sarcomere, contribute to the largest portion of familial and ambulatory DCM. The mechanisms for how TTNtv lead to cardiac dilation are unclear. Here, we show that reduction of Ttn expression by shRNA (Ttn shRNA) generated DCM in both mouse and rat. Ttn shRNA transduced mice developed typical DCM manifestations including impaired cardiac performance, enlarged LV and reduced LV wall thickness. Gene profiling indicates cardiac metabolism, cell proliferation and survival related genes are significantly dysregulated in Ttn shRNA-induced DCM. TUNEL assay showed Ttn shRNA induced a significant increase of cardiac cell apoptosis. A screen of 15 dysregulated downstream genes identified candidates, including Esrra, Esrrb and Yy1 significantly suppressed Ttn shRNA-induced cardiac dilation and/or DCM. Ttn shRNA induced cardiac cell apoptosis was ameliorated by Yy1. Importantly, by inducing D-type cyclin, Yy1 initiated cardiomyocyte cell cycle reentry facilitating the restoration of cardiac performance. Our findings demonstrate that DCM caused by Ttn insufficiency can be treated by therapeutically enhancing cardiac cell proliferation and survival.
-
108 GSE138280 对10周龄的alphaMHC-MCM-Fktn-cKO(Fktnflox/flox;alphaMHC-MCM+/-)和Control小鼠心脏进行tamoxifen处理4天,提取总RNA并采用微阵列分析,比较两组基因表达差异。
设计对10周龄的alphaMHC-MCM-Fktn-cKO(Fktnflox/flox;alphaMHC-MCM+/-)和Control小鼠心脏进行tamoxifen处理4天,提取总RNA并采用微阵列分析,比较两组基因表达差异。
摘要Heart failure is the major cause of death for muscular dystrophy patients; however, the molecular pathomechanism remains unknown. Here, we show the detailed molecular pathogenesis of muscular dystrophy-associated cardiomyopathy in mice lacking the fukutin gene (Fktn), the causative gene for Fukuyama muscular dystrophy. Although cardiac Fktn elimination markedly reduced alpha-dystroglycan glycosylation and dystrophin-glycoprotein complex proteins in sarcolemma at all developmental stages, cardiac dysfunction was observed only in later adulthood, suggesting that membrane fragility is not the sole etiology of cardiac dysfunction. During young adulthood, Fktn-deficient mice were vulnerable to pathological hypertrophic stress with downregulation of Akt and the MEF2-histone deacetylase axis. Acute Fktn elimination caused severe cardiac dysfunction and accelerated mortality with myocyte contractile dysfunction and disordered Golgi-microtubule networks, which were ameliorated with colchicine treatment. These data reveal fukutin is crucial for maintaining myocyte physiology to prevent heart failure, and thus, the results may lead to strategies for therapeutic intervention.
-
109 GSE154504 对野生型与同源型 titin A178D 突变小鼠左心室样本进行 RNA 测序,比较两组基因表达差异。
设计对野生型与同源型 titin A178D 突变小鼠左心室样本进行 RNA 测序,比较两组基因表达差异。
摘要Truncating variants in titin can cause dilated cardiomyopathy, however, the role of missense titin variants is less clear. In humans the heterozygous titin A178D variant is associated with dilated cardiomyopathy with left ventricular non-compaction. Using CRISPR-Cas9 mediated homology-directed repair the A178D titin variant was introduced into a mouse model. Homozygous A178D mice showed features of dilated cardiomyopathy. Total RNA was extracted from the left ventricles of WT and homozygous A178D littermate control mice and RNA-sequencing performed. Different patterns of gene expression were identified in wildtype and homozygous A178D left ventricles.
-
110 GSE148351 将雄性小鼠心脏组织按是否持续服用doxycycline分为两组:一组饮用含doxycycline的水(ON组),另一组停用doxycycline三天(3D组),每组3只生物重复。采用高通量测序技术检测心脏组织的转录组变化,比较ON组与3D组的基因表达差异。
设计将雄性小鼠心脏组织按是否持续服用doxycycline分为两组:一组饮用含doxycycline的水(ON组),另一组停用doxycycline三天(3D组),每组3只生物重复。采用高通量测序技术检测心脏组织的转录组变化,比较ON组与3D组的基因表达差异。
摘要Ischemic heart disease is a leading cause of heart failure and hypoxia inducible factor 1 (HIF1) has been shown to be a key transcription factor in the early response to hypoxic injury. We previously developed an inducble model of cardiomyopathy using cardiomyocyte-specific expression of a mutated, oxygen-stable form of HIF-1⍺ (HIF-PPN). In this study, we used high throughput sequencing to explore HIF1-mediated transcriptional changes in the heart.
-
111 GSE182949 将1天龄野生型(WT)与Rbpms基因敲除(KO)小鼠的心室组织进行RNA测序,比较两组间基因表达差异。研究通过stranded mRNA-seq分析Rbpms缺失对心肌细胞分裂及双核化的影响,样本包含3个WT生物重复和3个KO生物重复,按总单位数与组数估计分组。
设计将1天龄野生型(WT)与Rbpms基因敲除(KO)小鼠的心室组织进行RNA测序,比较两组间基因表达差异。研究通过stranded mRNA-seq分析Rbpms缺失对心肌细胞分裂及双核化的影响,样本包含3个WT生物重复和3个KO生物重复,按总单位数与组数估计分组。
摘要Noncompaction cardiomyopathy is a common congenital cardiomyopathy associated with a deficiency of ventricular cardiomyocytes and impaired pump function. The genetic basis and underlying mechanisms of this disorder remain elusive. Polyploidization is an intrinsic feature of mammalian cardiomyocytes, which occurs shortly after birth and is accompanied by cardiomyocyte cell cycle arrest. We show that genetic deletion of the RNA binding protein with multiple splicing (Rbpms) in mice results in premature onset of cardiomyocyte polyploidization (binucleation) and consequent noncompaction cardiomyopathy. A similar blockade to cytokinesis occurs in human iPSC-derived cardiomyocytes with RBPMS gene deletion. Paired-end RNA sequencing analysis revealed that Rbpms plays an essential role in RNA splicing and mediates isoform switching from the short to the long form of Pdlim5, a heart-specific LIM domain protein that connects the sarcomere with various signaling proteins during heart development. The loss of Rbpms leads to abnormal accumulation of short Pdlim5 isoforms that disrupt cardiomyocyte cytokinesis. Our results link premature cardiomyocyte binucleation to noncompaction cardiomyopathy and highlight the central role of Rbpms in this process.
-
112 GSE211106 对db/db小鼠与db/m小鼠左心室组织进行RNA测序,比较两者的基因表达差异。db/db小鼠接受16周高脂饮食处理,db/m小鼠接受16周实验室饲料处理,所有样本均来自新生雄性小鼠。
设计对db/db小鼠与db/m小鼠左心室组织进行RNA测序,比较两者的基因表达差异。db/db小鼠接受16周高脂饮食处理,db/m小鼠接受16周实验室饲料处理,所有样本均来自新生雄性小鼠。
摘要To explore the unique pathogenesis of DCM and analyzed the differences in gene expression, associated pathways and immune cell infiltration among different organs that are targeted by high glucose by bioinformatics-based strategy. In order to find the specific factors that trigger DCM, we contrasted the gene profile of DCM to that of other diabetic diseases including diabetic peripheral neuropathy (DPN) and nephropathy (DN). we performed RNA-seq and miRNA sequencing on heart tissue from db/db mice to explore the transcriptome alterations in DCM pathogenesis including lncRNA, miRNA and mRNA.
-
113 GSE224211 将六只雄性C57BL/6N小鼠随机分为对照组与DCM组,每组三只。对照组接受生理盐水腹腔注射,DCM组接受多柔比星腹腔注射以建立扩张型心肌病模型。注射后收集左心室组织进行RNA-Seq测序,获取150bp配对末端读数,比较两组间基因表达差异。
设计将六只雄性C57BL/6N小鼠随机分为对照组与DCM组,每组三只。对照组接受生理盐水腹腔注射,DCM组接受多柔比星腹腔注射以建立扩张型心肌病模型。注射后收集左心室组织进行RNA-Seq测序,获取150bp配对末端读数,比较两组间基因表达差异。
摘要Dilated cardiomyopathy (DCM) is characterized by left ventricular or biventricular enlargement with systolic dysfunction. To date, the underlying molecular mechanisms of dilated cardiomyopathy pathogenesis have not been fully elucidated, although some insights have been presented. In this study, we combined public database resources and a doxorubicin-induced DCM mouse model to explore the significant genes of DCM in full depth. We first retrieved six DCM-related microarray datasets from the GEO database using several keywords. Then we used the "LIMMA" (linear model for microarray data) R package to filter each microarray for differentially expressed genes (DEGs). Robust rank aggregation (RRA), an extremely robust rank aggregation method based on sequential statistics, was then used to integrate the results of the six microarray datasets to filter out the reliable differential genes. To further improve the reliability of our results, we established a doxorubicin-induced DCM model in C57BL/6N mice, using the "DESeq2" software package to identify DEGs in the sequencing data. We cross-validated the results of RRA analysis with those of animal experiments by taking intersections and identified three key differential genes (including Bex1, RGCC and VSIG4) associated with DCM as well as many important biological processes (extracellular matrix organization, extracellular structural organization, sulphur compound binding, and extracellular matrix structural components) and a signalling pathway (HIF-1 signalling pathway).
-
114 GSE276884 对9个月龄的Fiona/dko和Het/Fiona小鼠心脏组织进行bulk RNA测序,按性别分组,比较两组间的基因表达差异。样本量为6,按总单位数与组数估计。
设计对9个月龄的Fiona/dko和Het/Fiona小鼠心脏组织进行bulk RNA测序,按性别分组,比较两组间的基因表达差异。样本量为6,按总单位数与组数估计。
摘要Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder characterized by progressive muscle degeneration and cardiomyopathy leading to heart failure. While the inflammatory environment in dystrophic skeletal muscle has been well-studied, little is known about inflammation in the progression of DMD cardiomyopathy due to the lack of adequate animal models. To address this, we developed the Fiona/dko mouse model, which exhibits severe, isolated dystrophic cardiomyopathy. In this study, we used Fiona/dko mice to characterize the immune cell composition in dystrophic heart and investigated the contribution of T-cells to the onset and progression of cardiac pathology. Flow cytometry analysis revealed that T-cells constitute a significant proportion of the immune cell population in Fiona/dko hearts, in contrast to the predominantly myeloid signature observed in dystrophic skeletal muscle. Furthermore, we demonstrated that T-cell infiltration precedes the development of cardiac fibrosis and dysfunction in Fiona/dko mice and that depletion of circulating CD3+ T-cells ameliorates early pathology, suggesting a role for T-cells in the initiation and persistence of dystrophic cardiomyopathy. These findings highlight the distinct inflammatory environment in the dystrophic heart and provide new insights into the pathogenesis of DMD cardiomyopathy, paving the way for the development of targeted anti-inflammatory therapies.
-
115 GSE281344 将野生型小鼠与心肌细胞特异性 RBM20 过表达(RBM20cKI)小鼠的左心室组织进行 RNA 测序,比较两组间 RBM20 表达差异及其对 Atp6v0a1 剪接的影响,通过 LysoTracker 和 RFP-GFP-LC3 报告系统评估自噬流状态,分析 RBM20 对心肌细胞自噬过程的调控作用。
设计将野生型小鼠与心肌细胞特异性 RBM20 过表达(RBM20cKI)小鼠的左心室组织进行 RNA 测序,比较两组间 RBM20 表达差异及其对 Atp6v0a1 剪接的影响,通过 LysoTracker 和 RFP-GFP-LC3 报告系统评估自噬流状态,分析 RBM20 对心肌细胞自噬过程的调控作用。
摘要Dilated cardiomyopathy (DCM) is a common cause of heart failure and mutations in RNA-binding motif protein 20 (RBM20) are linked to hereditary DCM. However, the role of unmutated RBM20 in idiopathic DCM is still ambiguous. In this study, we found that RBM20 expression was upregulated by the transcription factor c-JUN in idiopathic DCM. Mice with cardiomyocyte-specific RBM20 overexpression (RBM20cKI) resulted in heart failure with ventricle dilation and lysosome accumulation. Using LysoTracker and a tandem fluorescence RFP-GFP-LC3 reporter system, we elucidated RBM20 blocks autophagic flux in DCM by alkalinizing lysosomal pH. RNA sequencing revealed RBM20 overexpression leads to vacuolar H+-ATPase proton translocation domain subunit a1 (Atp6v0a1) exon6 and exon7 exclusion, which was validated by sanger sequencing and serial amplification product electrophoresis. Transgenic expression of full-length Atp6v0a1 isotype attenuated cardiac dysfunction and restored lysosomal acidification in RBM20cKI mice. Our data suggest that RBM20 activity precisely regulates various cellular process in cardiomyocytes and any therapy targeting RBM20 requires extra cautious.
-
116 GSE295799 对携带Tnni3R193H突变的小鼠进行腺相关病毒(AAV)递送的ABE8e碱基编辑处理,采集心脏组织进行RNA测序,比较编辑处理组与未处理对照组的基因表达差异。
设计对携带Tnni3R193H突变的小鼠进行腺相关病毒(AAV)递送的ABE8e碱基编辑处理,采集心脏组织进行RNA测序,比较编辑处理组与未处理对照组的基因表达差异。
摘要Restrictive cardiomyopathy (RCM) is a severe cardiac disorder characterized by impaired ventricular filling and diastolic dysfunction, with mutations in sarcomeric proteins representing major causative factors. Mutations of TNNI3 gene (e.g. p.R192H) constitute major genetic causes of RCM, particularly affecting pediatric patients and being associated with poor prognosis. Here, we demonstrate that adenine base editor (ABE) is able effectively correct RCM-causing mutation and alleviate RCM in a murine model. We first developed a novel murine model harboring the Tnni3R193H mutation that recapitulates the hallmark features of human RCM. Importantly, targeted delivery of ABE via adeno-associated virus (AAV) achieved efficient and precise correction of the Tnni3R193H mutation in adult RCM mice, leading to significant improvement of cardiac functions. Our findings establish base editing as a therapeutic strategy for RCM and highlight its broader potential for treating genetic cardiomyopathies in clinical settings.
-
117 GSE310316 将 Mdx/Utrn dKO 雄性小鼠(2-3 月龄)分为 Setanaxib 治疗组和玉米油对照组,每日口服给药 12 周后处死并采集心脏组织进行转录组分析,比较两组间基因表达差异。
设计将 Mdx/Utrn dKO 雄性小鼠(2-3 月龄)分为 Setanaxib 治疗组和玉米油对照组,每日口服给药 12 周后处死并采集心脏组织进行转录组分析,比较两组间基因表达差异。
摘要Duchenne Muscular Dystrophy (DMD) is caused by mutations in dystrophin, leading to degeneration and weakness of the skeletal and cardiac muscles. Despite numerous efforts in developing therapies for this devastating disease, DMD remains a fatal disease. Our recent study showed that loss of the cardiac Isl1-interacting protein (CIP), which interacts with dystrophin in sarcolemma of cardiomyocytes, accelerates the progression of dystrophic cardiomyopathy. We identified Nox4 as one of the downstream mediators of this process. Here, we report that Setanaxib, a Nox1/4 inhibitor, protected the heart of CIP/Mdx double knockout (dKO) mice from heart failure and reduced cardiac fibrosis. Similarly, Setanaxib treatment exhibited lower cardiac fibrosis and protection against heart failure in Mdx/Utrn dKO mouse, another murine model for dystrophic cardiomyopathy. Additionally, treatment with Nox4 inhibitor reduced the expression of cardiomyopathy genes in dystrophic mice. Interestingly, transcriptomic analysis of the hearts from Mdx/Utrn dKO mice treated with Nox4 inhibitor reveals an enrichment of genes associated with fatty acid metabolism, oxidative phosphorylation, and protein binding, while genes related to inflammation and epithelial-mesenchymal transition were downregulated. Consistent with these results, we found increased expression of Pgc1a and Tcap in the hearts of Mdx/Utrn dKO mice treated with Nox 4 inhibitor, and reduced expression of Mcp1. Collectively, these findings suggest that Nox4 plays a key role in development of myocardial fibrosis and heart failure caused by dystrophin deficiency, and suggest that Nox4 inhibition could be a potential novel therapy to alleviate cardiomyopathy in DMD patients.
-
118 GSE327065 对糖尿病心肌病小鼠模型及条件性敲除糖尿病心肌病(CKO-DCM)小鼠模型进行转录组分析,两组各包含3只小鼠。研究通过高脂肪饮食联合链脲佐菌素诱导糖尿病,采集小鼠心肌组织进行RNA测序,检测总RNA的转录组变化,包括差异基因表达、可变剪接和通路富集分析,比较糖尿病心肌病与条件性敲除糖尿病心肌病小鼠的心肌转录特征。
设计对糖尿病心肌病小鼠模型及条件性敲除糖尿病心肌病(CKO-DCM)小鼠模型进行转录组分析,两组各包含3只小鼠。研究通过高脂肪饮食联合链脲佐菌素诱导糖尿病,采集小鼠心肌组织进行RNA测序,检测总RNA的转录组变化,包括差异基因表达、可变剪接和通路富集分析,比较糖尿病心肌病与条件性敲除糖尿病心肌病小鼠的心肌转录特征。
摘要Background Heart failure burden is still considerable in diabetes patients despite optimal glycemic control. Metabolic remodeling is involved in this process, but current understanding is still in its infancy. Methylmalonic acid (MMA) is a diagnostic marker of cobalamin (Cbl) deficiency in clinical practice. Paradoxically, MMA elevation-related cardiovascular mortality is more pronounced in diabetic patients with higher Cbl levels. We investigated the mechanisms underlying these contradictory features in diabetic heart and translational relevance. Methods We assessed serum Cbl, MMA, and cardiac biomarkers in 12,751 participants, and the Mmut protein (allosteric enzyme of MMA catabolism) in failing human hearts with diabetes and healthy donors. Cardiomyocyte-specific Mmut knockout and Mmut-overexpressing (delivered by AAV-Mmut with cTnT promoter) mice were subjected to high-fat diet/streptozotocin-induced diabetes. High glucose and/or palmitate stimulation of primary neonatal mouse ventricular cardiomyocytes (NMVMs) imitates diabetic conditions in vitro. Molecular mechanism was explored through RNA sequencing, immunoprecipitation, isotope tracing mass spectrometry and biolayer interferometry assays. Results Higher serum MMA was significantly associated with subclinical heart damage and poor outcomes among adults with diabetes in the absence of Cbl deficiency. Cardiac MMA overload and decreased protein expression of Mmut were observed in humans and mice with diabetes. Notably, MMA dysmetabolism in diabetic mice occurred before detectable cardiac damage and persisted even after glycemic control. Mechanistically, hyperglycemic memory-related molecule miR-499 binds to the mRNA of Mmut and inhibits its expression, leading to MMA overload under diabetes. Mmut knockout amplified cardiac MMA overload and exacerbated disturbances in glycolipid metabolism and mitochondrial quality control in diabetic hearts. Conversely, AAV-Mmut injection significantly reduces MMA load and alleviates the progression of cardiac remodeling in diabetic mice. Isotope tracing identified isoleucine and valine as the main sources of cardiac MMA under diabetes. A restricted-branched chain amino acid diet alleviated diabetes-induced MMA accumulation and heart damage. However, Cbl supplementation did not correct MMA overload in diabetic mice, even at high doses or in activated forms. Strikingly, both clinical and preclinical data showed metformin, a risk factor for Cbl deficiency, may mitigate MMA overload and related heart damage via dual mechanisms—activating AMPK-dependent mitochondrial quality control, enhancing tolerance to MMA insults; and direct Mmut-cobalamin cooperation, promoting MMA clearance independent of AMPK. Conclusions: This study provides a foundation for understanding diabetes-related MMA dysmetabolism as a trigger for subclinical heart damage resistant to glycemic control and Cbl supplementation. Our findings challenge the prevailing clinical consensus regarding the impacts of Cbl and metformin use on MMA elevation.
-
119 GSE333536 对12-16周龄WT雌性FVB小鼠心脏组织进行RNA-seq分析,分为vehicle组和3mg/kg Trametinib组,每日一次处理14天,比较两组转录组差异。
设计对12-16周龄WT雌性FVB小鼠心脏组织进行RNA-seq分析,分为vehicle组和3mg/kg Trametinib组,每日一次处理14天,比较两组转录组差异。
摘要Trametinib (Trm) is a highly selective MEK inhibitor that potently and persistently abrogates ERK1/2 activation. Trm initially was used to treat BRAF V600E-mutated melanoma but its FDA-approved indications are expanding rapidly. Trm generally is well tolerated but it can cause dose-limiting cardiomyopathy and heart failure. Here we characterize a mouse model of Trm cardiotoxicity using complementary in vitro approaches to show that Trm induces mitochondrial dysfunction in cardiomyocytes and some cancer cell types. In vivo, Trm caused contractile dysfunction within 3 days and heart failure within 2 weeks. High resolution respirometry using isolated cardiac mitochondria revealed that Trm compromises oxidative metabolism, in part through blunted activity of Electron Transport System Complexes. Trm-mediated mitochondrial injury led to the release of mitochondrial Damage-Associated Molecular Patterns including mitochondrial DNA in both mice and humans, triggering activation of canonical innate immune pathways including cGAS-STING. In multiple rodent and human cardiomyocyte platforms, Trm diminished mitochondrial respiratory capacity at nanomolar concentrations but this lesion was reversed by expression of a phosphomimetic STAT3-S727 construct. We also found that Trm induced mitochondrial dysfunction in some but not all cancer cell lines, identifying a previously unrecognized effect that could contribute to Trm’s anti-cancer efficacy.
-
120 GSE36502 对6周龄野生型(WT)和LmnaN195K突变型小鼠心脏组织进行cDNA微阵列分析,同时采用透射电镜观察心肌细胞结构并结合定量Western blot检测Cavβ和Cav3亚基表达水平,比较两组间离子通道相关蛋白的表达差异。WT组包含3个生物重复样本,N195K组包含3个生物重复样本,所有样本均来自C57Bl/6品系雄性小鼠。
设计对6周龄野生型(WT)和LmnaN195K突变型小鼠心脏组织进行cDNA微阵列分析,同时采用透射电镜观察心肌细胞结构并结合定量Western blot检测Cavβ和Cav3亚基表达水平,比较两组间离子通道相关蛋白的表达差异。WT组包含3个生物重复样本,N195K组包含3个生物重复样本,所有样本均来自C57Bl/6品系雄性小鼠。
摘要Lamin A/C proteins, encoded by the LMNA gene, are intermediate filament proteins of the nuclear lamina, and predominantly expressed in differentiated cells including cardiomyocytes. Mutations in LMNA are associated with laminopathies, congenital diseases affecting muscle and homeostasis. One of the laminopathies associated with a missense mutation (N195K) in the A-type lamins results in dilated cardiomyopathy (DCM) with arrhythmias and sudden death. However it is unknown how the mutation in this LMNA gene contributes to the mechanism of arrhythmia and sudden death. To investigate this a mouse line expressing the Lmna-N195K (LmnaN195K/N195K) was used. Mutant mice demonstrated reduced fractional shortening, LV mass, wall thickness and dilated cardiomyopathy by echocardiography at 6 weeks consistent with human DCM, and died at an early age (6-7 weeks). Comparative cDNA microarray analysis from LmnaN195K/N195K and the wild type (WT) control ventricles at 6 weeks age revealed significant alterations in the expression of ion channels, transporter proteins, caveolins and associated proteins such as MAP kinases. Transmission electron microscopy analysis showed structural alterations of the ventricular myocytes with increase in number of caveolae. Quantitative Western blot analysis confirmed reduced expression for Cavβ (2 fold) subunits of the L-type Ca2+ channel. In contrast the expression levels of Cav3 (2.5 fold) was significantly increased. To investigate the functional impact of Lmna N195K on the ICa,L, we transiently expressed either the WT LMNA+GFP, Lmna N195K+GFP or GFP (control) in isolated neonatal mouse ventricular myocytes and performed whole cell patch clamp analysis. Transient expression of Lmna N195K significantly reduced (58 %) peak ICa,L (-6.0 ± 2 pA/pF, n=9) compared to GFP control (-14 ± 2 pA/pF, n=8). Expression of WT LMNA did not affect the ICa,L (-14.2 ± 2.5 pA/pF, n=8) compared to control. Conclusion: We conclude that Lmna N195K mutation results in reduced expression of ion channels and scaffolding proteins in the left ventricle with a significant reduction in peak ICa,L in ventricular myocytes and these may contribute to the mechanism of arrhythmia and dilated cardiomyopathy.
-
121 GSE54372 将Nelf-b f/f野生型小鼠与Nelf-b f/f; CreER转基因小鼠按每组3只进行分组,于8周龄时注射Tamoxifen,20周龄时采集心脏组织进行总RNA提取,采用基因表达分析方法检测RNA,比较两组基因型小鼠心脏组织的转录组差异。
设计将Nelf-b f/f野生型小鼠与Nelf-b f/f; CreER转基因小鼠按每组3只进行分组,于8周龄时注射Tamoxifen,20周龄时采集心脏组织进行总RNA提取,采用基因表达分析方法检测RNA,比较两组基因型小鼠心脏组织的转录组差异。
摘要Negative elongation factor (NELF) is known to enforce promoter-proximal pausing of RNA polymerase II (Pol II), a pervasive phenomenon observed across multicellular genomes. However, the physiological impact of NELF on tissue homeostasis remains unclear. Here we show for the first time that whole-body conditional deletion of the B subunit of NELF (NELF-B) in adult mice results in cardiomyopathy and impaired response to cardiac stress. Tissue-specific knockout of NELF-B confirms its cell-autonomous function in cardiomyocytes. NELF directly supports transcription of those genes encoding rate-limiting enzymes in fatty acid oxidation and the tricarboxylic acid (TCA) cycle. NELF also shares extensively transcriptional target genes with peroxisome proliferator-activated receptors alpha (PPARalpha), a master regulator of energy metabolism in myocardium. Mechanistically, NELF helps stablize the transcription initation complex at the metabolism-related genes. Our findings strongly indicate that NELF is part of the PPARalpha-mediated transcription regulatory network that maintains metabolic homeostasis in cardiomyocytes.
-
122 GSE56286 对3个月龄Des-/-和TNFαDes-/-基因型小鼠的心脏组织进行基因表达分析,采用全基因组微阵列杂交技术,比较两种基因型的转录组差异。
设计对3个月龄Des-/-和TNFαDes-/-基因型小鼠的心脏组织进行基因表达分析,采用全基因组微阵列杂交技术,比较两种基因型的转录组差异。
摘要Tumor Necrosis Factor-α is greatly implicated in heart pathophysiology, while it is upregulated in the failing myocardium. A major target in TNF-α-induced heart failure is the muscle specific intermediate filament cytoskeleton, comprised by desmin. We analysed the effect of cardiac-specific overexpression of TNF-α in the Des-/- myocardium, which is a known model of dilated cardiomyopathy.
-
123 GSE63759 将 Myh6-MerCreMer; CAG-S-COUP-TFII 基因型小鼠与 Myh6-MerCreMer 对照组在 2.5 月龄时通过连续 3 天 40mg/kg/day 治疗性 tamoxifen 诱导 COUP-TFII 过表达,于首次 tamoxifen 剂量后 16 天采集心脏心室组织进行 microarray 分析,比较过表达组与对照组心室组织的分子特征差异。
设计将 Myh6-MerCreMer; CAG-S-COUP-TFII 基因型小鼠与 Myh6-MerCreMer 对照组在 2.5 月龄时通过连续 3 天 40mg/kg/day 治疗性 tamoxifen 诱导 COUP-TFII 过表达,于首次 tamoxifen 剂量后 16 天采集心脏心室组织进行 microarray 分析,比较过表达组与对照组心室组织的分子特征差异。
摘要Increased COUP-TFII levels are found in human dilated cardiomyopathy as well as in mouse models that develop cardiomyopathy. COUP-TFII overexpression in adult mouse hearts caused ventricular dilation and compromised cardiac functions. To gain insights on COUP-TFII’s effect in hearts, we identified the molecular profile of COUP-TFII overexpressing hearts through microarray analysis. The result may shred light on molecular mechanisms that mediate development of dilated cardiomyopathy.
-
124 GSE82188 对8-10周龄雄性C57BL/6野生型小鼠与心脏特异性过表达calreticulin转基因小鼠的心脏组织进行基因表达分析,每组取3只生物重复样本,采用MM9基因表达芯片检测,比较转基因组与野生型对照组的基因表达差异。
设计对8-10周龄雄性C57BL/6野生型小鼠与心脏特异性过表达calreticulin转基因小鼠的心脏组织进行基因表达分析,每组取3只生物重复样本,采用MM9基因表达芯片检测,比较转基因组与野生型对照组的基因表达差异。
摘要Investigation of global genome gene expression changes in cardiac-spcifically overexpressed calreticulin mice in 8-10 weeks-old male mice, compared to age and gender matched control mice The characteristics of the transgenic mice analyzed in this study are further discribed in Calreticulin Induces Dilated Cardiomyopathy, PLOS ONE 2013; 8(2): e56387
-
125 GSE193873 对心脏特异性 Prdm16 敲除小鼠与野生型小鼠胚胎心脏组织进行 RNA 测序,比较两种基因型下心脏组织的转录特征。
设计对心脏特异性 Prdm16 敲除小鼠与野生型小鼠胚胎心脏组织进行 RNA 测序,比较两种基因型下心脏组织的转录特征。
摘要Loss of the PR domain 16 (PRDM16) genetic locus has been suggested as the needed trigger for the development of left ventricular non-compaction cardiomyopathy (LVNC) and dilated cardiomyopathy (DCM) in patients with 1p36 deletion syndrome. Furthermore, lack of Prdm16 in the murine heart has recently been shown to cause a spectrum of cardiomyopathy phenotypes. In spite of these advances, our understanding of the downstream transcriptional pathways regulated by PRDM16 that lead to these cardiac phenotypes is limited. OBJECTIVE: to unveil the downstream transcriptional pathways involved in the development of cardiomyopathy phenotypes associated with PRDM16 mutations/deletion in human and mice. METHODS AND RESULTS: We hypothesized that PRDM16 acts as an upstream regulator of key transcriptional pathways involved in cardiac maturation. Induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) from a patient with a PRDM16 variant, cardiac tissue from mice expressing the human variant, mice with cardiac-specific deletion of Prdm16 and in vitro gain and loss of Prdm16 function were employed. Here we show that de novo pathogenic variants in PRDM16 are sufficient to cause LVNC in humans. In contrast, haploinsufficiency or complete deletion of Prdm16 in cardiomyocytes in mice led to pathological hypertrophy and dilated cardiomyopathy respectively. We demonstrated that PRDM16 regulates cardiac maturation through the maintenance of estrogen-related receptors (ERRs) expression. By contrast, PRDM16 acts as a supressor of transforming growth factor beta (TGFB) signaling. CONCLUSIONS: PRDM16 is a novel regulator of cardiac maturation acting upstream of ERRs and their regulators, and a suppressor of fibrotic signaling including TGFB.
-
126 GSE111418 对野生型和dICR/dICR基因型的6月龄雄性小鼠心脏组织进行RNA-Seq分析,比较两种基因型在心脏组织中的基因表达差异。
设计对野生型和dICR/dICR基因型的6月龄雄性小鼠心脏组织进行RNA-Seq分析,比较两种基因型在心脏组织中的基因表达差异。
摘要Igf2 and H19 are linked, reciprocally imprinted genes that play critical roles in mammalian development. Igf2 encodes a peptide hormone, Insulin-like Growth Factor 2, that binds to the InsR and Igf1R receptor kinases to regulate cell growth and metabolism through well-established pathways. H19 encodes a 2.3 kb lncRNA whose biochemical actions are only now being identified. Here we use a mouse model to investigate cardiomyopathies associated with maternal loss of imprinting at the locus. Increased circulating levels of IGF2 during fetal development result in activation of pAKT/mTOR signaling in cardiomyocytes to cause cellular hypertrophy and hyperplasia in neonatal hearts. This neonatal hypertrophy is unaffected by H19 RNA levels. However, loss of H19 does cause fibrosis and progressive cardiac pathology in adult mice. In hearts, H19 expression is concentrated in endothelial cells associated with blood vessels and capillaries and loss of H19 results in high incidence of trans differentiation of these cells to smooth muscle. H19 encoded miRNAs 675-3p and -5p are not sufficient to promote normal development. Thus these experiments define a novel role for the H19 lncRNA in regulating cell fate.
猪单细胞
Pig · Single-cell
-
01 GSE308244 对携带 MYH7-R403Q 突变的 Yucatan minipig 与野生型同窝仔,按年龄分组采集左心室游离壁组织,进行单核 RNA 测序与体积测量,比较基因型间的心肌细胞肥大及细胞外重塑差异。
设计对携带 MYH7-R403Q 突变的 Yucatan minipig 与野生型同窝仔,按年龄分组采集左心室游离壁组织,进行单核 RNA 测序与体积测量,比较基因型间的心肌细胞肥大及细胞外重塑差异。
摘要Hypertrophic cardiomyopathy (HCM), a genetic heart disease defined by unexplained cardiac wall thickening, is a leading cause of sudden death worldwide. However, the three-dimensional organization of cardiac tissue underlying left ventricular hypertrophy remains poorly understood. We developed CaMVIA-3D, a deep-learning volumetric imaging and analysis pipeline to characterize cardiac microarchitecture. Analysis of tissues from HCM hearts revealed genotype-specific differences in cardiomyocyte volume, morphology, and extracellular volume, with pathogenic variants exhibiting greater concentric cellular hypertrophy and disarray, and variant-negative cases showing predominant fibrosis. Longitudinal profiling of a pig HCM model revealed early-onset fibrosis preceding cardiomyocyte hypertrophy. Integrating transcriptomic and morphologic changes, we identified genes associated with cellular and extracellular remodeling. These findings define genotype-specific microstructural differences in HCM, offering insights to improve diagnostics and targeted therapies.
猫bulk 转录组
Cat · Bulk RNA-seq
-
01 GSE275971 对年轻健康雄性猫、成年健康雄性猫、年轻健康雌性猫、成年健康雌性猫以及患有肥厚型心肌病(HCM)的雌性和雄性猫的心肌样本进行转录组和小RNA测序,比较不同年龄、性别和HCM状态下的基因表达和小RNA特征。
设计对年轻健康雄性猫、成年健康雄性猫、年轻健康雌性猫、成年健康雌性猫以及患有肥厚型心肌病(HCM)的雌性和雄性猫的心肌样本进行转录组和小RNA测序,比较不同年龄、性别和HCM状态下的基因表达和小RNA特征。
摘要Next generation sequencing for the feline transcriptome (mRNA and microRNA profiles) was carried out using myocardial samples from female and male young healthy cats, adult healthy cats, and cats with hypertrophic cardiomyopathy.
犬bulk 转录组
Dog · Bulk RNA-seq
-
01 GSE5247 We have used chronic cardiac pacing in conscious dogs to study mechanism related to the development of dilated cardiomyopathy and the transition from compensated dysfunction (CD) to decompensated heart failure (HF). This occurs from the 3rd to 4th week of pacing with end-stage HF at 30?1 days. Keywords: disease state analysis
摘要We have used chronic cardiac pacing in conscious dogs to study mechanism related to the development of dilated cardiomyopathy and the transition from compensated dysfunction (CD) to decompensated heart failure (HF). This occurs from the 3rd to 4th week of pacing with end-stage HF at 30?1 days. Keywords: disease state analysis
大鼠bulk 转录组
Rat · Bulk RNA-seq
-
01 GSE201717 对10周龄健康与心力衰竭的Sprague-Dawley大鼠心脏进行RNA测序,样本包括上窦房结、下窦房结、左心房、右心房及左心室。通过升主动脉缩窄术诱导心力衰竭,比较健康与患病组间各区域基因表达差异。
设计对10周龄健康与心力衰竭的Sprague-Dawley大鼠心脏进行RNA测序,样本包括上窦房结、下窦房结、左心房、右心房及左心室。通过升主动脉缩窄术诱导心力衰竭,比较健康与患病组间各区域基因表达差异。
摘要Objectives: This study aimed to determine the transcriptional basis of functional silencing of one of the two dominant pacemakers in failing rat hearts. Background: Recently, our laboratory presented functional and molecular evidence for the presence of two competing sinoatrial node (SAN) pacemakers in the healthy human and rat hearts. Anatomically localized near the superior vena cava and inferior vena cava, the superior and inferior SANs (sSAN and iSAN), respectively, preferentially control fast and slow normal heart rates. However, only one dominant pacemaker, primarily sSAN, was functional in the failing rat heart with hypertrophic cardiomyopathy. Methods: Ascending aortic constriction was performed on 1-week-old male Sprague-Dawley rat pups to induce left ventricular hypertrophy and heart failure. The dominant pacemaker was anatomically mapped in adult (8-12 weeks old) healthy and failing rat hearts using optical mapping in isolated right atrial tissue preparations. RNA sequencing was used to identify regional sSAN/iSAN gene expression differences between healthy and failing rat hearts. Results: In all failing rat hearts optically mapped in this study (n=4), only the sSAN pacemaker was functional, while the iSAN was silent. Compared to healthy rat hearts, a total of 3,640 genes were downregulated and 4,518 genes were upregulated in failing rat hearts. The functional quiescence of the iSAN in these failing rat hearts may be explained by their downregulation of sodium, potassium, and calcium ion channels as well as their downregulation of certain structural genes, including ankyrin, titin, and myosin heavy chain. Moreover, the iSAN showed predominant downregulation of several key transcription factors such as TBX5, TBX3, SHOX2, and SMAD9. Conclusions: Pressure-overload-induced heart failure resulted in significant downregulation of critical transcription factors, ion channels, and structural transcripts of the iSAN, which could explain the functional silencing of the iSAN in failing rat hearts.
-
02 GSE4745 将150g雄性Wistar大鼠按糖尿病模型(STZ注射)与对照组(柠檬酸缓冲液)分组,分别在注射后3天、28天和42天采集心室组织进行基因表达分析,比较糖尿病与对照组在不同时间点的心室基因表达差异。
设计将150g雄性Wistar大鼠按糖尿病模型(STZ注射)与对照组(柠檬酸缓冲液)分组,分别在注射后3天、28天和42天采集心室组织进行基因表达分析,比较糖尿病与对照组在不同时间点的心室基因表达差异。
摘要Cardiomyopathy in type 1 diabetic patients is characterized by early onset diastolic and late onset systolic dysfunction. The mechanism underlying development of diastolic and systolic dysfunction in diabetes remains unknown. We used microarrays to detail the ventricle gene expression changes that underly development of diabetic cardiomyopathy. We identified distinct classes of up-regulated genes during this process. Keywords: disease state analysis, time course
-
03 GSE2876 Impact of the obesity on RNA total levels of male SHHF left ventricular aged from 4 and 10 months old. Keywords: Comparative cDNA hybridization
-
04 GSE352263 对老龄野生型和疾病模型小鼠分别给予高剂量 DHA 或不予处理,采集海马组织进行 RNA 测序,比较两种基因型下处理组与相应对照的基因表达。
设计对老龄野生型和疾病模型小鼠分别给予高剂量 DHA 或不予处理,采集海马组织进行 RNA 测序,比较两种基因型下处理组与相应对照的基因表达。
摘要This study characterizes time-dependent myocardial gene expression in a rat model of norepinephrine-induced Takotsubo-like cardiomyopathy. Bulk RNA sequencing was performed on left ventricular myocardium from adult female Sprague-Dawley rats at untreated baseline and at 3, 12, and 24 h after norepinephrine administration. The dataset includes 16 independent biological samples, with four rats in each group. Poly(A)-enriched mRNA libraries were sequenced using paired-end reads on a SURFSeq Q sequencer. The data support investigation of transcriptional changes associated with oxidative stress, inflammation, and cell-death-related pathways.
-
05 GSE266124 Septic cardiomyopathy (SCM) is the predominant cause of death in sepsis patients with undefined mechanism to date. Our study analyzed RNA sequencing (RNA-seq) data from rat heart tissue to discover key targets and potential pharmacological actions of the calcitonin gene-related peptide (CGRP) against SCM. A lipopolysaccharide-induced SCM model was established in rats (LPS 10 mg/kg, intraperitoneal (i.p.)). Thereafter, the myocardial tissues from the three groups of rats (Ctrl group, LPS group, and CGRP group) (n=5) were extracted and underwent RNA-seq, followed by bioinformatics analyses. Our findings suggest a basis for finding potential targets for CGRP in the treatment of SCM.
摘要Septic cardiomyopathy (SCM) is the predominant cause of death in sepsis patients with undefined mechanism to date. Our study analyzed RNA sequencing (RNA-seq) data from rat heart tissue to discover key targets and potential pharmacological actions of the calcitonin gene-related peptide (CGRP) against SCM. A lipopolysaccharide-induced SCM model was established in rats (LPS 10 mg/kg, intraperitoneal (i.p.)). Thereafter, the myocardial tissues from the three groups of rats (Ctrl group, LPS group, and CGRP group) (n=5) were extracted and underwent RNA-seq, followed by bioinformatics analyses. Our findings suggest a basis for finding potential targets for CGRP in the treatment of SCM.
-
06 GSE197999 Diabetic cardiomyopathy (DCM) is one of the major causes of heart failure in diabetic patients, but its pathogenesis remains unclear. Long non-coding RNAs (lncRNAs) are involved in the development of various cardiovascular diseases, but is little known in DCM. We build diabetic cardiomyopathy (DCM) rat model and investigated the genome-wide expression profiling of cardiac lncRNAs and mRNAs in rat model with and without DCM by RNA sequencing, to uncovers potential path mechanisms target of DCM.
摘要Diabetic cardiomyopathy (DCM) is one of the major causes of heart failure in diabetic patients, but its pathogenesis remains unclear. Long non-coding RNAs (lncRNAs) are involved in the development of various cardiovascular diseases, but is little known in DCM. We build diabetic cardiomyopathy (DCM) rat model and investigated the genome-wide expression profiling of cardiac lncRNAs and mRNAs in rat model with and without DCM by RNA sequencing, to uncovers potential path mechanisms target of DCM.
-
07 GSE15449 In order to examine the mechanism of TPO on cardiac protection against DOX damage, we have employed whole genome microarray expression profiling as a discovery platform to identify genes with the potential to delineate the TPO cardioprotective mechanism against DOX-induced cardiomyopathy
摘要In order to examine the mechanism of TPO on cardiac protection against DOX damage, we have employed whole genome microarray expression profiling as a discovery platform to identify genes with the potential to delineate the TPO cardioprotective mechanism against DOX-induced cardiomyopathy
-
08 GSE267352 对糖尿病性心肌病(DCM)模型大鼠与正常大鼠的心脏组织进行转录组和代谢组联合分析,比较两组间基因表达与代谢物水平的差异。DCM组通过单次STZ剂量诱导,正常组未接受处理,所有样本均采用Trizol提取总RNA,检测方式包括RNA测序和代谢组学分析。
设计对糖尿病性心肌病(DCM)模型大鼠与正常大鼠的心脏组织进行转录组和代谢组联合分析,比较两组间基因表达与代谢物水平的差异。DCM组通过单次STZ剂量诱导,正常组未接受处理,所有样本均采用Trizol提取总RNA,检测方式包括RNA测序和代谢组学分析。
摘要Diabetic cardiomyopathy (DCM) is a unique form of cardiomyopathy observed in diabetic patients, and in this study we aimed to gain a comprehensive understanding of the underlying mechanisms of DCM by integrating transcriptomics and metabolomics
斑马鱼bulk 转录组
Zebrafish · Bulk RNA-seq
-
01 GSE208408 To determine transcriptional changes caused by the overexpression of wild-type and mutant TMEM43 and to gain insights into the mechanisms responsible for the phenotype of arrhythmogenic cardiomyopathy We performed RNA-sequencing in adult zebrafish hearts
-
02 GSE333349 对野生型、转基因野生型对照及PRKAG2 R299Q变异型斑马鱼的心室组织进行RNA测序,每组设4个生物重复,比较各组间转录组差异。
设计对野生型、转基因野生型对照及PRKAG2 R299Q变异型斑马鱼的心室组织进行RNA测序,每组设4个生物重复,比较各组间转录组差异。
摘要Introduction: Variants in PRKAG2 cause hypertrophic cardiomyopathy (HCM) and conduction disturbances. While prior studies associated PRKAG2-related hypertrophy with increased glycogen storage, many HCM phenotypes remain unexplained. We aimed to uncover how PRKAG2 variants induce myocyte hypertrophy and electrical changes during early cardiac development. Methods: We generated transgenic zebrafish expressing wild-type (TgWT) or pathogenic variant (TgR299Q) Prkag2 cDNA under a myocardium-specific promoter, and examined cardiac electrophysiology, contractile function, and cytoarchitecture during cardiogenesis and in adult hearts. Results: TgR299Q fish showed hypertrophic cardiomyocytes and progressive contractile abnormalities, recapitulating human HCM phenotypes. Cardiomyocyte glycogen was elevated in adult but not embryonic hearts. Despite the absence of glycogen accumulation at 6-day post-fertilization, TgR299Q hearts showed electrical abnormalities, including reduced conduction velocity and prolonged action potential and Ca2+ transient durations. We observed decreased AMPK phosphorylation in the TgR299Q hearts. However, AMPK activation did not rescue the electrophysiological abnormalities in TgR299Q. Proximity ligation assays and co-immunoprecipitation identified a physical interaction between AMPKγ2 and myosin, enhanced by the R299Q variant and accompanied by increased AMPKγ2 localization to the myofilament. Na+/Ca2+ exchanger (NCX) inhibition increased Ca2+ duration and diastolic Ca2+ in TgWT but not TgR299Q hearts, indicating reduced free cytosolic Ca2+ for NCX-mediated extrusion in TgR299Q. These findings suggest that enhanced AMPKγ2-myosin interaction may promote myofilament Ca2+ retention, thereby prolonging Ca2+ transient duration and APD in the mutant. Notably, the myosin inhibitor mavacamten reduced AMPKγ2-myosin interaction in TgR299Q hearts, and both mavacamten and vmhcl knockdown rescued the early electrophysiological abnormalities. Conclusions: The PRKAG2 variant altered cardiac excitability, contractility, and Ca2+ handling during cardiogenesis, independent of glycogen accumulation. Enhanced interactions between AMPKγ2 and myosin contributed to these early changes. Our study revealed a novel link between cellular energy sensing and contractile machinery, with therapeutic potential for modulating contractile function in cardiomyopathies.

课题合作 · 扫码加微信
bioinformaticsboy